<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Hematology - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / qBank / Pharmacology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">35</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x2f2fe6=_0x3c9d;(function(_0x43f3df,_0x5f362b){const _0x5a471c=_0x3c9d,_0x572ecb=_0x43f3df();while(!![]){try{const _0x35acf0=parseInt(_0x5a471c(0x1e9))/0x1+-parseInt(_0x5a471c(0x389))/0x2+-parseInt(_0x5a471c(0x212))/0x3*(parseInt(_0x5a471c(0x398))/0x4)+parseInt(_0x5a471c(0x308))/0x5+parseInt(_0x5a471c(0x472))/0x6*(parseInt(_0x5a471c(0x392))/0x7)+parseInt(_0x5a471c(0x451))/0x8*(parseInt(_0x5a471c(0x402))/0x9)+-parseInt(_0x5a471c(0x1a0))/0xa*(-parseInt(_0x5a471c(0x230))/0xb);if(_0x35acf0===_0x5f362b)break;else _0x572ecb['push'](_0x572ecb['shift']());}catch(_0x288389){_0x572ecb['push'](_0x572ecb['shift']());}}}(_0x3d4e,0xcf766));const _0x472bf5=(function(){const _0x357191=_0x3c9d,_0x282a2d={'efMtw':function(_0x552b60){return _0x552b60();},'OEgIS':_0x357191(0x227),'ylhiA':_0x357191(0x39e)};let _0x17e1f2=!![];return function(_0x55d601,_0x3372b8){const _0x319d25=_0x357191;if(_0x282a2d['OEgIS']===_0x282a2d[_0x319d25(0x20f)])_0x2e4da2['preventDefault'](),_0x282a2d[_0x319d25(0x2f8)](_0x14d02d);else{const _0x3ba492=_0x17e1f2?function(){const _0x4998e3=_0x319d25;if(_0x3372b8){const _0x16a931=_0x3372b8[_0x4998e3(0x327)](_0x55d601,arguments);return _0x3372b8=null,_0x16a931;}}:function(){};return _0x17e1f2=![],_0x3ba492;}};}()),_0x5a0614=_0x472bf5(this,function(){const _0x2ae34d=_0x3c9d,_0x2d8d16={'rSYkC':_0x2ae34d(0x3ee)};return _0x5a0614[_0x2ae34d(0x314)]()['search'](_0x2d8d16[_0x2ae34d(0x254)])['toString']()[_0x2ae34d(0x2bd)](_0x5a0614)[_0x2ae34d(0x186)](_0x2d8d16[_0x2ae34d(0x254)]);});_0x5a0614();const _0x22fb91=(function(){const _0x54d17d={'QObBz':'tYyGy','VEgCZ':'nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20'};let _0x5719be=!![];return function(_0x4ed24d,_0xce93d2){const _0x22a921=_0x3c9d,_0x309fb3={'MdbDq':function(_0x1e0e0b,_0x2e8858){return _0x1e0e0b!==_0x2e8858;},'qvprr':_0x22a921(0x315),'emFPK':_0x54d17d['VEgCZ']},_0x13cc00=_0x5719be?function(){const _0x233741=_0x22a921;if(_0x233741(0x2b0)!==_0x54d17d[_0x233741(0x1ac)]){if(_0xce93d2){const _0x10e219=_0xce93d2[_0x233741(0x327)](_0x4ed24d,arguments);return _0xce93d2=null,_0x10e219;}}else{if(_0x309fb3['MdbDq'](_0x39011e['selectedAnswer'],null))_0x1ca857=_0x309fb3[_0x233741(0x30d)];else _0x580268=_0x309fb3[_0x233741(0x42c)];}}:function(){};return _0x5719be=![],_0x13cc00;};}()),_0x3a9f8c=_0x22fb91(this,function(){const _0x4a2fc7=_0x3c9d,_0x4c7f4f={'aRjsu':_0x4a2fc7(0x29b),'tDpFD':function(_0x61aaf9,_0x11b3c3){return _0x61aaf9!==_0x11b3c3;},'jiRTU':'mtonj','siieP':function(_0x50a290,_0x18d98f){return _0x50a290+_0x18d98f;},'CqtOW':function(_0x21e1f6,_0x4de6f5){return _0x21e1f6+_0x4de6f5;},'QEXys':'return\x20(function()\x20','mQyHy':_0x4a2fc7(0x2e7),'zgtdq':function(_0x57d810){return _0x57d810();},'MaKzB':_0x4a2fc7(0x38b),'oiTUg':_0x4a2fc7(0x2f6),'XJBrM':'info','TDdmb':_0x4a2fc7(0x1c2),'Zaefc':_0x4a2fc7(0x2d9),'ILmxJ':_0x4a2fc7(0x2c1),'rlfiF':'trace','eoaWu':function(_0x670f98,_0x3b2c9c){return _0x670f98<_0x3b2c9c;},'wcXVS':'ncJVH','hccfw':_0x4a2fc7(0x37d)},_0x95401c=function(){const _0x97d7d=_0x4a2fc7;if(_0x4c7f4f['tDpFD'](_0x97d7d(0x3cf),_0x4c7f4f[_0x97d7d(0x41e)])){if(_0xe63f2f['isSupported']()){const _0x9dc4b5=new _0x4ca6a3();_0x9dc4b5[_0x97d7d(0x471)](_0x34fa70),_0x9dc4b5[_0x97d7d(0x258)](_0x3db62d);}else _0x17e8f3[_0x97d7d(0x43a)](_0x4c7f4f['aRjsu'])&&(_0x5c20e4[_0x97d7d(0x33c)]=_0x158bd9);}else{let _0x2758b3;try{_0x2758b3=Function(_0x4c7f4f[_0x97d7d(0x411)](_0x4c7f4f[_0x97d7d(0x463)](_0x4c7f4f[_0x97d7d(0x2b3)],_0x4c7f4f['mQyHy']),');'))();}catch(_0xbc25d4){_0x2758b3=window;}return _0x2758b3;}},_0x160d44=_0x4c7f4f[_0x4a2fc7(0x1e7)](_0x95401c),_0x1d50f5=_0x160d44[_0x4a2fc7(0x1b9)]=_0x160d44[_0x4a2fc7(0x1b9)]||{},_0x31d6a0=[_0x4c7f4f[_0x4a2fc7(0x364)],_0x4c7f4f[_0x4a2fc7(0x2d4)],_0x4c7f4f[_0x4a2fc7(0x388)],_0x4c7f4f[_0x4a2fc7(0x220)],_0x4c7f4f[_0x4a2fc7(0x2ff)],_0x4c7f4f[_0x4a2fc7(0x394)],_0x4c7f4f[_0x4a2fc7(0x194)]];for(let _0x3a14a0=0x0;_0x4c7f4f[_0x4a2fc7(0x3f6)](_0x3a14a0,_0x31d6a0[_0x4a2fc7(0x2a8)]);_0x3a14a0++){if(_0x4c7f4f[_0x4a2fc7(0x2b6)]===_0x4c7f4f[_0x4a2fc7(0x312)]){const _0x25bbf0=_0x129e94[_0x4a2fc7(0x468)](_0x499213['getItem'](_0x4a2fc7(0x470)))||{},_0x175f3c=_0x25bbf0[_0x3bcc38];if(_0x175f3c){const _0x3d405f='3|2|0|5|1|4'['split']('|');let _0x49d11e=0x0;while(!![]){switch(_0x3d405f[_0x49d11e++]){case'0':_0x354414=_0x175f3c[_0x4a2fc7(0x429)];continue;case'1':_0xdb7db3['log'](_0x4a2fc7(0x1d3));continue;case'2':_0x491de6=_0x175f3c[_0x4a2fc7(0x37e)];continue;case'3':_0x253f1e=_0x175f3c[_0x4a2fc7(0x387)];continue;case'4':return!![];case'5':_0x944147=_0x175f3c[_0x4a2fc7(0x3bd)];continue;}break;}}return![];}else{const _0x12974f=_0x22fb91[_0x4a2fc7(0x2bd)][_0x4a2fc7(0x306)][_0x4a2fc7(0x353)](_0x22fb91),_0x5056c0=_0x31d6a0[_0x3a14a0],_0x4c88a0=_0x1d50f5[_0x5056c0]||_0x12974f;_0x12974f['__proto__']=_0x22fb91[_0x4a2fc7(0x353)](_0x22fb91),_0x12974f[_0x4a2fc7(0x314)]=_0x4c88a0['toString'][_0x4a2fc7(0x353)](_0x4c88a0),_0x1d50f5[_0x5056c0]=_0x12974f;}}});_0x3a9f8c();let questionsData=[{'id':0x1f90,'choices':[{'id':0x7e20,'text':_0x2f2fe6(0x2ee)},{'id':0x7e21,'text':_0x2f2fe6(0x1d5)},{'id':0x7e22,'text':_0x2f2fe6(0x2e2)},{'id':0x7e23,'text':_0x2f2fe6(0x2d0)}],'text':_0x2f2fe6(0x2d3),'unique_key':_0x2f2fe6(0x3d8),'question_audio':null,'question_video':null,'map_id':0x8da8,'difficulty_level':'intermediate','subjects_id':[0x4],'solution':_0x2f2fe6(0x200),'correct_choice_id':0x7e21,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x2c2),_0x2f2fe6(0x380)]},{'id':0x1fd3,'choices':[{'id':0x7f2c,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Prostacyclin</span></span></span></p>'},{'id':0x7f2d,'text':_0x2f2fe6(0x1da)},{'id':0x7f2e,'text':_0x2f2fe6(0x379)},{'id':0x7f2f,'text':_0x2f2fe6(0x2cb)}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Platelet\x20aggregation\x20is\x20blocked\x20by\x20aspirin\x20due\x20to\x20its\x20action\x20on:\x20</span></span></span></p>','unique_key':'Q6662670','question_audio':null,'question_video':null,'map_id':0x8dba,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20C.\x20Thromboxane\x20A2</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Aspirin</strong>\x20works\x20by<strong>\x20irreversibly\x20inhibiting\x20the\x20enzyme\x20cyclooxygenase-1\x20(COX-1)\x20in\x20platelets,\x20</strong>which\x20is\x20crucial\x20for\x20the\x20<strong>synthesis\x20of</strong>\x20<strong>thromboxane\x20A2</strong>,\x20a\x20substance\x20that\x20<strong>stimulates\x20platelets\x20to\x20aggregate</strong>\x20and\x20<strong>arteries\x20to\x20constrict.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Incorrect</strong>.<strong>\x20Prostacyclin\x20(PGI2)\x20</strong>is\x20an\x20<strong>anti-aggregatory\x20prostaglandin</strong>\x20produced\x20by\x20<strong>endothelial\x20cells</strong>,\x20and\x20<strong>aspirin\x20</strong>actually\x20helps\x20to<strong>\x20prevent\x20thrombosis</strong>\x20partly\x20by<strong>\x20not</strong>\x20significantly\x20affecting<strong>\x20prostacyclin\x20production.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Incorrect.\x20PGF\x202&alpha;\x20(Prostaglandin\x20F2\x20alpha)</strong>\x20is<strong>\x20not</strong>\x20a\x20major\x20target\x20of<strong>\x20aspirin</strong>\x20in\x20the\x20context\x20of\x20<strong>antiplatelet\x20therapy.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Option\x20D:\x20Incorrect.</strong>\x20<strong>Phospholipase\x20C</strong>\x20is\x20<strong>not</strong>\x20inhibited\x20by<strong>\x20aspirin</strong>;\x20aspirin\x20<strong>targets\x20COX\x20enzymes.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Aspirin</strong>\x20<strong>blocks\x20platelet\x20aggregation</strong>\x20by<strong>\x20inhibiting\x20the\x20production\x20of\x20thromboxane\x20A2</strong>\x20through<strong>\x20irreversible\x20acetylation\x20of\x20the\x20COX-1</strong>\x20<strong>enzyme\x20in\x20platelets</strong>,\x20affecting\x20their\x20<strong>function</strong>\x20for\x20the\x20remainder\x20of\x20<strong>their\x20lifespan.</strong></span></span><strong>\x20</strong></span></span></span></p>','correct_choice_id':0x7f2e,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x17c)]},{'id':0x1ff8,'choices':[{'id':0x7fc0,'text':_0x2f2fe6(0x36c)},{'id':0x7fc1,'text':_0x2f2fe6(0x34a)},{'id':0x7fc2,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Dabigatran</span></span></span></p>'},{'id':0x7fc3,'text':_0x2f2fe6(0x39d)}],'text':_0x2f2fe6(0x28e),'unique_key':_0x2f2fe6(0x17d),'question_audio':null,'question_video':null,'map_id':0x8dc0,'difficulty_level':_0x2f2fe6(0x1ec),'subjects_id':[0x4],'solution':_0x2f2fe6(0x313),'correct_choice_id':0x7fc1,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x1ab)]},{'id':0x1fe6,'choices':[{'id':0x7f78,'text':_0x2f2fe6(0x181)},{'id':0x7f79,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Protamine</span></span></span></p>'},{'id':0x7f7a,'text':_0x2f2fe6(0x25a)},{'id':0x7f7b,'text':_0x2f2fe6(0x32e)}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20is\x20an\x20antifibrinolytic\x20agent?</span></span></span></p>','unique_key':_0x2f2fe6(0x21c),'question_audio':null,'question_video':null,'map_id':0x8dbd,'difficulty_level':_0x2f2fe6(0x3a0),'subjects_id':[0x4],'solution':_0x2f2fe6(0x349),'correct_choice_id':0x7f7b,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2f2fe6(0x1ab)]},{'id':0x1fc1,'choices':[{'id':0x7ee4,'text':_0x2f2fe6(0x1fb)},{'id':0x7ee5,'text':_0x2f2fe6(0x35b)},{'id':0x7ee6,'text':_0x2f2fe6(0x221)},{'id':0x7ee7,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Iron\x20dextran</span></span></span></p>'}],'text':_0x2f2fe6(0x251),'unique_key':_0x2f2fe6(0x1a4),'question_audio':null,'question_video':null,'map_id':0x8db1,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':_0x2f2fe6(0x207),'correct_choice_id':0x7ee5,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x2c2),_0x2f2fe6(0x380)]},{'id':0x200f,'choices':[{'id':0x801c,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ticlopidine</span></span></span></p>'},{'id':0x801d,'text':_0x2f2fe6(0x2fb)},{'id':0x801e,'text':_0x2f2fe6(0x1df)},{'id':0x801f,'text':_0x2f2fe6(0x299)}],'text':_0x2f2fe6(0x419),'unique_key':_0x2f2fe6(0x2ca),'question_audio':null,'question_video':null,'map_id':0x8da7,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20B.\x20Tirofiban</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Tirofiban</strong>\x20is<strong>\x20not</strong>\x20an\x20<strong>ADP\x20inhibitor.</strong>\x20It\x20is\x20a\x20<strong>glycoprotein\x20IIb/IIIa\x20inhibitor</strong>,\x20which<strong>\x20prevents\x20fibrinogen</strong>\x20from\x20<strong>binding\x20to\x20platelets,</strong>\x20thereby\x20<strong>inhibiting\x20platelet\x20aggregation.\x20Tirofiban\x20acts</strong>\x20on\x20a<strong>\x20different\x20pathway\x20</strong>in\x20the\x20<strong>platelet\x20aggregation\x20process\x20</strong>compared\x20to\x20<strong>ADP</strong>\x20<strong>inhibitors.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.\x20Ticlopidine:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Ticlopidine\x20is\x20an\x20<strong>ADP\x20receptor\x20inhibitor</strong>\x20that\x20<strong>inhibits\x20platelet\x20aggregation</strong>\x20by<strong>\x20blocking\x20the\x20P2Y12\x20ADP\x20recepto</strong>r\x20on\x20the<strong>\x20platelet\x20surface,</strong>\x20making\x20it\x20<strong>less\x20responsive\x20to\x20stimuli\x20</strong>that\x20cause\x20<strong>aggregation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Clopidogrel:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Clopidogrel\x20</strong>is\x20also\x20an\x20<strong>ADP\x20receptor\x20inhibitor</strong>,\x20similar\x20to\x20ticlopidine,\x20that\x20works\x20by\x20<strong>irreversibly\x20inhibiting</strong>\x20the\x20<strong>P2Y12\x20subtype\x20of\x20the\x20ADP\x20receptor</strong>\x20on\x20platelets,\x20thus\x20<strong>reducing\x20platelet\x20aggregation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Prasugrel:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Prasugrel\x20is\x20a\x20third\x20example\x20of\x20an\x20<strong>ADP\x20receptor\x20inhibitor.</strong>\x20It\x20is\x20a<strong>\x20prodrug\x20</strong>that,\x20<strong>once\x20metabolized,</strong>\x20<strong>inhibits\x20</strong>the\x20<strong>P2Y12\x20ADP\x20receptor\x20on\x20platelets</strong>,\x20leading\x20to\x20<strong>decreased\x20platelet\x20aggregation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20<strong>identify\x20the\x20classification\x20of\x20antiplatelet\x20drugs,</strong>\x20specifically\x20distinguishing<strong>\x20ADP\x20receptor\x20inhibitors</strong>\x20<strong>(ticlopidine,\x20clopidogrel,\x20and\x20prasugrel)</strong>\x20from\x20<strong>other\x20classes\x20</strong>such\x20as\x20<strong>glycoprotein\x20IIb/IIIa\x20inhibitors\x20(tirofiban).\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Antiplatelet\x20Drugs</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture7.jpg\x22\x20style=\x22height:500px;\x20width:1000px\x22\x20/></p>','correct_choice_id':0x801d,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x1ab)]},{'id':0x202c,'choices':[{'id':0x808f,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Warfarin</span></span></span></p>'},{'id':0x8090,'text':_0x2f2fe6(0x181)},{'id':0x8091,'text':_0x2f2fe6(0x2a9)},{'id':0x8092,'text':_0x2f2fe6(0x28f)}],'text':_0x2f2fe6(0x3d5),'unique_key':'Q6336489','question_audio':null,'question_video':null,'map_id':0x8dac,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20A.\x20Warfarin</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p>&nbsp;</p>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p>&nbsp;</p>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20figure\x20shows\x20the\x20clinical\x20picture\x20of\x20<strong>dermal\x20vascular\x20necrosis</strong>,\x20also\x20known\x20as<strong>\x20&lsquo;purple\x20toe\x20syndrome.&rsquo;</strong>\x20It\x20is\x20an<strong>\x20early\x20adverse\x20effect</strong>\x20of<strong>\x20warfarin\x20therapy</strong>.\x20This\x20condition\x20is\x20seen\x20in\x20patients\x20with\x20<strong>genetic\x20protein\x20C\x20deficiency.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p>&nbsp;</p>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Dermal\x20Vascular\x20Necrosis:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Warfarin-induced\x20dermal\x20vascular\x20necrosis\x20</strong>is\x20a<strong>\x20rare\x20</strong>complication\x20of\x20<strong>warfarin\x20therapy</strong>.\x20It\x20is\x20characterized\x20by\x20the\x20development\x20of\x20<strong>painful\x20skin\x20lesions</strong>\x20in\x20patients\x20taking<strong>\x20warfarin.\x20I</strong>t\x20is\x20thought\x20to\x20be\x20<strong>caused\x20by\x20a\x20transient\x20hypercoagulable\x20state</strong>\x20resulting\x20from\x20a<strong>\x20rapid\x20reduction\x20in\x20protein\x20C\x20levels\x20</strong>in\x20patients\x20with<strong>\x20underlying\x20protein\x20C\x20deficiency\x20</strong>or\x20other\x20risk\x20factors.\x20The\x20lesions\x20typically<strong>\x20occur\x20</strong>in\x20areas\x20with\x20a<strong>\x20high\x20concentration\x20of\x20adipose\x20tissue,\x20</strong>such\x20as\x20the<strong>\x20breasts,\x20thighs,\x20and\x20buttocks</strong>.\x20The\x20initial\x20symptoms\x20include\x20<strong>red\x20or\x20purple\x20spots\x20on\x20the\x20skin</strong><strong>\x20</strong>that\x20can<strong>\x20quickly\x20progress\x20to\x20painful,\x20necrotic\x20lesions\x20</strong>with\x20a\x20<strong>central\x20blister\x20</strong>or\x20<strong>eschar.</strong>\x20The<strong>\x20diagnosis\x20</strong>is\x20usually\x20made\x20<strong>clinically</strong>\x20based\x20on\x20the\x20<strong>characteristic\x20appearance\x20of\x20the\x20lesions\x20</strong>and\x20the\x20<strong>patient&#39;s\x20history\x20of</strong>\x20<strong>warfarin\x20therapy.</strong>\x20The\x20treatment\x20of\x20<strong>dermal\x20vascular\x20necrosis</strong>\x20involves<strong>\x20stopping\x20warfarin\x20</strong>and\x20<strong>initiating\x20alternative\x20anticoagulant</strong>\x20therapy,\x20such\x20as\x20<strong>heparin\x20or\x20low\x20molecular\x20weight\x20heparin.</strong>\x20In\x20<strong>severe\x20cases,\x20surgical\x20intervention</strong>\x20may\x20be\x20necessary\x20to<strong>\x20remove</strong>\x20the\x20<strong>necrotic\x20tissue\x20and\x20prevent\x20further\x20damage.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p>&nbsp;</p>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p>&nbsp;</p>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Dabigatran:\x20</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Dabigatran\x20is\x20a\x20<strong>direct\x20thrombin\x20inhibitor</strong>\x20and\x20is\x20<strong>not\x20associated\x20with\x20dermal\x20vascular\x20necrosis</strong>.\x20It<strong>\x20does\x20not</strong>\x20<strong>affect\x20protein\x20C\x20levels</strong>\x20or\x20lead\x20to\x20<strong>hypercoagulable\x20states</strong>\x20like<strong>\x20warfarin.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p>&nbsp;</p>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Rivaroxaban:\x20</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Rivaroxaban\x20is\x20a<strong>\x20factor\x20Xa\x20inhibitor</strong>\x20and\x20is<strong>\x20not\x20</strong>associated\x20with\x20<strong>dermal\x20vascular\x20necrosis</strong>.\x20Like\x20dabigatran,\x20it\x20<strong>does\x20not\x20</strong>affect<strong>\x20protein\x20C\x20levels</strong>\x20or<strong>\x20lead\x20to\x20hypercoagulable\x20states</strong>\x20like<strong>\x20warfarin.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p>&nbsp;</p>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Heparin:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Heparin</strong>\x20is\x20a\x20different\x20class\x20of<strong>\x20anticoagulant\x20</strong>and\x20is\x20<strong>not</strong>\x20associated\x20with\x20<strong>dermal\x20vascular\x20necrosis</strong>.\x20It\x20works\x20by\x20<strong>enhancing\x20the\x20activity\x20of\x20antithrombin\x20III\x20</strong>and<strong>\x20inhibiting\x20</strong>the<strong>\x20coagulation\x20cascade\x20at\x20multiple\x20points.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p>&nbsp;</p>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><br\x20/>\x0d\x0a<span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Warfarin-induced\x20dermal\x20vascular\x20necrosis,</strong>\x20also\x20known\x20as\x20<strong>&#39;purple\x20toe\x20syndrome,&#39;</strong>\x20is\x20a\x20<strong>rare</strong>\x20complication\x20of<strong>\x20warfarin\x20therapy\x20</strong>seen\x20in\x20patients\x20with<strong>\x20genetic\x20protein\x20C\x20deficiency</strong>.\x20<strong>Prompt\x20recognition\x20and\x20management</strong>\x20are\x20<strong>essential\x20to\x20prevent\x20further\x20complications.</strong></span></span></span></span></span></p>','correct_choice_id':0x808f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2f2fe6(0x1ab),'ImageBased']},{'id':0x1fcc,'choices':[{'id':0x7f10,'text':_0x2f2fe6(0x1fd)},{'id':0x7f11,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>It\x20results\x20in\x20decrease\x20in\x20reticulocyte\x20count.</span></span></span></p>'},{'id':0x7f12,'text':_0x2f2fe6(0x334)},{'id':0x7f13,'text':_0x2f2fe6(0x3d6)}],'text':_0x2f2fe6(0x27f),'unique_key':_0x2f2fe6(0x320),'question_audio':null,'question_video':null,'map_id':0x8db6,'difficulty_level':'beginner','subjects_id':[0x4],'solution':_0x2f2fe6(0x410),'correct_choice_id':0x7f11,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x1ab)]},{'id':0x1ffb,'choices':[{'id':0x7fcc,'text':_0x2f2fe6(0x30f)},{'id':0x7fcd,'text':_0x2f2fe6(0x2b5)},{'id':0x7fce,'text':_0x2f2fe6(0x340)},{'id':0x7fcf,'text':_0x2f2fe6(0x45d)}],'text':_0x2f2fe6(0x233),'unique_key':_0x2f2fe6(0x19b),'question_audio':null,'question_video':null,'map_id':0x8dc1,'difficulty_level':'intermediate','subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20B.\x20It\x20is\x20contraindicated\x20in\x20stroke.</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Prasugrel\x20</strong>is\x20an\x20<strong>antiplatelet\x20drug</strong>\x20that\x20<strong>inhibits\x20ADP-mediated\x20platelet\x20activation\x20</strong>and\x20<strong>aggregation</strong>\x20by\x20<strong>irreversibly\x20binding\x20to\x20P2Y12</strong>\x20<strong>receptors\x20on\x20platelets.\x20</strong>It\x20is\x20a<strong>\x20thienopyridine</strong>\x20that\x20is\x20converted\x20to\x20<strong>its\x20active\x20metabolite</strong>\x20<strong>more\x20rapidly\x20</strong>than\x20clopidogrel,\x20leading\x20to\x20<strong>more\x20potent\x20and\x20rapid\x20platelet\x20inhibition.</strong>\x20Therefore,\x20<strong>option\x20A\x20is\x20incorrect.</strong>\x20<strong>Prasugrel</strong>\x20is\x20<strong>indicated\x20</strong>for\x20the\x20treatment\x20of\x20<strong>acute</strong>\x20<strong>coronary\x20syndromes\x20(ACS)</strong>\x20and\x20<strong>in\x20patients\x20</strong>undergoing\x20<strong>percutaneous\x20coronary\x20intervention\x20(PCI).</strong>\x20However,\x20it\x20is\x20<strong>contraindicated\x20</strong>in\x20patients\x20with\x20a<strong>\x20history\x20of\x20stroke\x20or\x20transient\x20ischemic\x20attack\x20(TIA)\x20</strong>due\x20to\x20an\x20<strong>increased\x20risk\x20of\x20bleeding</strong>.\x20Therefore,\x20<strong>option\x20B\x20</strong>is\x20the\x20c<strong>orrect\x20answer</strong>.\x20Both\x20prasugrel\x20and\x20clopidogrel\x20<strong>irreversibly</strong>\x20bind\x20to\x20<strong>P2Y12\x20receptors\x20on\x20platelets,</strong>\x20making\x20them\x20<strong>irreversible</strong>\x20antagonists.\x20Therefore,\x20<strong>option\x20C\x20is\x20incorrect.\x20Prasugrel\x20</strong>has\x20been\x20associated\x20with\x20an\x20<strong>increased\x20risk\x20of\x20bleeding\x20</strong>compared\x20to\x20<strong>clopidogrel</strong>,\x20especially\x20in\x20patients\x20with\x20a<strong>\x20history\x20of\x20stroke\x20or\x20TIA</strong>.\x20Therefore,\x20<strong>option\x20D\x20is</strong>\x20<strong>also\x20incorrect.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20It\x20is\x20<strong>slower\x20acting\x20</strong>than\x20clopidogrel:<strong>\x20Prasugrel</strong>\x20is\x20actually\x20<strong>converted\x20to\x20its\x20active\x20metabolite</strong>\x20<strong>more\x20rapidly</strong>\x20than\x20clopidogrel,\x20leading\x20to<strong>\x20more\x20potent\x20</strong>and<strong>\x20rapid\x20platelet\x20inhibition</strong>.\x20Therefore,\x20this\x20statement\x20is<strong>\x20incorrect.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20It\x20is\x20a\x20<strong>reversible\x20antagonist</strong>\x20of\x20<strong>ADP\x20receptors:</strong>\x20<strong>Prasugrel,\x20like\x20clopidogrel</strong>,\x20is\x20an<strong>\x20irreversible\x20antagonist\x20</strong>of\x20<strong>ADP\x20receptors\x20on</strong>\x20<strong>platelets</strong>.\x20It\x20forms\x20a\x20<strong>covalent\x20bond\x20with\x20the\x20P2Y12\x20receptor,</strong>\x20resulting\x20in<strong>\x20irreversible\x20inhibition</strong>\x20of\x20<strong>platelet\x20aggregation.\x20</strong>Thus,\x20this\x20statement\x20is<strong>\x20incorrect.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Decrease\x20</strong>the<strong>\x20risk\x20of\x20bleeding</strong>:<strong>\x20Prasugrel</strong>\x20has\x20been\x20associated\x20with\x20an<strong>\x20increased\x20risk\x20of\x20bleeding</strong>\x20compared\x20to\x20<strong>clopidogrel,</strong>\x20especially\x20in\x20<strong>certain\x20patient\x20populations</strong>.\x20Therefore,\x20this\x20statement\x20is<strong>\x20incorrect.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Prasugrel\x20</strong>is\x20<strong>contraindicated\x20in\x20patients</strong>\x20with\x20a<strong>\x20history\x20of\x20stroke\x20or\x20transient\x20ischemic\x20attack\x20(TIA)\x20</strong>due\x20to\x20an\x20<strong>increased\x20risk\x20of\x20bleeding.</strong></span></span></span></span></span></p>','correct_choice_id':0x7fcd,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x2c2),_0x2f2fe6(0x380)]},{'id':0x1fa1,'choices':[{'id':0x7e64,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Protamine\x20sulphate</span></span></span></p>'},{'id':0x7e65,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Vitamin\x20K</span></span></span></p>'},{'id':0x7e66,'text':_0x2f2fe6(0x2a0)},{'id':0x7e67,'text':_0x2f2fe6(0x281)}],'text':_0x2f2fe6(0x3a4),'unique_key':_0x2f2fe6(0x45f),'question_audio':null,'question_video':null,'map_id':0x8daa,'difficulty_level':'beginner','subjects_id':[0x4],'solution':_0x2f2fe6(0x3d1),'correct_choice_id':0x7e64,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x380)]},{'id':0x2050,'choices':[{'id':0x811f,'text':_0x2f2fe6(0x1c7)},{'id':0x8120,'text':_0x2f2fe6(0x1f8)},{'id':0x8121,'text':_0x2f2fe6(0x33f)},{'id':0x8122,'text':_0x2f2fe6(0x332)}],'text':_0x2f2fe6(0x424),'unique_key':_0x2f2fe6(0x282),'question_audio':null,'question_video':null,'map_id':0x8db9,'difficulty_level':'beginner','subjects_id':[0x4],'solution':_0x2f2fe6(0x2f9),'correct_choice_id':0x811f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x1ab)]},{'id':0x1ff1,'choices':[{'id':0x7fa4,'text':_0x2f2fe6(0x415)},{'id':0x7fa5,'text':_0x2f2fe6(0x381)},{'id':0x7fa6,'text':_0x2f2fe6(0x431)},{'id':0x7fa7,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Osteogenin</span></span></span></p>'}],'text':_0x2f2fe6(0x1ea),'unique_key':_0x2f2fe6(0x20a),'question_audio':null,'question_video':null,'map_id':0x8dbe,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':_0x2f2fe6(0x261),'correct_choice_id':0x7fa6,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x380)]},{'id':0x1faf,'choices':[{'id':0x7e9c,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Alcohol</span></span></span></p>'},{'id':0x7e9d,'text':_0x2f2fe6(0x464)},{'id':0x7e9e,'text':_0x2f2fe6(0x205)},{'id':0x7e9f,'text':_0x2f2fe6(0x46e)}],'text':_0x2f2fe6(0x224),'unique_key':'Q4760285','question_audio':null,'question_video':null,'map_id':0x8dae,'difficulty_level':'difficult','subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20C.\x20Chloroquine</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Chloroquine,</strong>\x20an\x20<strong>antimalarial\x20medication</strong>,\x20<strong>does\x20not</strong>\x20interfere\x20with\x20<strong>folate\x20metabolism</strong>,\x20making\x20it\x20the<strong>\x20least\x20likely</strong>\x20of\x20the\x20options\x20provided\x20to\x20precipitate<strong>\x20megaloblastic\x20anemia</strong>\x20in\x20patients\x20with\x20<strong>subclinical\x20folate\x20deficiency.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Chronic\x20alcohol</strong>\x20use\x20can\x20<strong>lead</strong>\x20to\x20various\x20<strong>nutritional\x20deficiencies,\x20</strong>including<strong>\x20folate\x20deficiency,\x20</strong>because\x20of\x20<strong>poor\x20diet,</strong>\x20<strong>malabsorption</strong>,\x20and\x20<strong>ethanol&#39;s</strong>\x20interference\x20with<strong>\x20folate\x20metabolism.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Phenytoin,</strong>\x20a\x20widely\x20used\x20<strong>anticonvulsant,</strong>\x20can\x20impair\x20the\x20<strong>absorption\x20of\x20folate\x20</strong>and\x20lead\x20to\x20<strong>megaloblastic\x20anemia,</strong>\x20particularly\x20if\x20<strong>folate\x20reserves</strong>\x20are\x20already<strong>\x20compromised.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Sulfasalazine,</strong>\x20used\x20in\x20the\x20treatment\x20of\x20<strong>inflammatory\x20bowel\x20diseases</strong>,\x20can\x20also\x20<strong>impair\x20folate\x20absorption</strong>\x20and\x20contribute\x20to\x20the\x20<strong>development\x20of\x20megaloblastic\x20anemia.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>In\x20the\x20context\x20of\x20drugs\x20that\x20may<strong>\x20exacerbate\x20or\x20precipitate\x20megaloblastic\x20anemia</strong>\x20due\x20to\x20<strong>folate\x20deficiency</strong>,\x20<strong>chloroquine</strong>\x20is\x20<strong>not</strong>\x20associated\x20with\x20<strong>interference\x20in\x20folate\x20metabolism</strong>\x20and\x20is\x20thus\x20the<strong>\x20least\x20likely\x20</strong>to\x20cause\x20this\x20condition\x20among\x20the\x20options\x20listed.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>DRUGS\x20CAUSING\x20MEGALOBLASTIC\x20ANEMIA</span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture2.jpg\x22\x20style=\x22height:527px;\x20width:1000px\x22\x20/></span></span></p>','correct_choice_id':0x7e9e,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x2c2),_0x2f2fe6(0x17c)]},{'id':0x1fde,'choices':[{'id':0x7f58,'text':_0x2f2fe6(0x3e1)},{'id':0x7f59,'text':_0x2f2fe6(0x17e)},{'id':0x7f5a,'text':_0x2f2fe6(0x323)},{'id':0x7f5b,'text':_0x2f2fe6(0x3c8)}],'text':_0x2f2fe6(0x3f9),'unique_key':_0x2f2fe6(0x324),'question_audio':null,'question_video':null,'map_id':0x8dbb,'difficulty_level':_0x2f2fe6(0x3a0),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20A.\x20Low\x20molecular\x20weight\x20heparin</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Low\x20molecular\x20weight\x20heparin\x20(LMWH)\x20</strong>is\x20widely\x20used\x20for\x20the<strong>\x20prevention\x20and\x20treatment\x20of\x20thromboembolism</strong>,\x20including\x20in\x20<strong>cancer\x20patients.\x20</strong>It\x20has\x20a<strong>\x20more\x20predictable\x20anticoagulant\x20response\x20</strong>and\x20<strong>doesn&#39;t</strong>\x20require<strong>\x20monitoring,</strong>\x20making\x20it\x20<strong>more\x20convenient\x20for\x20both</strong>\x20<strong>inpatient\x20and\x20outpatient\x20settings.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Incorrect</strong>.<strong>\x20Antithrombin\x20III\x20inhibitors\x20aren&#39;t\x20</strong>typically\x20used\x20in\x20the\x20treatment\x20of\x20<strong>thromboembolism;</strong>\x20in\x20fact,<strong>\x20antithrombin</strong>\x20is\x20a<strong>\x20natural\x20inhibitor\x20of\x20coagulation\x20factors</strong>,\x20and<strong>\x20heparins\x20enhance\x20its\x20activity.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Incorrect.\x20</strong>While\x20<strong>direct\x20Xa\x20inhibitors\x20</strong>are\x20used\x20in\x20the\x20treatment\x20of\x20<strong>thromboembolism</strong>,\x20<strong>LMWH\x20</strong>remains\x20the\x20<strong>standard\x20treatment\x20</strong>for\x20<strong>cancer-associated\x20thrombosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Incorrect</strong>.\x20<strong>Warfarin\x20</strong>is\x20used\x20<strong>less\x20frequently\x20in\x20the\x20cancer\x20</strong>population\x20for<strong>\x20thromboembolism\x20</strong>due\x20to\x20the\x20need\x20for<strong>\x20regular\x20monitoring\x20and\x20dose\x20adjustments</strong>,\x20and\x20it<strong>\x20has\x20been\x20surpassed\x20by\x20LMWH\x20</strong>in\x20terms\x20of<strong>\x20efficacy\x20and\x20safety.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Low\x20molecular\x20weight\x20heparin</strong>\x20is\x20the\x20preferred\x20agent\x20for\x20<strong>treating\x20cancer-associated\x20thromboembolism</strong>\x20due\x20to\x20<strong>its\x20efficacy\x20and\x20safety</strong>\x20<strong>profile,</strong>\x20especially\x20<strong>compared\x20to\x20warfarin.</strong></span></span></span></p>','correct_choice_id':0x7f58,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x1ab)]},{'id':0x203f,'choices':[{'id':0x80db,'text':_0x2f2fe6(0x2c0)},{'id':0x80dc,'text':_0x2f2fe6(0x401)},{'id':0x80dd,'text':_0x2f2fe6(0x298)},{'id':0x80de,'text':_0x2f2fe6(0x26a)}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>A\x2048-year-old\x20male\x20with\x20a\x20diagnosis\x20of\x20chronic\x20idiopathic\x20thrombocytopenic\x20purpura\x20(ITP)\x20presents\x20with\x20easy\x20bruising\x20and\x20a\x20platelet\x20count\x20of\x2025,000/&micro;L.\x20He\x20has\x20previously\x20been\x20treated\x20with\x20corticosteroids\x20with\x20temporary\x20improvement\x20in\x20platelet\x20counts.\x20The\x20physician\x20considers\x20adding\x20Eltrombopag\x20for\x20treatment\x20of\x20this\x20patient.\x20What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20this\x20drug?\x20</span></span></span></p>','unique_key':_0x2f2fe6(0x322),'question_audio':null,'question_video':null,'map_id':0x8db0,'difficulty_level':'intermediate','subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20A.\x20Thrombopoietin\x20agonist\x20</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Eltrombopag</strong>\x20is\x20a\x20<strong>thrombopoietin\x20receptor\x20agonist.</strong>\x20Its<strong>\x20mechanism\x20of\x20action</strong>\x20involves\x20<strong>binding\x20to\x20and\x20activating\x20</strong>the<strong>\x20thrombopoietin</strong>\x20<strong>receptor\x20on\x20the\x20surface\x20of\x20megakaryocytes</strong>\x20and\x20<strong>megakaryocyte\x20precursors</strong>\x20within\x20the\x20<strong>bone\x20marrow.\x20</strong>This\x20<strong>activation\x20</strong>leads\x20to\x20<strong>increased\x20production\x20and\x20maturation\x20of\x20platelets</strong>,\x20making\x20it\x20an\x20<strong>effective\x20treatment\x20for\x20patients\x20</strong>with\x20<strong>chronic\x20idiopathic</strong>\x20<strong>thrombocytopenic\x20purpura\x20(ITP),\x20</strong>who\x20have<strong>\x20low\x20platelet\x20counts\x20</strong>and\x20are\x20<strong>at\x20risk\x20of\x20bleeding.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Thrombopoietin\x20antagonist:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20This\x20would\x20be\x20<strong>incorrect</strong>\x20because\x20an\x20<strong>antagonist</strong>\x20would<strong>\x20block</strong>\x20the\x20effect\x20of\x20<strong>thrombopoietin</strong>,\x20which\x20<strong>would\x20not\x20</strong>help\x20to<strong>\x20increase\x20platelet\x20counts\x20</strong>in\x20a\x20patient\x20with\x20ITP.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Spleen\x20tyrosine\x20kinase\x20inhibitor:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>fostamatinib\x20</strong>is\x20an\x20example\x20of\x20a\x20<strong>spleen\x20tyrosine\x20kinase\x20(Syk)\x20inhibitor,</strong>\x20which\x20has\x20a\x20different<strong>\x20mechanism\x20of\x20action</strong>.\x20<strong>Fostamatinib</strong>\x20is\x20<strong>used\x20</strong>in\x20the\x20treatment\x20of<strong>\x20ITP\x20by\x20inhibiting\x20the\x20Syk\x20enzyme</strong>,\x20leading\x20to\x20a\x20<strong>reduction\x20in</strong>\x20the\x20<strong>immune-mediated\x20destruction\x20of\x20platelets.</strong>\x20It<strong>\x20targets</strong>\x20the\x20<strong>signalling\x20pathways</strong>\x20in<strong>\x20immune\x20cells</strong>\x20that\x20are\x20involved\x20in\x20the\x20pathogenesis\x20of\x20<strong>autoimmune\x20diseases</strong>\x20and\x20has\x20been\x20indicated\x20for<strong>\x20adult\x20patients\x20with\x20chronic\x20ITP</strong>\x20who\x20have\x20<strong>not\x20</strong>responded\x20<strong>adequately\x20</strong>to\x20other\x20therapies.\x20Patients\x20on\x20<strong>fostamatinib</strong>\x20are<strong>\x20monitored\x20for\x20side\x20effects\x20</strong>such\x20as\x20<strong>hypertension\x20and\x20liver\x20function</strong>\x20<strong>abnormalities</strong>.\x20<strong>Spleen\x20tyrosine\x20kinase\x20inhibitors</strong>\x20work\x20on\x20<strong>different\x20pathways</strong>,<strong>\x20</strong>typically\x20related\x20to\x20the<strong>\x20immune\x20response,</strong>\x20and\x20<strong>are\x20not</strong>\x20used\x20to<strong>\x20increase\x20platelet\x20production.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Recombinant\x20IL-11:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20This\x20option\x20is\x20<strong>incorrect</strong>\x20because\x20<strong>eltrombopag</strong>\x20is<strong>\x20not</strong>\x20a\x20form\x20of<strong>\x20recombinant\x20interleukin-11</strong>,\x20which\x20is\x20another\x20<strong>cytokine</strong>\x20used\x20in\x20different\x20clinical\x20contexts.\x20</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Recombinant\x20IL-11</strong>,\x20known\x20as\x20<strong>oprelvekin</strong>,\x20is\x20used\x20to\x20treat<strong>\x20thrombocytopenia,</strong>\x20but\x20it\x20is\x20<strong>not\x20</strong>the\x20drug\x20in\x20question.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20<strong>recognize\x20the\x20mechanism\x20of\x20action\x20of\x20eltrombopag</strong>\x20as\x20a<strong>\x20thrombopoietin\x20receptor\x20agonist</strong>,\x20which\x20is\x20<strong>used\x20to\x20treat\x20thrombocytopenia\x20</strong>in\x20conditions\x20such\x20as<strong>\x20chronic\x20ITP</strong>\x20by\x20<strong>stimulating\x20platelet\x20production\x20</strong>in\x20the\x20bone\x20marrow.</span></span></p>','correct_choice_id':0x80db,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2f2fe6(0x1ab)]},{'id':0x1fc8,'choices':[{'id':0x7f00,'text':_0x2f2fe6(0x26b)},{'id':0x7f01,'text':_0x2f2fe6(0x3ae)},{'id':0x7f02,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20reticulocyte\x20count\x20should\x20begin\x20to\x20increase\x20in\x20two\x20weeks\x20and\x20peak\x20in\x20four\x20weeks\x20-\x20this\x20suggests\x20a\x20good\x20response\x20to\x20treatment.</span></span></span></p>'},{'id':0x7f03,'text':_0x2f2fe6(0x3b1)}],'text':_0x2f2fe6(0x17f),'unique_key':_0x2f2fe6(0x3c5),'question_audio':null,'question_video':null,'map_id':0x8db4,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:16px\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20D.\x20The\x20treatment\x20should\x20not\x20be\x20discontinued\x20immediately\x20once\x20haemoglobin\x20normalizes\x20to\x20prevent\x20recurrence\x20of\x20iron\x20deficiency\x20anaemia.</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:16px\x22>The\x20statement\x20&quot;The\x20<strong>treatment</strong>\x20should\x20be<strong>\x20discontinued\x20immediately\x20once\x20hemoglobin\x20normalizes\x20</strong>to\x20prevent<strong>\x20side</strong>\x20<strong>effects\x20of\x20iron&quot;</strong>\x20is<strong>\x20incorrect.\x20Iron\x20supplementation</strong>\x20should\x20continue\x20for\x20an<strong>\x20additional\x203-6\x20months\x20</strong>after<strong>\x20hemoglobin</strong>\x20<strong>levels\x20normalize</strong>.\x20This\x20<strong>extended\x20treatment</strong>\x20ensures\x20that\x20<strong>body\x20iron\x20stores\x20</strong>are\x20<strong>fully\x20replenished,</strong>\x20which\x20helps\x20<strong>prevent</strong>\x20a\x20r<strong>elapse\x20of\x20anemia</strong>.\x20<strong>Stopping</strong>\x20treatment\x20<strong>prematurely</strong>\x20can\x20result\x20in<strong>\x20incomplete\x20iron\x20store\x20replenishment\x20</strong>and\x20a\x20<strong>recurrence\x20of\x20anemia.</strong></span></p>\x0d\x0a\x0d\x0a<h2><span\x20style=\x22font-size:16px\x22>Explanation\x20of\x20Other\x20Options</span></h2>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:16px\x22><strong>A.\x20If\x20200-300\x20mg\x20elemental\x20iron\x20is\x20consumed,\x20about\x2050\x20mg\x20is\x20absorbed:&nbsp;</strong>This\x20<strong>statement\x20is\x20accurate.\x20</strong>The\x20body\x20typically\x20<strong>absorbs</strong>\x20about\x20<strong>10-20%\x20</strong>of\x20the\x20<strong>elemental\x20iron\x20from\x20oral\x20supplements.</strong>\x20Therefore,\x20from\x20a<strong>\x20dose\x20of\x20200-300\x20mg</strong>,\x20approximately\x20<strong>20-60\x20mg\x20of\x20iron\x20is\x20absorbed.</strong>\x20This\x20amount\x20can\x20<strong>vary\x20depending</strong>\x20on\x20the\x20individual&#39;s\x20<strong>current\x20iron\x20levels\x20</strong>and<strong>\x20overall\x20health.</strong></span></p>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:16px\x22><strong>B.\x20The\x20proportion\x20of\x20iron\x20absorbed\x20reduces\x20as\x20hemoglobin\x20improves:&nbsp;</strong>This\x20statement\x20is\x20<strong>correct</strong>.\x20As\x20<strong>iron\x20stores</strong>\x20are<strong>\x20replenished\x20and\x20hemoglobin\x20levels\x20improve</strong>,\x20the<strong>\x20body\x20regulates\x20</strong>and\x20<strong>decreases\x20the\x20absorption\x20efficiency\x20of\x20iron.\x20</strong>This\x20is\x20a\x20<strong>natural\x20feedback\x20</strong>mechanism\x20to\x20<strong>prevent\x20iron\x20overload.</strong></span></p>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:16px\x22><strong>C.\x20The\x20reticulocyte\x20count\x20should\x20begin\x20to\x20increase\x20in\x20two\x20weeks\x20and\x20peak\x20in\x20four\x20weeks\x20-\x20this\x20suggests\x20a\x20good\x20response\x20to\x20treatment:&nbsp;</strong>This\x20is\x20a\x20<strong>true\x20statement</strong>.\x20An<strong>\x20increase</strong>\x20in\x20the\x20<strong>reticulocyte\x20count\x20</strong>indicates\x20that\x20the<strong>\x20bone\x20marrow</strong>\x20is\x20responding\x20to<strong>\x20iron</strong>\x20<strong>therapy.</strong>\x20This<strong>\x20increase\x20</strong>typically\x20begins\x20<strong>within\x207-10\x20days</strong>\x20of\x20<strong>starting\x20treatment\x20</strong>and\x20<strong>peaks\x20at\x20around\x202-4\x20weeks,</strong>\x20<strong>reflecting\x20effective\x20erythropoiesis\x20</strong>(production\x20of\x20red\x20blood\x20cells).</span></p>\x0d\x0a\x0d\x0a<h2><strong><span\x20style=\x22font-size:16px\x22>Educational\x20Objective</span></strong></h2>\x0d\x0a\x0d\x0a<p><span\x20style=\x22font-size:16px\x22>When\x20treating<strong>\x20iron\x20deficiency\x20anemia</strong>\x20with\x20<strong>oral\x20iron\x20supplements</strong>,\x20it\x20is\x20essential\x20to\x20understand\x20that\x20the\x20<strong>body\x20absorbs</strong>\x20about<strong>\x2010-20%\x20</strong>of\x20the<strong>\x20elemental\x20iron</strong>\x20from\x20these<strong>\x20supplements</strong>,\x20meaning\x20that\x20from\x20a<strong>\x20dose\x20of\x20200-300\x20mg,\x20</strong>around\x20<strong>20-60</strong>\x20<strong>mg</strong>\x20is<strong>\x20absorbed</strong>.\x20As\x20<strong>hemoglobin\x20levels\x20improve,</strong>\x20the\x20<strong>efficiency\x20of\x20iron\x20absorption\x20decreases</strong>\x20due\x20to\x20the\x20body&#39;s\x20<strong>natural\x20regulatory\x20mechanisms</strong>\x20to<strong>\x20prevent\x20iron\x20overload.\x20</strong>An\x20effective\x20response\x20to\x20treatment\x20is\x20indicated\x20by\x20an\x20<strong>increase\x20in\x20reticulocyte\x20count</strong>,\x20typically\x20observed<strong>\x20within\x202\x20weeks</strong>\x20and\x20<strong>peaking\x20at\x204\x20weeks.</strong>\x20Importantly,<strong>\x20iron</strong>\x20<strong>supplementation\x20</strong>should\x20<strong>continue\x20for\x203-6\x20months\x20</strong>after\x20<strong>hemoglobin\x20normalization</strong>\x20to\x20ensure\x20<strong>complete\x20replenishment</strong>\x20of<strong>\x20iron\x20stores</strong>\x20and<strong>\x20prevent</strong>\x20the\x20<strong>recurrence\x20of\x20anemia,</strong>\x20highlighting\x20that\x20<strong>stopping\x20</strong>treatment\x20<strong>immediately</strong>\x20<strong>after\x20normalization</strong>\x20is<strong>\x20incorrect.\x20</strong>Understanding\x20these\x20principles<strong>\x20helps</strong>\x20in\x20the<strong>\x20effective\x20management\x20of\x20iron\x20deficiency</strong>\x20<strong>anemia</strong>\x20and\x20in\x20<strong>preventing\x20its\x20recurrence.</strong></span></p>','correct_choice_id':0x7f03,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x380)]},{'id':0x1fab,'choices':[{'id':0x7e8c,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Clopidogrel</span></span></span></p>'},{'id':0x7e8d,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Cephalosporins</span></span></span></p>'},{'id':0x7e8e,'text':_0x2f2fe6(0x37c)},{'id':0x7e8f,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Multivitamins</span></span></span></p>'}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>A\x20healthy\x20volunteer\x20was\x20taken\x20for\x20a\x20blood\x20donation.\x20A\x20history\x20was\x20taken\x20from\x20the\x20volunteer\x20before\x20the\x20experiment\x20regarding\x20exposure\x20of\x20NSAIDs,\x20which\x20he\x20specifically\x20denied.\x20But\x20on\x20testing,\x20the\x20bleeding\x20time\x20was\x20found\x20to\x20be\x20increased.\x20All\x20the\x20following\x20can\x20be\x20responsible\x20for\x20increase\x20in\x20bleeding\x20time\x20in\x20this\x20person\x20EXCEPT</span></span></span></p>','unique_key':_0x2f2fe6(0x454),'question_audio':null,'question_video':null,'map_id':0x8dab,'difficulty_level':_0x2f2fe6(0x3a0),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20D.\x20Multivitamins\x20</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>An\x20<strong>increased\x20bleeding\x20time\x20(BT)\x20</strong>can\x20indicate\x20a\x20defect\x20in<strong>\x20primary\x20hemostasis,</strong>\x20which\x20may\x20be\x20caused\x20by\x20<strong>platelet\x20dysfunction\x20or</strong>\x20<strong>vascular\x20abnormalities.</strong>\x20Multivitamins,\x20typically\x20composed\x20of<strong>\x20vitamins\x20and\x20minerals\x20essential\x20for\x20health,\x20</strong>are<strong>\x20not\x20</strong>known\x20to\x20<strong>affect</strong>\x20<strong>bleeding\x20time</strong>\x20significantly.\x20While\x20<strong>certain\x20nutrients\x20(like\x20vitamin\x20K)</strong>\x20can\x20<strong>impact\x20blood\x20coagulation\x20pathways</strong>,<strong>\x20multivitamins</strong>\x20in\x20<strong>standard\x20dosages</strong>\x20<strong>do\x20no</strong>t\x20adversely\x20affect<strong>\x20platelet\x20function\x20or\x20bleeding\x20time</strong>.\x20Therefore,\x20they\x20are\x20the<strong>\x20least\x20likely\x20</strong>to\x20be\x20responsible\x20for\x20an<strong>\x20increased\x20bleeding\x20time\x20</strong>in\x20a\x20<strong>healthy\x20volunteer\x20</strong>who\x20has\x20denied\x20NSAID\x20use.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.\x20Clopidogrel:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Clopidogrel\x20is\x20an<strong>\x20antiplatelet\x20drug\x20that\x20inhibits\x20the\x20P2Y12\x20ADP\x20receptor\x20on\x20platelets,\x20preventing\x20platelet</strong>\x20<strong>aggregation</strong>\x20and\x20thus\x20can<strong>\x20increase\x20bleeding\x20time</strong>.\x20It\x20is\x20used\x20to<strong>\x20reduce\x20the\x20risk\x20of\x20heart\x20disease\x20</strong>and<strong>\x20stroke</strong>\x20in\x20those\x20at\x20high\x20risk.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Cephalosporins:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Certain\x20<strong>cephalosporins,</strong>\x20especially\x20those\x20with\x20a<strong>\x20methylthiotetrazole\x20(MTT)</strong>\x20side\x20chain\x20(like<strong>\x20cefotetan</strong>\x20and\x20<strong>cefoperazone</strong>),\x20can\x20<strong>interfere\x20with\x20vitamin\x20K\x20metabolism\x20</strong>or\x20have\x20a<strong>\x20direct\x20effect\x20on\x20platelet\x20function</strong>,\x20leading\x20to\x20an<strong>\x20increased\x20risk\x20of</strong>\x20<strong>bleeding</strong>.\x20This\x20makes\x20<strong>cephalosporins\x20a\x20plausible\x20</strong>cause\x20for\x20an<strong>\x20increased\x20bleeding\x20time\x20in\x20individuals</strong>\x20<strong>without</strong>\x20apparent\x20exposure\x20to\x20<strong>NSAIDs.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Anti-depressants:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Some\x20antidepressants,\x20particularly\x20<strong>selective\x20serotonin\x20reuptake\x20inhibitors\x20(SSRIs)</strong>,\x20can\x20<strong>increase</strong>\x20<strong>bleeding\x20time</strong>.\x20SSRIs\x20<strong>increase\x20serotonin\x20levels</strong>\x20in\x20the\x20central\x20nervous\x20system\x20but\x20can\x20also<strong>\x20lead\x20to\x20a\x20reduction\x20in\x20serotonin\x20storage</strong>\x20<strong>within\x20platelets</strong>,\x20which\x20plays\x20a\x20role\x20in<strong>\x20platelet\x20aggregation.</strong>\x20This\x20effect\x20can\x20subtly<strong>\x20increase\x20bleeding\x20time</strong>,\x20making\x20<strong>antidepressants\x20</strong>a\x20possible\x20<strong>cause\x20for\x20the\x20observation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20<strong>recognize\x20substances</strong>\x20that\x20can\x20<strong>affect\x20bleeding\x20time</strong>,\x20with\x20a\x20<strong>specific\x20focus</strong>\x20on\x20understanding\x20that\x20c<strong>ommon\x20multivitamins</strong>\x20<strong>do\x20not\x20</strong>typically\x20cause\x20an<strong>\x20increase\x20in\x20bleeding\x20time.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Important\x20Drugs\x20that\x20can\x20increasing\x20bleeding\x20time</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture1_hSfcgav.jpg\x22\x20style=\x22height:436px;\x20width:1000px\x22\x20/></span></strong></span></span></p>','correct_choice_id':0x7e8f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x1ab)]},{'id':0x2043,'choices':[{'id':0x80eb,'text':_0x2f2fe6(0x26f)},{'id':0x80ec,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Vitamin\x20K</span></span></span></p>'},{'id':0x80ed,'text':_0x2f2fe6(0x3ba)},{'id':0x80ee,'text':_0x2f2fe6(0x3be)}],'text':_0x2f2fe6(0x2d7),'unique_key':'Q7667022','question_audio':null,'question_video':null,'map_id':0x8db2,'difficulty_level':'beginner','subjects_id':[0x4],'solution':_0x2f2fe6(0x24c),'correct_choice_id':0x80ee,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual']},{'id':0x2046,'choices':[{'id':0x80f7,'text':_0x2f2fe6(0x30c)},{'id':0x80f8,'text':_0x2f2fe6(0x342)},{'id':0x80f9,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>These\x20can\x20produce\x20bleeding\x20like\x20hematuria\x20and\x20cerebral\x20hemorrhage.</span></span></span></p>'},{'id':0x80fa,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Their\x20action\x20starts\x20immediately,\x20so\x20are\x20useful\x20for\x20initiation\x20of\x20therapy\x20in\x20deep\x20vein\x20thrombosis.</span></span></span></p>'}],'text':_0x2f2fe6(0x2db),'unique_key':'Q8490239','question_audio':null,'question_video':null,'map_id':0x8db3,'difficulty_level':_0x2f2fe6(0x1ec),'subjects_id':[0x4],'solution':_0x2f2fe6(0x275),'correct_choice_id':0x80f9,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2f2fe6(0x17c)]},{'id':0x204c,'choices':[{'id':0x810f,'text':_0x2f2fe6(0x371)},{'id':0x8110,'text':'<p><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Prasugrel</span></span></p>'},{'id':0x8111,'text':_0x2f2fe6(0x256)},{'id':0x8112,'text':_0x2f2fe6(0x3c9)}],'text':_0x2f2fe6(0x3a1),'unique_key':'Q6485862','question_audio':null,'question_video':null,'map_id':0x8db7,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':_0x2f2fe6(0x2fa),'correct_choice_id':0x8111,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x1ab),_0x2f2fe6(0x46c)]},{'id':0x1fca,'choices':[{'id':0x7f08,'text':'<p><span\x20style=\x22font-size:12pt;\x22>Tolerable\x20dose\x20will\x20deliver\x2040\x20to\x2060\x20mg\x20of\x20iron\x20per\x20dose.</span></p>'},{'id':0x7f09,'text':_0x2f2fe6(0x369)},{'id':0x7f0a,'text':_0x2f2fe6(0x2d5)},{'id':0x7f0b,'text':_0x2f2fe6(0x25d)}],'text':_0x2f2fe6(0x416),'unique_key':_0x2f2fe6(0x1ed),'question_audio':null,'question_video':null,'map_id':0x8db5,'difficulty_level':_0x2f2fe6(0x3a0),'subjects_id':[0x4],'solution':_0x2f2fe6(0x1e0),'correct_choice_id':0x7f08,'solution_audio':null,'solution_video':null,'audio_explanation_heading':'','video_explanation_heading':'','solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x380)]},{'id':0x1f97,'choices':[{'id':0x7e3c,'text':_0x2f2fe6(0x386)},{'id':0x7e3d,'text':_0x2f2fe6(0x211)},{'id':0x7e3e,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Heparin</span></span></span></p>'},{'id':0x7e3f,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Streptokinase</span></span></span></p>'}],'text':_0x2f2fe6(0x195),'unique_key':_0x2f2fe6(0x1f1),'question_audio':null,'question_video':null,'map_id':0x8da9,'difficulty_level':'beginner','subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20A.\x20Epsilon\x20Aminocaproic\x20acid</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Epsilon\x20aminocaproic\x20acid\x20(EACA)</strong>\x20is\x20an<strong>\x20antifibrinolytic\x20agent</strong>\x20that\x20acts\x20as\x20a\x20<strong>competitive\x20inhibitor</strong>\x20of\x20<strong>plasminogen\x20activation.</strong>\x20During\x20<strong>fibrinolytic\x20therapy</strong>,\x20agents\x20like<strong>\x20streptokinase</strong>\x20are\x20administered\x20to\x20<strong>dissolve\x20blood\x20clots</strong>.\x20However,\x20if\x20<strong>bleeding\x20becomes\x20excessive,</strong>\x20agents\x20such\x20as<strong>\x20EACA\x20</strong>are\x20used\x20to<strong>\x20inhibit\x20further\x20breakdown\x20of\x20fibrin</strong>,\x20thus<strong>\x20stabilizing\x20existing\x20clots\x20and\x20reducing\x20bleeding.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Protamine:&nbsp;</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>This\x20is<strong>\x20incorrect\x20as\x20protamine</strong>\x20is\x20used\x20to\x20<strong>reverse\x20the\x20effects\x20of\x20heparin,</strong>\x20not\x20fibrinolytic\x20therapy.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Heparin:&nbsp;</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>This\x20is<strong>\x20incorrect\x20as\x20heparin\x20</strong>is\x20an<strong>\x20anticoagulant\x20</strong>and\x20would\x20exacerbate\x20bleeding.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Streptokinase:&nbsp;</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>This\x20is\x20<strong>incorrect\x20</strong>as\x20<strong>streptokinase\x20is\x20a\x20fibrinolytic\x20agent</strong>,\x20not\x20an\x20antidote.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Epsilon\x20aminocaproic\x20acid\x20</strong>is\x20used\x20to\x20manage<strong>\x20excessive\x20bleeding\x20by\x20inhibiting\x20fibrinolysis\x20</strong>following\x20<strong>fibrinolytic\x20therapy\x20</strong>in<strong>\x20acute</strong>\x20<strong>myocardial\x20infarction.</strong>\x20It\x20is\x20a\x20<strong>lysine</strong>\x20analog\x20that<strong>\x20prevents\x20plasminogen\x20from\x20binding\x20to\x20fibrin,</strong>\x20thereby\x20<strong>reducing\x20the\x20breakdown\x20of</strong>\x20<strong>fibrin\x20clots.</strong></span></span></span></p>','correct_choice_id':0x7e3c,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':['ClinicalVignette','TreatmentBased']},{'id':0x1fad,'choices':[{'id':0x7e94,'text':_0x2f2fe6(0x299)},{'id':0x7e95,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ticlopidine</span></span></span></p>'},{'id':0x7e96,'text':_0x2f2fe6(0x2fb)},{'id':0x7e97,'text':_0x2f2fe6(0x19e)}],'text':_0x2f2fe6(0x45e),'unique_key':_0x2f2fe6(0x2c7),'question_audio':null,'question_video':null,'map_id':0x8dad,'difficulty_level':'beginner','subjects_id':[0x4],'solution':_0x2f2fe6(0x239),'correct_choice_id':0x7e97,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual']},{'id':0x1fe2,'choices':[{'id':0x7f68,'text':_0x2f2fe6(0x2ef)},{'id':0x7f69,'text':_0x2f2fe6(0x338)},{'id':0x7f6a,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Protein\x20S</span></span></span></p>'},{'id':0x7f6b,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Thrombomodulin</span></span></span></p>'}],'text':_0x2f2fe6(0x3f0),'unique_key':'Q1164278','question_audio':null,'question_video':null,'map_id':0x8dbc,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':_0x2f2fe6(0x3ec),'correct_choice_id':0x7f68,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x1ab)]},{'id':0x1ff5,'choices':[{'id':0x7fb4,'text':_0x2f2fe6(0x351)},{'id':0x7fb5,'text':_0x2f2fe6(0x3a7)},{'id':0x7fb6,'text':_0x2f2fe6(0x39b)},{'id':0x7fb7,'text':_0x2f2fe6(0x2bf)}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Warfarin\x20induced\x20skin\x20necrosis\x20is\x20seen\x20in.\x20</span></span></span></p>','unique_key':_0x2f2fe6(0x1c1),'question_audio':null,'question_video':null,'map_id':0x8dbf,'difficulty_level':'beginner','subjects_id':[0x4],'solution':_0x2f2fe6(0x273),'correct_choice_id':0x7fb4,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x1ab)]},{'id':0x2034,'choices':[{'id':0x80af,'text':_0x2f2fe6(0x41a)},{'id':0x80b0,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Clopidogrel\x20</span></span></span></p>'},{'id':0x80b1,'text':_0x2f2fe6(0x305)},{'id':0x80b2,'text':_0x2f2fe6(0x40c)}],'text':_0x2f2fe6(0x234),'unique_key':'Q5701325','question_audio':null,'question_video':null,'map_id':0x8daf,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':_0x2f2fe6(0x34c),'correct_choice_id':0x80af,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2f2fe6(0x1ab),_0x2f2fe6(0x46c)]},{'id':0x204e,'choices':[{'id':0x8117,'text':_0x2f2fe6(0x427)},{'id':0x8118,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Argatroban</span></span></span></p>'},{'id':0x8119,'text':_0x2f2fe6(0x270)},{'id':0x811a,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Dabigatran</span></span></span></p>'}],'text':_0x2f2fe6(0x27b),'unique_key':_0x2f2fe6(0x3fa),'question_audio':null,'question_video':null,'map_id':0x8db8,'difficulty_level':'beginner','subjects_id':[0x4],'solution':_0x2f2fe6(0x2be),'correct_choice_id':0x811a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':['ClinicalVignette',_0x2f2fe6(0x380)]},{'id':0x1feb,'choices':[{'id':0x7f8c,'text':_0x2f2fe6(0x179)},{'id':0x7f8d,'text':_0x2f2fe6(0x31c)},{'id':0x7f8e,'text':_0x2f2fe6(0x3bc)},{'id':0x7f8f,'text':_0x2f2fe6(0x191)}],'text':_0x2f2fe6(0x434),'unique_key':'Q5202963','question_audio':null,'question_video':null,'map_id':0x8dc4,'difficulty_level':_0x2f2fe6(0x3a0),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20C.\x20Carbamazepine</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Carbamazepine</strong>\x20is\x20an<strong>\x20enzyme\x20inducer\x20and\x20increases\x20the\x20metabolism\x20of\x20warfarin</strong>.\x20This\x20will<strong>\x20reduce\x20the\x20action\x20of\x20warfarin,</strong>\x20<strong>decreasing</strong>\x20the\x20<strong>risk\x20of\x20bleeding.</strong>\x20<strong>All\x20other\x20drugs</strong>\x20given\x20in\x20the\x20options<strong>\x20increase\x20the\x20risk\x20of\x20bleeding\x20with\x20warfarin</strong>.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:\x20Isoniazid:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Isoniazid\x20is\x20an<strong>\x20inhibitor\x20of\x20CYP2C9</strong>,\x20which\x20can<strong>\x20inhibit\x20the\x20metabolism\x20of\x20warfarin.</strong>\x20This<strong>\x20inhibition\x20leads\x20to</strong>\x20<strong>increased\x20plasma\x20concentration\x20of\x20warfarin</strong>,\x20thereby\x20<strong>increasing\x20the\x20risk\x20of\x20bleeding.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:\x20Amiodarone:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Amiodarone\x20is\x20also\x20an<strong>\x20inhibitor\x20of\x20CYP2C9.</strong>\x20Like\x20isoniazid,\x20it<strong>\x20inhibits\x20the\x20metabolism\x20of\x20warfarin,</strong>\x20leading\x20to\x20<strong>increased\x20plasma\x20concentration</strong>\x20and\x20an<strong>\x20increased\x20risk\x20of\x20bleeding.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D:\x20Cimetidine:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Cimetidine</strong>\x20is\x20yet\x20another<strong>\x20inhibitor\x20of\x20CYP2C9.</strong>\x20As\x20with<strong>\x20isoniazid\x20and\x20amiodarone,\x20</strong>it<strong>\x20inhibits\x20the\x20metabolism</strong>\x20of<strong>\x20warfarin,</strong>\x20resulting\x20in<strong>\x20elevated\x20plasma\x20concentrations</strong>\x20and\x20an<strong>\x20increased\x20</strong>likelihood\x20of<strong>\x20bleeding.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><br\x20/>\x0d\x0a<span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Carbamazepine,\x20</strong>as\x20an<strong>\x20enzyme\x20inducer,\x20decreases</strong>\x20the\x20<strong>plasma\x20concentration\x20of\x20warfarin,\x20reducing\x20</strong>the\x20<strong>risk\x20of\x20bleeding</strong>\x20when<strong>\x20used</strong>\x20<strong>concomitantly.</strong></span></span><strong>\x20</strong></span></span></span></p>','correct_choice_id':0x7f8e,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x17c),_0x2f2fe6(0x1ab)]},{'id':0x2024,'choices':[{'id':0x806f,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Rivaroxaban</span></span></span></p>'},{'id':0x8070,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Argatroban</span></span></span></p>'},{'id':0x8071,'text':_0x2f2fe6(0x181)},{'id':0x8072,'text':_0x2f2fe6(0x270)}],'text':_0x2f2fe6(0x20c),'unique_key':_0x2f2fe6(0x27e),'question_audio':null,'question_video':null,'map_id':0x8dc3,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':_0x2f2fe6(0x262),'correct_choice_id':0x806f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x380)]},{'id':0x1fac,'choices':[{'id':0x7e90,'text':_0x2f2fe6(0x44b)},{'id':0x7e91,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>HIT\x20is\x20a\x20rare\x20condition\x20that\x20only\x20occurs\x20in\x20patients\x20with\x20a\x20history\x20of\x20thrombosis</span></span></span></p>'},{'id':0x7e92,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>HIT\x20is\x20caused\x20by\x20the\x20formation\x20of\x20antibodies\x20against\x20platelet\x20factor\x204\x20(PF4)\x20complexed\x20with\x20heparin.</span></span></span></p>'},{'id':0x7e93,'text':_0x2f2fe6(0x475)}],'text':_0x2f2fe6(0x284),'unique_key':_0x2f2fe6(0x1cf),'question_audio':null,'question_video':null,'map_id':0x8dc5,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':_0x2f2fe6(0x2c4),'correct_choice_id':0x7e92,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x380)]},{'id':0x203a,'choices':[{'id':0x80c7,'text':_0x2f2fe6(0x3f8)},{'id':0x80c8,'text':'<p><span\x20style=\x22font-size:12pt;\x22>Protamine\x20sulphate\x20reverses\x20its\x20action.</span></p>'},{'id':0x80c9,'text':_0x2f2fe6(0x396)},{'id':0x80ca,'text':'<p><span\x20style=\x22font-size:12pt;\x22>Target\x20INR\x20for\x20patients\x20of\x20Pulmonary\x20embolism\x20on\x20warfarin\x20therapy\x20is\x20generally\x206-8</span></p>'}],'text':'<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22>Which\x20of\x20the\x20following\x20statements\x20is\x20true\x20about\x20warfarin?</span></p>','unique_key':_0x2f2fe6(0x3c4),'question_audio':null,'question_video':null,'map_id':0x8dc9,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':_0x2f2fe6(0x3c3),'correct_choice_id':0x80c9,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x1ab)]},{'id':0x204f,'choices':[{'id':0x811b,'text':_0x2f2fe6(0x2ec)},{'id':0x811c,'text':_0x2f2fe6(0x41c)},{'id':0x811d,'text':_0x2f2fe6(0x3df)},{'id':0x811e,'text':_0x2f2fe6(0x449)}],'text':_0x2f2fe6(0x266),'unique_key':_0x2f2fe6(0x421),'question_audio':null,'question_video':null,'map_id':0x8dc7,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':_0x2f2fe6(0x2ae),'correct_choice_id':0x811d,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x380)]},{'id':0x1f93,'choices':[{'id':0x7e2c,'text':_0x2f2fe6(0x3c9)},{'id':0x7e2d,'text':_0x2f2fe6(0x256)},{'id':0x7e2e,'text':_0x2f2fe6(0x1df)},{'id':0x7e2f,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Prasugrel</span></span></span></p>'}],'text':_0x2f2fe6(0x303),'unique_key':_0x2f2fe6(0x21e),'question_audio':null,'question_video':null,'map_id':0x8dc8,'difficulty_level':_0x2f2fe6(0x3a0),'subjects_id':[0x4],'solution':_0x2f2fe6(0x400),'correct_choice_id':0x7e2d,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2f2fe6(0x380)]},{'id':0x1fae,'choices':[{'id':0x7e98,'text':_0x2f2fe6(0x2eb)},{'id':0x7e99,'text':_0x2f2fe6(0x2a4)},{'id':0x7e9a,'text':_0x2f2fe6(0x3a3)},{'id':0x7e9b,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Parenteral\x20iron\x20is\x20the\x20preferred\x20treatment\x20due\x20to\x20adverse\x20effects\x20of\x20oral\x20iron.</span></span></span></p>'}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20statements\x20is\x20true\x20regarding\x20iron\x20replacement\x20therapy\x20for\x20iron\x20deficiency\x20anaemia?</span></span></span></p>','unique_key':_0x2f2fe6(0x3d2),'question_audio':null,'question_video':null,'map_id':0x8dc6,'difficulty_level':_0x2f2fe6(0x3a0),'subjects_id':[0x4],'solution':_0x2f2fe6(0x3fd),'correct_choice_id':0x7e99,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':[_0x2f2fe6(0x1ab)]},{'id':0x1fda,'choices':[{'id':0x7f48,'text':_0x2f2fe6(0x299)},{'id':0x7f49,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Abciximab</span></span></span></p>'},{'id':0x7f4a,'text':'<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Tirofiban</span></span></span></p>'},{'id':0x7f4b,'text':_0x2f2fe6(0x2ce)}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>All\x20the\x20following\x20drugs\x20are\x20Gp\x20IIb/IIIa\x20inhibitors\x20except:</span></span></span></p>','unique_key':'Q7585198','question_audio':null,'question_video':null,'map_id':0x8dc2,'difficulty_level':_0x2f2fe6(0x22d),'subjects_id':[0x4],'solution':_0x2f2fe6(0x35a),'correct_choice_id':0x7f48,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2f2fe6(0x32c),'tags':['ClinicalVignette',_0x2f2fe6(0x380)]}],quizName=_0x2f2fe6(0x27d);const quizFilename=_0x2f2fe6(0x46d);let hierarchy=[_0x2f2fe6(0x180),_0x2f2fe6(0x341),'Pharmacology'];if(window['location']['pathname']['endsWith'](_0x2f2fe6(0x1f3))){const customData=JSON[_0x2f2fe6(0x468)](localStorage['getItem']('customQuizData'));customData&&(questionsData=customData['questions'],quizName=customData[_0x2f2fe6(0x238)],hierarchy=customData[_0x2f2fe6(0x346)],document[_0x2f2fe6(0x2e1)]=quizName+'\x20-\x20Brain\x20And\x20Scalpel',document[_0x2f2fe6(0x1a8)](_0x2f2fe6(0x3f4))[_0x2f2fe6(0x18d)]=questionsData[_0x2f2fe6(0x2a8)],document['getElementById'](_0x2f2fe6(0x33b))['textContent']=hierarchy[_0x2f2fe6(0x209)]('\x20>\x20'));}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x2f2fe6(0x1dc),timer=null,timeRemaining=0x0,questionStartTime=Date['now'](),quizStartTime=Date[_0x2f2fe6(0x1de)](),isQuizCompleted=![],questionStates=new Array(questionsData['length'])['fill'](null)['map'](()=>({'status':'not_attempted','bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x2f2fe6(0x2a8)]};function saveProgress(){const _0x423011=_0x2f2fe6,_0x385edf={'ktVsJ':'userHistory','YWZOw':_0x423011(0x2b1)};if(isQuizCompleted)return;const _0x1d9d1d=JSON['parse'](localStorage[_0x423011(0x204)](_0x385edf[_0x423011(0x1e8)]))||{};_0x1d9d1d[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x385edf[_0x423011(0x1ba)],'lastSeen':new Date()[_0x423011(0x3de)]()},localStorage['setItem'](_0x385edf[_0x423011(0x1e8)],JSON[_0x423011(0x196)](_0x1d9d1d));}function loadProgress(){const _0x200e78=_0x2f2fe6,_0x5d5911={'xcmXE':'userHistory'},_0x166fb4=JSON[_0x200e78(0x468)](localStorage[_0x200e78(0x204)](_0x5d5911[_0x200e78(0x3fb)]))||{},_0x32eeae=_0x166fb4[quizFilename];if(_0x32eeae){const _0x19aa0d=_0x200e78(0x1d7)['split']('|');let _0x16ed4e=0x0;while(!![]){switch(_0x19aa0d[_0x16ed4e++]){case'0':currentMode=_0x32eeae[_0x200e78(0x3bd)];continue;case'1':console['log'](_0x200e78(0x1d3));continue;case'2':stats=_0x32eeae[_0x200e78(0x37e)];continue;case'3':currentQuestionIndex=_0x32eeae[_0x200e78(0x429)];continue;case'4':questionStates=_0x32eeae[_0x200e78(0x387)];continue;case'5':return!![];}break;}}return![];}function clearProgress(){const _0x55ff64=_0x2f2fe6,_0x205fa9={'cQiGJ':'userHistory','UOQzc':'Previous\x20progress\x20cleared.'},_0x17595b=JSON['parse'](localStorage[_0x55ff64(0x204)](_0x205fa9[_0x55ff64(0x337)]))||{};_0x17595b[quizFilename]&&(delete _0x17595b[quizFilename],localStorage['setItem'](_0x55ff64(0x470),JSON[_0x55ff64(0x196)](_0x17595b)),console['log'](_0x205fa9['UOQzc']));}function markQuizAsCompleted(){const _0x4c15f1=_0x2f2fe6,_0x762ac={'BJVne':_0x4c15f1(0x470),'zdhuN':'completed'},_0x3880eb=JSON[_0x4c15f1(0x468)](localStorage['getItem'](_0x762ac[_0x4c15f1(0x29d)]))||{},_0x31f30d=questionsData[_0x4c15f1(0x2a8)],_0x7f7bd5=stats[_0x4c15f1(0x201)]||0x0;_0x3880eb[quizFilename]={'score':_0x7f7bd5,'total':_0x31f30d,'status':_0x762ac['zdhuN'],'completedOn':new Date()[_0x4c15f1(0x3de)]()},localStorage['setItem'](_0x762ac['BJVne'],JSON['stringify'](_0x3880eb));}const urlParams=new URLSearchParams(window[_0x2f2fe6(0x1a3)][_0x2f2fe6(0x186)]),startAt=parseInt(urlParams[_0x2f2fe6(0x222)](_0x2f2fe6(0x46a))),resume=urlParams[_0x2f2fe6(0x222)](_0x2f2fe6(0x39f))===_0x2f2fe6(0x2fc);function goBack(){const _0x27c4db=_0x2f2fe6,_0x539006={'AVgnu':function(_0x42319f){return _0x42319f();},'MfblR':_0x27c4db(0x23b)};if(!isQuizCompleted)_0x539006[_0x27c4db(0x2b7)](saveProgress);window[_0x27c4db(0x1a3)]['href']=document[_0x27c4db(0x437)]||_0x539006['MfblR'];}function selectMode(_0x4859a2){const _0x446570=_0x2f2fe6,_0x5119f9={'DzoHJ':_0x446570(0x367),'UXypA':_0x446570(0x22c),'jHvbx':function(_0x18a3b2){return _0x18a3b2();}};currentMode=_0x4859a2,document['getElementById'](_0x5119f9[_0x446570(0x184)])[_0x446570(0x1c9)][_0x446570(0x216)]=_0x5119f9[_0x446570(0x3a2)],_0x5119f9['jHvbx'](initializeQuiz);}function initializeQuiz(){const _0x24e36e=_0x2f2fe6,_0x4e1db3={'gkAEv':_0x24e36e(0x430),'pCePG':'markReviewBtn','KZDbl':_0x24e36e(0x433),'IoGJA':function(_0x528d04,_0x12df93){return _0x528d04===_0x12df93;},'XdBDZ':'timed_exam','TrOSA':_0x24e36e(0x330),'mLVyQ':_0x24e36e(0x22c),'kjgIW':_0x24e36e(0x373),'DDyRZ':'testModeLegend','WivTe':'submitSection','upFIa':'flex','wtsZh':_0x24e36e(0x412),'EhQsQ':function(_0x5b7ed1,_0x505f5f){return _0x5b7ed1===_0x505f5f;},'ntMLv':'timerContainer','wLhKw':function(_0x4d6e9a,_0x71b570){return _0x4d6e9a>=_0x71b570;},'DOfHu':function(_0x3188f3,_0x51bcbe){return _0x3188f3<_0x51bcbe;},'pjgeu':function(_0xe7c84f){return _0xe7c84f();},'bmDIi':function(_0x26001f){return _0x26001f();}};quizStartTime=Date[_0x24e36e(0x1de)]();const _0x351fbf=document[_0x24e36e(0x1a8)](_0x4e1db3[_0x24e36e(0x23f)]),_0x2a2af2=document[_0x24e36e(0x1a8)](_0x4e1db3[_0x24e36e(0x438)]),_0x1144a3=document[_0x24e36e(0x1a8)](_0x4e1db3[_0x24e36e(0x452)]),_0x125423=_0x4e1db3['IoGJA'](currentMode,'test')||_0x4e1db3['IoGJA'](currentMode,_0x4e1db3[_0x24e36e(0x1fe)]);document[_0x24e36e(0x1a8)](_0x4e1db3[_0x24e36e(0x3b0)])['style']['display']=_0x125423?_0x4e1db3[_0x24e36e(0x3fe)]:_0x4e1db3[_0x24e36e(0x3f1)],document[_0x24e36e(0x1a8)](_0x24e36e(0x407))['style']['display']=_0x125423?_0x24e36e(0x22c):_0x4e1db3['kjgIW'],document[_0x24e36e(0x1a8)](_0x4e1db3['DDyRZ'])[_0x24e36e(0x1c9)][_0x24e36e(0x216)]=_0x125423?_0x4e1db3[_0x24e36e(0x3f1)]:'none',document[_0x24e36e(0x1a8)](_0x4e1db3[_0x24e36e(0x3dc)])['style'][_0x24e36e(0x216)]=_0x125423?_0x4e1db3['kjgIW']:_0x4e1db3[_0x24e36e(0x3fe)],_0x351fbf[_0x24e36e(0x1c9)][_0x24e36e(0x216)]=_0x125423?_0x4e1db3[_0x24e36e(0x3fe)]:_0x4e1db3['upFIa'],_0x2a2af2['style'][_0x24e36e(0x216)]=_0x125423?_0x4e1db3['upFIa']:_0x4e1db3['mLVyQ'],_0x1144a3[_0x24e36e(0x1c9)][_0x24e36e(0x216)]=_0x125423?_0x24e36e(0x35f):'none',(_0x4e1db3[_0x24e36e(0x1b8)](currentMode,_0x4e1db3[_0x24e36e(0x2cd)])||_0x4e1db3[_0x24e36e(0x2dd)](currentMode,_0x4e1db3['XdBDZ']))&&document[_0x24e36e(0x1a8)](_0x4e1db3[_0x24e36e(0x357)])[_0x24e36e(0x33a)]['remove'](_0x24e36e(0x2c6)),!isNaN(startAt)&&_0x4e1db3[_0x24e36e(0x192)](startAt,0x0)&&_0x4e1db3[_0x24e36e(0x3e2)](startAt,questionsData[_0x24e36e(0x2a8)])&&(currentQuestionIndex=startAt),loadBookmarkedQuestions(),_0x4e1db3['pjgeu'](generateQuestionNav),_0x4e1db3[_0x24e36e(0x1e5)](updateStats),_0x4e1db3[_0x24e36e(0x395)](displayQuestion);}function generateQuestionNav(){const _0x1ce51a=_0x2f2fe6,_0x4b1e72={'AXKTU':_0x1ce51a(0x3ee),'RFmHB':'questionNav','fqtTj':function(_0x3cc62c,_0x215ce3){return _0x3cc62c<_0x215ce3;},'xhvvd':function(_0x540c93,_0x24b65b){return _0x540c93===_0x24b65b;},'LIDOb':_0x1ce51a(0x219),'sxyed':'button','ccDbo':function(_0x29bd4b,_0x3b24b2){return _0x29bd4b+_0x3b24b2;},'YJnms':_0x1ce51a(0x23c),'vvnIj':function(_0x5f1b69){return _0x5f1b69();}},_0x150a78=document[_0x1ce51a(0x1a8)](_0x4b1e72['RFmHB']);_0x150a78[_0x1ce51a(0x296)]='';for(let _0x1b6311=0x0;_0x4b1e72[_0x1ce51a(0x280)](_0x1b6311,questionsData[_0x1ce51a(0x2a8)]);_0x1b6311++){if(_0x4b1e72['xhvvd'](_0x4b1e72[_0x1ce51a(0x3dd)],_0x4b1e72[_0x1ce51a(0x3dd)])){const _0x45e99f=document[_0x1ce51a(0x374)](_0x4b1e72['sxyed']);_0x45e99f[_0x1ce51a(0x18d)]=_0x4b1e72['ccDbo'](_0x1b6311,0x1),_0x45e99f[_0x1ce51a(0x459)]=_0x4b1e72['YJnms'],_0x45e99f['onclick']=()=>jumpToQuestion(_0x1b6311),_0x45e99f['id']=_0x1ce51a(0x45c)+_0x1b6311,_0x150a78['appendChild'](_0x45e99f);}else return _0x89db30['toString']()[_0x1ce51a(0x186)](OOvYXo[_0x1ce51a(0x1d6)])[_0x1ce51a(0x314)]()[_0x1ce51a(0x2bd)](_0x58f5a7)[_0x1ce51a(0x186)](OOvYXo[_0x1ce51a(0x1d6)]);}_0x4b1e72[_0x1ce51a(0x274)](updateQuestionNav);}function updateQuestionNav(){const _0x11a5fd=_0x2f2fe6,_0x1a7c8c={'QqLtF':function(_0x3e5fae,_0x315956){return _0x3e5fae<_0x315956;},'KeToe':function(_0x62f5dc,_0x4778cd){return _0x62f5dc===_0x4778cd;},'ElwNl':function(_0x55cb22,_0x43a93c){return _0x55cb22===_0x43a93c;},'EmaOE':_0x11a5fd(0x1dc),'JXlGu':'timed_study','GYxMi':function(_0x3d31c3,_0x3c615c){return _0x3d31c3===_0x3c615c;},'pyeYQ':function(_0xdccc23,_0x3dd702){return _0xdccc23===_0x3dd702;},'ZmCnl':_0x11a5fd(0x343),'lRqCa':_0x11a5fd(0x3b6),'xrPha':'nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','yDpAP':function(_0x5dbda9,_0x28d283){return _0x5dbda9!==_0x28d283;},'mLEua':_0x11a5fd(0x315)};for(let _0x2094d2=0x0;_0x1a7c8c[_0x11a5fd(0x3b2)](_0x2094d2,questionsData['length']);_0x2094d2++){const _0x2d730f=document[_0x11a5fd(0x1a8)](_0x11a5fd(0x45c)+_0x2094d2),_0x399719=questionStates[_0x2094d2];let _0x5f0ef7='';if(_0x1a7c8c[_0x11a5fd(0x43c)](_0x2094d2,currentQuestionIndex))_0x5f0ef7='nav-btn-current';else{if(_0x399719[_0x11a5fd(0x188)])_0x5f0ef7=_0x11a5fd(0x42b);else{if(_0x399719[_0x11a5fd(0x21f)])_0x5f0ef7=_0x11a5fd(0x3f5);else{if(_0x1a7c8c[_0x11a5fd(0x268)](currentMode,_0x1a7c8c[_0x11a5fd(0x1ef)])||_0x1a7c8c['ElwNl'](currentMode,_0x1a7c8c[_0x11a5fd(0x2ea)])){if(_0x1a7c8c[_0x11a5fd(0x38e)](_0x399719[_0x11a5fd(0x29e)],_0x11a5fd(0x28b)))_0x5f0ef7=_0x11a5fd(0x1a7);else{if(_0x1a7c8c[_0x11a5fd(0x265)](_0x399719[_0x11a5fd(0x29e)],_0x1a7c8c[_0x11a5fd(0x22e)]))_0x5f0ef7=_0x1a7c8c['lRqCa'];else _0x5f0ef7=_0x1a7c8c[_0x11a5fd(0x30b)];}}else{if(_0x1a7c8c[_0x11a5fd(0x405)](_0x399719[_0x11a5fd(0x193)],null))_0x5f0ef7=_0x1a7c8c[_0x11a5fd(0x1c8)];else _0x5f0ef7=_0x1a7c8c[_0x11a5fd(0x30b)];}}}}_0x2d730f[_0x11a5fd(0x459)]=_0x11a5fd(0x1cc)+_0x5f0ef7;}}function jumpToQuestion(_0x9c12b3){const _0x4df6b5=_0x2f2fe6,_0x539afa={'wvTHK':_0x4df6b5(0x441),'XImVK':function(_0x437533){return _0x437533();},'POOeD':function(_0x4e965a,_0x207fca){return _0x4e965a>=_0x207fca;},'SUKRz':'ZsLcb','cCOjT':function(_0x37d3df,_0x5a4415){return _0x37d3df-_0x5a4415;},'Meoln':function(_0x143e8a){return _0x143e8a();},'Jmwdq':function(_0x420e56){return _0x420e56();}};_0x539afa['POOeD'](_0x9c12b3,0x0)&&_0x9c12b3<questionsData[_0x4df6b5(0x2a8)]&&('hecnd'!==_0x539afa[_0x4df6b5(0x2df)]?(questionStartTime&&(questionStates[currentQuestionIndex][_0x4df6b5(0x3d9)]+=_0x539afa[_0x4df6b5(0x214)](Date[_0x4df6b5(0x1de)](),questionStartTime)),currentQuestionIndex=_0x9c12b3,_0x539afa['Meoln'](displayQuestion),_0x539afa['Jmwdq'](saveProgress)):_0x4de540(_0x539afa[_0x4df6b5(0x22a)])&&_0x539afa[_0x4df6b5(0x2a6)](_0x4c0908));}function updateStats(){const _0x2bf6b3=_0x2f2fe6,_0x2014a6={'DBjbM':function(_0x376294,_0x5cd1db){return _0x376294===_0x5cd1db;},'VJPfQ':_0x2bf6b3(0x1dc),'frgSt':_0x2bf6b3(0x2e6),'oaATI':_0x2bf6b3(0x36a),'xbRVB':_0x2bf6b3(0x2c8),'VdSlU':function(_0x40952e,_0x1836ed){return _0x40952e>_0x1836ed;},'JoxLF':function(_0x4f0edf,_0x2bc503){return _0x4f0edf*_0x2bc503;},'nnnGz':function(_0x4ffbcd,_0x480b3e){return _0x4ffbcd/_0x480b3e;},'oRYty':'accuracy','WlDed':function(_0x413e13,_0x45e9cf){return _0x413e13+_0x45e9cf;},'OLgvB':function(_0x526a36,_0x818ea9){return _0x526a36%_0x818ea9;},'hDLgx':'timeSpent','DWRvA':function(_0x24c427,_0x172092){return _0x24c427+_0x172092;}};if(_0x2014a6[_0x2bf6b3(0x460)](currentMode,_0x2014a6[_0x2bf6b3(0x32d)])||currentMode===_0x2bf6b3(0x412)){document[_0x2bf6b3(0x1a8)](_0x2014a6[_0x2bf6b3(0x436)])[_0x2bf6b3(0x18d)]=stats[_0x2bf6b3(0x201)],document['getElementById'](_0x2014a6[_0x2bf6b3(0x2e9)])['textContent']=stats[_0x2bf6b3(0x237)],document[_0x2bf6b3(0x1a8)](_0x2014a6[_0x2bf6b3(0x3a8)])[_0x2bf6b3(0x18d)]=stats['totalAttempted'];const _0x4dedda=_0x2014a6['VdSlU'](stats[_0x2bf6b3(0x2c8)],0x0)?Math[_0x2bf6b3(0x182)](_0x2014a6['JoxLF'](_0x2014a6['nnnGz'](stats[_0x2bf6b3(0x201)],stats[_0x2bf6b3(0x2c8)]),0x64)):0x0;document[_0x2bf6b3(0x1a8)](_0x2014a6['oRYty'])[_0x2bf6b3(0x18d)]=_0x2014a6[_0x2bf6b3(0x236)](_0x4dedda,'%'),stats[_0x2bf6b3(0x24d)]=questionStates[_0x2bf6b3(0x42f)]((_0x1ce503,_0x4ae33f)=>_0x1ce503+_0x4ae33f[_0x2bf6b3(0x3d9)],0x0);const _0x3628f3=Math[_0x2bf6b3(0x247)](_0x2014a6[_0x2bf6b3(0x217)](stats[_0x2bf6b3(0x24d)],0x3e8)),_0x5df2e1=Math[_0x2bf6b3(0x247)](_0x3628f3/0x3c),_0x54a0a2=_0x2014a6[_0x2bf6b3(0x359)](_0x3628f3,0x3c);document['getElementById'](_0x2014a6[_0x2bf6b3(0x1b5)])['textContent']=_0x2014a6['DWRvA'](_0x5df2e1+':',_0x54a0a2[_0x2bf6b3(0x314)]()[_0x2bf6b3(0x25c)](0x2,'0'));}}function setupVideo(_0x25e271,_0x59eecf){const _0x2ddd7c=_0x2f2fe6,_0x295615={'xXPxd':_0x2ddd7c(0x29b)};if(Hls[_0x2ddd7c(0x289)]()){const _0x259dda=new Hls();_0x259dda['loadSource'](_0x59eecf),_0x259dda[_0x2ddd7c(0x258)](_0x25e271);}else _0x25e271[_0x2ddd7c(0x43a)](_0x295615[_0x2ddd7c(0x365)])&&(_0x25e271[_0x2ddd7c(0x33c)]=_0x59eecf);}function displayQuestion(){const _0x4eb29e=_0x2f2fe6,_0x1cae9a={'tjJUk':_0x4eb29e(0x470),'VxTXN':function(_0x56c3a4,_0x4f1c9e){return _0x56c3a4+_0x4f1c9e;},'EUzaY':_0x4eb29e(0x300),'Iojnh':_0x4eb29e(0x44f),'QSrKK':_0x4eb29e(0x336),'RNrWV':function(_0x585e6d,_0x24bdc6){return _0x585e6d(_0x24bdc6);},'ktcqr':_0x4eb29e(0x278),'eCeFc':function(_0x69ca61,_0xf3e7b5){return _0x69ca61===_0xf3e7b5;},'GIxFN':'TPmuY','diJpy':_0x4eb29e(0x3cb),'NzawA':function(_0x236798,_0x481130){return _0x236798*_0x481130;},'jxIwa':function(_0x15011d,_0x5ccfc8){return _0x15011d/_0x5ccfc8;},'PIEee':function(_0x52bea4,_0x5a2944){return _0x52bea4+_0x5a2944;},'QmyRK':'progressBar','TueDs':_0x4eb29e(0x21a),'agXsF':function(_0x1cc819){return _0x1cc819();},'rbWFg':'hidden','vgqGi':_0x4eb29e(0x190),'YyrvS':_0x4eb29e(0x45b),'QAQju':_0x4eb29e(0x3a5),'KprTn':'optionsContainer','srMJH':_0x4eb29e(0x3ed),'wBtvs':_0x4eb29e(0x412),'TeyfE':function(_0x324e4f,_0x4bccb4){return _0x324e4f===_0x4bccb4;},'OumOs':'timed_exam','IYucU':function(_0x8635d,_0x17cd65){return _0x8635d!==_0x17cd65;},'UvYxp':_0x4eb29e(0x358)};if(!questionsData||_0x1cae9a[_0x4eb29e(0x1b3)](questionsData['length'],0x0)){if(_0x1cae9a[_0x4eb29e(0x36f)]!==_0x1cae9a[_0x4eb29e(0x36f)]){if(_0x6e6665)return;const _0x2fa9b6=_0xba7eaa[_0x4eb29e(0x468)](_0x39e571[_0x4eb29e(0x204)](_0x1cae9a[_0x4eb29e(0x3ce)]))||{};_0x2fa9b6[_0x3f84cc]={'questionStates':_0x5d7bcd,'stats':_0x373d4b,'currentQuestionIndex':_0x3dc6be,'currentMode':_0x58bdc5,'status':_0x4eb29e(0x2b1),'lastSeen':new _0xa2183d()[_0x4eb29e(0x3de)]()},_0x151a2f[_0x4eb29e(0x199)](_0x1cae9a[_0x4eb29e(0x3ce)],_0x3c1bbe[_0x4eb29e(0x196)](_0x2fa9b6));}else{document[_0x4eb29e(0x1a8)](_0x4eb29e(0x190))['innerHTML']=_0x1cae9a['diJpy'];return;}};const _0x35db26=questionsData[currentQuestionIndex];questionStartTime=Date[_0x4eb29e(0x1de)](),selectedOption=questionStates[currentQuestionIndex][_0x4eb29e(0x193)];const _0x4e023f=_0x1cae9a['NzawA'](_0x1cae9a[_0x4eb29e(0x37a)](_0x1cae9a[_0x4eb29e(0x255)](currentQuestionIndex,0x1),questionsData[_0x4eb29e(0x2a8)]),0x64);document[_0x4eb29e(0x1a8)](_0x1cae9a[_0x4eb29e(0x28c)])[_0x4eb29e(0x1c9)][_0x4eb29e(0x20d)]=_0x1cae9a[_0x4eb29e(0x326)](_0x4e023f,'%'),document[_0x4eb29e(0x1a8)](_0x1cae9a[_0x4eb29e(0x2a1)])[_0x4eb29e(0x18d)]=_0x1cae9a[_0x4eb29e(0x326)](currentQuestionIndex,0x1),_0x1cae9a['agXsF'](updateQuestionNav),document[_0x4eb29e(0x1a8)](_0x4eb29e(0x38f))[_0x4eb29e(0x28d)]=_0x1cae9a[_0x4eb29e(0x1b3)](currentQuestionIndex,0x0),document[_0x4eb29e(0x1a8)](_0x4eb29e(0x36d))['classList'][_0x4eb29e(0x35e)](_0x1cae9a['rbWFg']),document[_0x4eb29e(0x1a8)](_0x1cae9a[_0x4eb29e(0x3e5)])[_0x4eb29e(0x296)]=_0x35db26[_0x4eb29e(0x46f)]||_0x1cae9a[_0x4eb29e(0x382)];let _0x4dfe77='';if(_0x35db26[_0x4eb29e(0x41d)])_0x4dfe77+=_0x4eb29e(0x1eb)+_0x35db26['question_audio']+_0x4eb29e(0x3c1);if(_0x35db26['question_video'])_0x4dfe77+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22'+_0x35db26[_0x4eb29e(0x456)]+'\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>';_0x35db26[_0x4eb29e(0x301)]&&_0x35db26[_0x4eb29e(0x301)][_0x4eb29e(0x33e)](_0x48dc3b=>{const _0x3a5040=_0x4eb29e;if(_0x48dc3b)_0x4dfe77+=_0x3a5040(0x27c)+_0x48dc3b+_0x3a5040(0x455);});document[_0x4eb29e(0x1a8)](_0x1cae9a[_0x4eb29e(0x240)])[_0x4eb29e(0x296)]=_0x4dfe77;const _0x30cab1=document[_0x4eb29e(0x1a8)](_0x1cae9a[_0x4eb29e(0x3e8)]);_0x30cab1[_0x4eb29e(0x296)]='',_0x30cab1[_0x4eb29e(0x33a)]['remove'](_0x4eb29e(0x362)),_0x35db26['choices']&&Array[_0x4eb29e(0x40d)](_0x35db26[_0x4eb29e(0x2a7)])&&(_0x35db26[_0x4eb29e(0x2a7)]['forEach']((_0x31c513,_0x285d5c)=>{const _0x400dfd=_0x4eb29e,_0x149f52=String['fromCharCode'](_0x1cae9a[_0x400dfd(0x326)](0x41,_0x285d5c)),_0x161777=selectedOption===_0x285d5c,_0x45e196=document[_0x400dfd(0x374)](_0x400dfd(0x2a2));_0x45e196[_0x400dfd(0x296)]=_0x400dfd(0x295)+(_0x161777?_0x1cae9a[_0x400dfd(0x2cc)]:'')+_0x400dfd(0x1e1)+_0x285d5c+_0x400dfd(0x2dc)+_0x149f52+_0x400dfd(0x423)+(_0x31c513[_0x400dfd(0x46f)]||_0x1cae9a[_0x400dfd(0x326)](_0x1cae9a['Iojnh'],_0x285d5c+0x1))+_0x400dfd(0x260),_0x30cab1[_0x400dfd(0x444)](_0x45e196);}),_0x30cab1[_0x4eb29e(0x3b5)](_0x1cae9a[_0x4eb29e(0x352)],function(_0x26710d){const _0xad7545=_0x4eb29e,_0x4af731=_0x26710d[_0xad7545(0x31f)][_0xad7545(0x228)](_0x1cae9a['QSrKK']);if(_0x4af731){const _0x2ac8eb=_0x1cae9a[_0xad7545(0x43d)](parseInt,_0x4af731['getAttribute'](_0x1cae9a[_0xad7545(0x2bb)]));selectOption(_0x2ac8eb);}})),_0x1cae9a['agXsF'](updateBookmarkButton),updateMarkReviewButton(),(_0x1cae9a[_0x4eb29e(0x1b3)](currentMode,_0x1cae9a['wBtvs'])||_0x1cae9a[_0x4eb29e(0x40b)](currentMode,_0x1cae9a[_0x4eb29e(0x345)]))&&!isQuizCompleted&&(_0x1cae9a[_0x4eb29e(0x479)](_0x1cae9a['UvYxp'],_0x1cae9a[_0x4eb29e(0x1b2)])?_0x4defcc[_0x4eb29e(0x447)]<_0x5eccf8[_0x4eb29e(0x2a8)]&&(_0x6c5d1e[_0x242893['questionIndex']]['bookmarked']=!![]):_0x1cae9a[_0x4eb29e(0x428)](startTimer));}function selectOption(_0x313d22){const _0x36e72f=_0x2f2fe6,_0x40fcaa={'tnxXh':_0x36e72f(0x257),'zrIJn':_0x36e72f(0x300),'PMQys':function(_0xc43537,_0x4cd465){return _0xc43537===_0x4cd465;},'NXDSV':function(_0x273b27,_0x529d9e){return _0x273b27(_0x529d9e);},'ftFTJ':_0x36e72f(0x1f3),'CYmrk':function(_0x744763){return _0x744763();},'qaxVT':function(_0x1cbb78){return _0x1cbb78();},'yHtmQ':_0x36e72f(0x206),'XdqXL':function(_0x941d2e,_0x842dd){return _0x941d2e-_0x842dd;},'LaWNx':_0x36e72f(0x336),'ZGXIa':function(_0x428f51,_0x3aff7f){return _0x428f51===_0x3aff7f;},'JRyrW':_0x36e72f(0x1dc),'pdsbY':_0x36e72f(0x248),'FfPOi':function(_0x3eafcc){return _0x3eafcc();},'QFTLl':_0x36e72f(0x355),'rapjH':_0x36e72f(0x18e),'IiikE':function(_0x5983a6,_0x4eb4d9){return _0x5983a6===_0x4eb4d9;}},_0x34862c=document[_0x36e72f(0x1a8)](_0x40fcaa['yHtmQ']);if(_0x34862c[_0x36e72f(0x33a)]['contains']('answered'))return;questionStartTime&&(questionStates[currentQuestionIndex][_0x36e72f(0x3d9)]+=_0x40fcaa[_0x36e72f(0x208)](Date[_0x36e72f(0x1de)](),questionStartTime),questionStartTime=Date['now']()),selectedOption=_0x313d22,questionStates[currentQuestionIndex][_0x36e72f(0x193)]=_0x313d22,document[_0x36e72f(0x1a9)](_0x40fcaa[_0x36e72f(0x36e)])[_0x36e72f(0x33e)]((_0x56a6fe,_0x14387d)=>{const _0x531b3c=_0x36e72f;if(_0x40fcaa['tnxXh']===_0x531b3c(0x31b)){const _0x3fa37d=_0x4b73db['apply'](_0x35f3ea,arguments);return _0x1a0769=null,_0x3fa37d;}else _0x56a6fe[_0x531b3c(0x33a)]['toggle'](_0x40fcaa['zrIJn'],_0x40fcaa['PMQys'](_0x14387d,_0x313d22));}),_0x40fcaa[_0x36e72f(0x30e)](currentMode,_0x40fcaa['JRyrW'])||_0x40fcaa[_0x36e72f(0x30e)](currentMode,_0x36e72f(0x412))?_0x40fcaa[_0x36e72f(0x1b7)](_0x40fcaa[_0x36e72f(0x3ff)],_0x40fcaa[_0x36e72f(0x3ff)])?_0x40fcaa[_0x36e72f(0x40e)](processAnswer):_0x40fcaa[_0x36e72f(0x47a)](_0x3a8d56,_0x36e72f(0x1b0))&&(_0x2f200e[_0x36e72f(0x1a3)][_0x36e72f(0x3e9)]['endsWith'](_0x40fcaa['ftFTJ'])&&_0x154b67[_0x36e72f(0x24a)](_0x36e72f(0x202)),_0x40fcaa['CYmrk'](_0x3e76ab),_0x44f625[_0x36e72f(0x249)]()):_0x40fcaa['QFTLl']!==_0x40fcaa['rapjH']?(_0x40fcaa[_0x36e72f(0x3d4)](questionStates[currentQuestionIndex]['status'],'not_attempted')&&(questionStates[currentQuestionIndex][_0x36e72f(0x29e)]=_0x36e72f(0x362),stats[_0x36e72f(0x2c8)]++,stats[_0x36e72f(0x453)]--),updateQuestionNav()):_0x40fcaa['qaxVT'](_0x3f4923),saveProgress();}function processAnswer(){const _0xa4036f=_0x2f2fe6,_0x181c5d={'YHqXj':_0xa4036f(0x1f3),'iDvNz':_0xa4036f(0x202),'LPaSC':function(_0x16bcfa){return _0x16bcfa();},'wcsih':function(_0x3fea47,_0x2631d3){return _0x3fea47===_0x2631d3;},'QPXSD':_0xa4036f(0x318),'UgAff':function(_0xb65244,_0x952b1c){return _0xb65244===_0x952b1c;},'KZukI':_0xa4036f(0x425),'ZXUik':_0xa4036f(0x310),'xztuf':function(_0x9d2656,_0xcb9244){return _0x9d2656(_0xcb9244);}},_0x40d53f=questionsData[currentQuestionIndex],_0x4dc541=_0x40d53f[_0xa4036f(0x1bf)];if(selectedOption===null)return;const _0x5dfb04=_0x40d53f[_0xa4036f(0x2a7)][selectedOption],_0xd154b1=_0x181c5d[_0xa4036f(0x241)](_0x5dfb04['id'],_0x4dc541);if(_0x181c5d[_0xa4036f(0x241)](questionStates[currentQuestionIndex]['status'],_0x181c5d[_0xa4036f(0x347)])){if(_0x181c5d['UgAff'](_0x181c5d[_0xa4036f(0x19f)],_0x181c5d['ZXUik']))_0x4710a7[_0xa4036f(0x1a3)]['pathname'][_0xa4036f(0x18c)](_0x181c5d[_0xa4036f(0x2c9)])&&_0x4d0465['removeItem'](_0x181c5d['iDvNz']),_0x181c5d[_0xa4036f(0x363)](_0x1844f4),_0x4b2257['reload']();else{stats[_0xa4036f(0x2c8)]++,stats[_0xa4036f(0x453)]--;if(_0xd154b1)stats[_0xa4036f(0x201)]++;else stats[_0xa4036f(0x237)]++;}}questionStates[currentQuestionIndex][_0xa4036f(0x29e)]=_0xd154b1?_0xa4036f(0x28b):_0xa4036f(0x343),_0x181c5d[_0xa4036f(0x363)](updateStats),_0x181c5d[_0xa4036f(0x3ea)](showInlineFeedback,_0xd154b1),_0x181c5d['LPaSC'](updateQuestionNav);}function showInlineFeedback(_0x8d794d){const _0xc46371=_0x2f2fe6,_0xb158be={'GpXxU':function(_0x3a714d,_0xed092c){return _0x3a714d===_0xed092c;},'kPhRC':'cupxc','fUxYH':_0xc46371(0x28b),'BWNwT':_0xc46371(0x343),'hdLlr':function(_0x531324,_0x446912){return _0x531324!==_0x446912;},'OgJdi':_0xc46371(0x1dc),'PSDco':function(_0x4c026d,_0x39b612){return _0x4c026d!==_0x39b612;},'lNGSV':_0xc46371(0x412),'Kukjs':'optionsContainer','znyYo':_0xc46371(0x362),'ozgXR':function(_0xd22d40){return _0xd22d40();}};if(_0xb158be[_0xc46371(0x18a)](currentMode,_0xb158be[_0xc46371(0x46b)])&&_0xb158be[_0xc46371(0x38a)](currentMode,_0xb158be[_0xc46371(0x467)]))return;const _0x2ae984=document[_0xc46371(0x1a8)](_0xb158be[_0xc46371(0x31a)]),_0x3e82df=_0x2ae984['querySelectorAll'](_0xc46371(0x336)),_0x314601=questionsData[currentQuestionIndex],_0x2b3146=_0x314601[_0xc46371(0x1bf)];let _0x30bcb9=_0x314601[_0xc46371(0x2a7)][_0xc46371(0x23d)](_0x726fc2=>_0x726fc2['id']===_0x2b3146);_0x2ae984[_0xc46371(0x33a)]['add'](_0xb158be[_0xc46371(0x20b)]),_0x3e82df['forEach']((_0x29ec94,_0xd7aa1b)=>{const _0x4fe84b=_0xc46371;if(_0xb158be[_0x4fe84b(0x335)](_0xb158be[_0x4fe84b(0x2e3)],_0xb158be['kPhRC'])){_0x29ec94[_0x4fe84b(0x33a)]['remove'](_0x4fe84b(0x300));if(_0xd7aa1b===_0x30bcb9)_0x29ec94[_0x4fe84b(0x33a)][_0x4fe84b(0x35e)](_0xb158be[_0x4fe84b(0x360)]);else{if(_0xb158be[_0x4fe84b(0x335)](_0xd7aa1b,selectedOption)&&!_0x8d794d)_0x29ec94[_0x4fe84b(0x33a)][_0x4fe84b(0x35e)](_0xb158be[_0x4fe84b(0x448)]);}}else _0x360a19=_0x8de649;}),_0xb158be['ozgXR'](showSolution);}function showSolution(){const _0x127a59=_0x2f2fe6,_0x131255={'CezcB':function(_0x2971fe){return _0x2971fe();},'nBieW':_0x127a59(0x202),'uYEgk':function(_0x50da47,_0x4caab2){return _0x50da47+_0x4caab2;},'KcJRX':_0x127a59(0x2e8),'BufIS':_0x127a59(0x3f4),'ydzob':_0x127a59(0x33b),'FZwXD':function(_0x486791,_0x463d33){return _0x486791!==_0x463d33;},'znROj':_0x127a59(0x412),'LWjSL':_0x127a59(0x197),'YEleN':'solutionVideo','Oyafe':function(_0x472bed,_0x16757d){return _0x472bed!==_0x16757d;},'qavFv':'hRtna','osjsj':_0x127a59(0x2c6),'koqtV':_0x127a59(0x354),'Jclnr':function(_0xda95c8,_0x285afa,_0xbb032e){return _0xda95c8(_0x285afa,_0xbb032e);},'xcdbA':function(_0x1f8a7e,_0x268d50){return _0x1f8a7e===_0x268d50;},'AbLjd':_0x127a59(0x185),'qvAuN':_0x127a59(0x19c),'gpyVo':'solutionContainer'};if(_0x131255[_0x127a59(0x26d)](currentMode,_0x127a59(0x1dc))&&_0x131255[_0x127a59(0x26d)](currentMode,_0x131255[_0x127a59(0x41b)]))return;const _0x255b93=questionsData[currentQuestionIndex];document['getElementById'](_0x127a59(0x3b7))['innerHTML']=_0x255b93[_0x127a59(0x36b)]||_0x131255[_0x127a59(0x399)];const _0x294952=document[_0x127a59(0x1a8)](_0x131255[_0x127a59(0x3b8)]),_0x190c8b=document[_0x127a59(0x1a8)](_0x127a59(0x3b9)),_0x591706=_0x255b93[_0x127a59(0x418)];if(_0x591706){if(_0x131255[_0x127a59(0x2fe)](_0x131255[_0x127a59(0x242)],_0x127a59(0x21d)))_0x17c94e&&(_0x44d499[_0x151388]['timeSpent']+=_0x3517e4['now']()-_0x2ee10b),_0x50c44b=_0x259a1c,_0x131255[_0x127a59(0x432)](_0x10a915),_0x131255[_0x127a59(0x432)](_0x5d195f);else{_0x294952[_0x127a59(0x33a)][_0x127a59(0x1c3)](_0x131255[_0x127a59(0x37f)]);if(_0x591706[_0x127a59(0x2d1)](_0x131255['koqtV']))_0x131255['Jclnr'](setupVideo,_0x190c8b,_0x591706);else _0x190c8b['src']=_0x591706;}}else _0x294952['classList'][_0x127a59(0x35e)](_0x127a59(0x2c6));const _0x4d7007=document['getElementById'](_0x127a59(0x1f0));_0x4d7007[_0x127a59(0x296)]='';_0x255b93[_0x127a59(0x446)]&&(_0x4d7007[_0x127a59(0x296)]+=_0x127a59(0x1b1)+_0x255b93['explanation_audio_eng']+_0x127a59(0x3c1));if(_0x255b93[_0x127a59(0x243)]){if(_0x131255[_0x127a59(0x267)](_0x131255['AbLjd'],_0x131255['AbLjd']))_0x4d7007[_0x127a59(0x296)]+=_0x127a59(0x25f)+_0x255b93[_0x127a59(0x243)]+_0x127a59(0x3c1);else{const _0x3233d2=_0x9a2a61[_0x127a59(0x468)](_0x2298d4['getItem'](_0x131255[_0x127a59(0x408)]));_0x3233d2&&(_0xf2869e=_0x3233d2[_0x127a59(0x291)],_0x24a82f=_0x3233d2[_0x127a59(0x238)],_0x53bd31=_0x3233d2['hierarchy'],_0x3510f1['title']=_0x131255['uYEgk'](_0x315609,_0x131255[_0x127a59(0x19a)]),_0x4d5ebb[_0x127a59(0x1a8)](_0x131255[_0x127a59(0x348)])[_0x127a59(0x18d)]=_0x25d5c4['length'],_0x1f314d[_0x127a59(0x1a8)](_0x131255[_0x127a59(0x1f7)])['textContent']=_0x531d4b['join'](_0x127a59(0x287)));}}const _0x5d2566=document[_0x127a59(0x1a8)](_0x131255[_0x127a59(0x393)]);_0x5d2566[_0x127a59(0x296)]='',_0x255b93[_0x127a59(0x1c4)]&&_0x255b93[_0x127a59(0x1c4)][_0x127a59(0x33e)](_0x5a9a19=>{const _0x47a135=_0x127a59;if(_0x5a9a19)_0x5d2566[_0x47a135(0x296)]+=_0x47a135(0x3cd)+_0x5a9a19+_0x47a135(0x368);}),document[_0x127a59(0x1a8)](_0x131255['gpyVo'])[_0x127a59(0x33a)][_0x127a59(0x1c3)](_0x131255['osjsj']);}function _0x3c9d(_0x5bcd3f,_0x3ca4eb){const _0x46a555=_0x3d4e();return _0x3c9d=function(_0x3a9f8c,_0x22fb91){_0x3a9f8c=_0x3a9f8c-0x178;let _0x32c9ef=_0x46a555[_0x3a9f8c];return _0x32c9ef;},_0x3c9d(_0x5bcd3f,_0x3ca4eb);}function submitQuiz(){const _0x45a045=_0x2f2fe6,_0x190040={'urHIk':function(_0x3041d5,_0x5909d5){return _0x3041d5===_0x5909d5;},'MRkdx':'wDGHJ','ugXHg':function(_0x1df88a,_0x58a769){return _0x1df88a===_0x58a769;},'MrNUh':_0x45a045(0x28b),'lmrhx':_0x45a045(0x343),'hxhzL':function(_0x35361c,_0x5a875c){return _0x35361c(_0x5a875c);},'gRerV':function(_0x84de80,_0x5f2879){return _0x84de80(_0x5f2879);},'qobjY':_0x45a045(0x235),'HgwkJ':function(_0x2af9cd,_0x2a2732){return _0x2af9cd-_0x2a2732;},'phwiR':'quizPerformanceData','seXcF':function(_0x119e8d,_0x512a00){return _0x119e8d+_0x512a00;},'IDCOu':function(_0x5eaf64){return _0x5eaf64();},'jLvKP':function(_0x25a47b,_0x269281,_0x2cf2f4,_0x3a5063,_0x181bde){return _0x25a47b(_0x269281,_0x2cf2f4,_0x3a5063,_0x181bde);}};if(timer)_0x190040[_0x45a045(0x2ad)](clearInterval,timer);if(!_0x190040[_0x45a045(0x331)](confirm,_0x190040[_0x45a045(0x1e4)]))return;isQuizCompleted=!![];let _0x28a084=0x0,_0x5dd887=0x0;const _0x51c944=_0x190040[_0x45a045(0x1f5)](Date[_0x45a045(0x1de)](),quizStartTime);questionsData['forEach']((_0x405d4a,_0x1643b7)=>{const _0x117035=_0x45a045;if(_0x190040[_0x117035(0x366)](_0x117035(0x231),_0x190040[_0x117035(0x33d)])){const _0x312b1d=questionStates[_0x1643b7];if(_0x312b1d[_0x117035(0x193)]!==null){if(_0x190040[_0x117035(0x366)](_0x405d4a['choices'][_0x312b1d[_0x117035(0x193)]]['id'],_0x405d4a[_0x117035(0x1bf)])){if(_0x190040['ugXHg']('XgMOU','nXXAH')){const _0x46fd4f=_0x27b55d?function(){if(_0x20ba63){const _0x1ea0d7=_0x3578a9['apply'](_0x2e5cab,arguments);return _0x9e849f=null,_0x1ea0d7;}}:function(){};return _0x1a19cb=![],_0x46fd4f;}else _0x28a084++,_0x312b1d[_0x117035(0x29e)]=_0x190040['MrNUh'];}else _0x5dd887++,_0x312b1d[_0x117035(0x29e)]=_0x190040['lmrhx'];}}else _0xf40fb1=_0x19f4fb[_0x117035(0x316)](_0x4220dc=>!(_0x4220dc['quizFile']['includes'](_0x39cb86[_0x117035(0x39a)]()[_0x117035(0x223)](/ /g,'-'))&&_0x4220dc[_0x117035(0x447)]===_0x4a6557));});const _0x4c3c0d=JSON['parse'](localStorage[_0x45a045(0x204)](_0x190040[_0x45a045(0x183)]))||[];_0x4c3c0d['push']({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x45a045(0x1de)](),'totalTime':_0x51c944,'stats':{'correct':_0x28a084,'incorrect':_0x5dd887,'notAttempted':_0x190040[_0x45a045(0x1f5)](questionsData['length'],_0x190040['seXcF'](_0x28a084,_0x5dd887))}}),localStorage[_0x45a045(0x199)](_0x45a045(0x29c),JSON[_0x45a045(0x196)](_0x4c3c0d)),stats[_0x45a045(0x201)]=_0x28a084,stats[_0x45a045(0x237)]=_0x5dd887,_0x190040[_0x45a045(0x319)](markQuizAsCompleted),_0x190040[_0x45a045(0x469)](showPerformanceAnalysis,_0x28a084,_0x5dd887,_0x190040['HgwkJ'](questionsData['length'],_0x190040['seXcF'](_0x28a084,_0x5dd887)),_0x51c944);}function showPerformanceAnalysis(_0x3cc95e,_0x3c3af3,_0x320687,_0x3084af){const _0x40b661=_0x2f2fe6,_0x1cc7b5={'jkXmj':'performanceModal','fEBkl':function(_0x4bb99a,_0x2c11f8){return _0x4bb99a+_0x2c11f8;},'GKbFu':function(_0x224ee9,_0x24f7bd){return _0x224ee9*_0x24f7bd;},'ibuBb':_0x40b661(0x25e),'XqFhS':_0x40b661(0x44e),'NxQID':_0x40b661(0x376),'WPsqa':_0x40b661(0x187),'jyDpD':_0x40b661(0x30a),'dRxof':function(_0x3ff954,_0x15ec12){return _0x3ff954/_0x15ec12;},'XxKOL':function(_0x3ac209,_0x5586c8){return _0x3ac209%_0x5586c8;},'kPOud':_0x40b661(0x466),'CJWda':function(_0x114f5f,_0x12b34e){return _0x114f5f/_0x12b34e;},'WVbjN':function(_0x2b7a27,_0x2d355e){return _0x2b7a27/_0x2d355e;},'HWekc':_0x40b661(0x1b6),'rsfOL':_0x40b661(0x2c6)},_0x5031ec=document[_0x40b661(0x1a8)](_0x1cc7b5['jkXmj']),_0x410bd2=_0x1cc7b5['fEBkl'](_0x3cc95e,_0x3c3af3)>0x0?Math[_0x40b661(0x182)](_0x3cc95e/(_0x3cc95e+_0x3c3af3)*0x64):0x0,_0x30306a=_0x1cc7b5[_0x40b661(0x414)](_0x1cc7b5[_0x40b661(0x414)](0x2,Math['PI']),0x41),_0x526810=document[_0x40b661(0x1a8)](_0x1cc7b5[_0x40b661(0x3ca)]);_0x526810[_0x40b661(0x1c9)]['strokeDasharray']=_0x30306a+'\x20'+_0x30306a,_0x526810['style'][_0x40b661(0x3c0)]=_0x30306a-_0x1cc7b5[_0x40b661(0x414)](_0x410bd2/0x64,_0x30306a),document['getElementById'](_0x1cc7b5[_0x40b661(0x2ed)])['textContent']=_0x410bd2+'%',document[_0x40b661(0x1a8)](_0x1cc7b5['NxQID'])[_0x40b661(0x18d)]=questionsData[_0x40b661(0x2a8)],document[_0x40b661(0x1a8)](_0x40b661(0x3e0))['textContent']=_0x3cc95e,document['getElementById'](_0x1cc7b5['WPsqa'])[_0x40b661(0x18d)]=_0x3c3af3,document[_0x40b661(0x1a8)](_0x1cc7b5['jyDpD'])[_0x40b661(0x18d)]=_0x320687;const _0x462255=Math[_0x40b661(0x247)](_0x3084af/0xea60),_0x47fcaa=Math['floor'](_0x1cc7b5[_0x40b661(0x2ab)](_0x1cc7b5[_0x40b661(0x3bf)](_0x3084af,0xea60),0x3e8));document['getElementById'](_0x1cc7b5[_0x40b661(0x385)])[_0x40b661(0x18d)]=_0x462255+':'+_0x47fcaa['toString']()[_0x40b661(0x25c)](0x2,'0');const _0x5263d5=_0x1cc7b5[_0x40b661(0x213)](_0x3084af,questionsData['length']),_0x273110=Math['floor'](_0x1cc7b5['WVbjN'](_0x5263d5,0xea60)),_0x46d305=Math[_0x40b661(0x247)](_0x1cc7b5[_0x40b661(0x276)](_0x5263d5%0xea60,0x3e8));document[_0x40b661(0x1a8)](_0x1cc7b5[_0x40b661(0x1d0)])['textContent']=_0x273110+':'+_0x46d305[_0x40b661(0x314)]()[_0x40b661(0x25c)](0x2,'0'),_0x5031ec[_0x40b661(0x33a)][_0x40b661(0x1c3)](_0x1cc7b5[_0x40b661(0x44d)]);}function closePerformanceModal(){const _0x18db70=_0x2f2fe6,_0x469072={'Zemdv':_0x18db70(0x2b4),'QaFxP':_0x18db70(0x2c6)};document[_0x18db70(0x1a8)](_0x469072['Zemdv'])['classList'][_0x18db70(0x35e)](_0x469072[_0x18db70(0x40f)]);}function reviewQuestions(){const _0x79d4ab=_0x2f2fe6,_0x2bf4dc={'zsTnc':function(_0x30f843,_0x597340){return _0x30f843-_0x597340;},'RkwgF':function(_0x7bdcc5){return _0x7bdcc5();},'CyTOx':function(_0x43f3c9,_0x33b27b){return _0x43f3c9===_0x33b27b;},'zxhMH':'border-green-500','xwlWl':_0x79d4ab(0x1af),'nQYxc':function(_0x25a2a0,_0x331e59){return _0x25a2a0+_0x331e59;},'MVfDq':function(_0xe6b96a,_0x332949){return _0xe6b96a===_0x332949;},'JlYHr':'ZNlGj','gfXEZ':'not-attempted','sYEsW':function(_0x30c471,_0x40d980){return _0x30c471!==_0x40d980;},'jjRpZ':_0x79d4ab(0x28b),'UeuGY':_0x79d4ab(0x325),'YeCtS':_0x79d4ab(0x2aa),'SxhXh':'TANCB','AMySF':'incorrect','pmxjZ':_0x79d4ab(0x2a2),'yVsjj':function(_0x3ef990,_0x2c41de){return _0x3ef990+_0x2c41de;},'CsiLB':_0x79d4ab(0x1d2),'Peyoa':'red','SUeFq':_0x79d4ab(0x3aa),'ymWso':_0x79d4ab(0x2c6),'DVxPY':_0x79d4ab(0x478)};document[_0x79d4ab(0x1a8)]('questionReviewSection')['classList'][_0x79d4ab(0x1c3)](_0x2bf4dc[_0x79d4ab(0x3bb)]);const _0x5886dd=document[_0x79d4ab(0x1a8)](_0x2bf4dc['DVxPY']);_0x5886dd['innerHTML']='',questionsData[_0x79d4ab(0x33e)]((_0x177c80,_0x4b3fb8)=>{const _0x503c2c=_0x79d4ab,_0x1710c6={'mMSOR':function(_0x331681,_0x28d6de){const _0x25d51d=_0x3c9d;return _0x2bf4dc[_0x25d51d(0x31e)](_0x331681,_0x28d6de);},'syXPm':_0x2bf4dc[_0x503c2c(0x1ce)],'euJuE':_0x2bf4dc[_0x503c2c(0x1cd)],'yLuGR':function(_0x29800f,_0x20abbe){const _0x3e6fce=_0x503c2c;return _0x2bf4dc[_0x3e6fce(0x290)](_0x29800f,_0x20abbe);}};if(_0x2bf4dc[_0x503c2c(0x43b)](_0x2bf4dc[_0x503c2c(0x26e)],_0x2bf4dc['JlYHr'])){const _0x387e62=questionStates[_0x4b3fb8],_0x3c4073=_0x177c80['correct_choice_id'];let _0x384153=_0x2bf4dc[_0x503c2c(0x3a9)],_0x34241e=_0x503c2c(0x339);if(_0x2bf4dc[_0x503c2c(0x1d4)](_0x387e62[_0x503c2c(0x193)],null)){const _0x5e5a9a=_0x177c80['choices'][_0x387e62[_0x503c2c(0x193)]];_0x2bf4dc[_0x503c2c(0x31e)](_0x5e5a9a['id'],_0x3c4073)?(_0x384153=_0x2bf4dc[_0x503c2c(0x2d2)],_0x34241e=_0x2bf4dc['UeuGY']):_0x2bf4dc[_0x503c2c(0x1fa)]!==_0x2bf4dc[_0x503c2c(0x22f)]?(_0x384153=_0x2bf4dc[_0x503c2c(0x321)],_0x34241e=_0x503c2c(0x250)):(_0x46263a[_0x4b2f66][_0x503c2c(0x3d9)]+=_0x2bf4dc[_0x503c2c(0x27a)](_0x4f120c['now'](),_0x3ecdf9),_0x47f604=_0x4767aa[_0x503c2c(0x1de)]());}const _0x2fe3c4=document[_0x503c2c(0x374)](_0x2bf4dc['pmxjZ']);_0x2fe3c4[_0x503c2c(0x459)]=_0x503c2c(0x409)+_0x384153;let _0x21dfbb=(_0x177c80[_0x503c2c(0x2a7)]||[])[_0x503c2c(0x28a)]((_0x4d2ea3,_0x58fc20)=>{const _0x2637fb=_0x503c2c,_0x562531=_0x1710c6[_0x2637fb(0x1c0)](_0x387e62[_0x2637fb(0x193)],_0x58fc20),_0x2ca0fb=_0x1710c6[_0x2637fb(0x1c0)](_0x4d2ea3['id'],_0x3c4073);let _0x1010ad=_0x2637fb(0x293);if(_0x2ca0fb)_0x1010ad=_0x1710c6[_0x2637fb(0x440)];else{if(_0x562531)_0x1010ad=_0x1710c6[_0x2637fb(0x43e)];}return _0x2637fb(0x2c3)+_0x1010ad+_0x2637fb(0x443)+String[_0x2637fb(0x279)](_0x1710c6[_0x2637fb(0x3a6)](0x41,_0x58fc20))+_0x2637fb(0x42d)+_0x4d2ea3[_0x2637fb(0x46f)]+'</span></div>';})[_0x503c2c(0x209)]('');const _0x3c3f69=_0x177c80['explanation_video']?_0x503c2c(0x1dd)+_0x4b3fb8+_0x503c2c(0x1f6)+_0x177c80[_0x503c2c(0x418)]+'\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>':'';let _0x4f14cb='';if(_0x177c80[_0x503c2c(0x446)])_0x4f14cb+=_0x503c2c(0x34d)+_0x177c80['explanation_audio_eng']+_0x503c2c(0x3c1);if(_0x177c80[_0x503c2c(0x243)])_0x4f14cb+=_0x503c2c(0x3e6)+_0x177c80['explanation_audio_hin']+_0x503c2c(0x3c1);let _0xc59089=(_0x177c80['explanation_images']||[])[_0x503c2c(0x28a)](_0x252e9c=>_0x252e9c?'<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x252e9c+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>':'')[_0x503c2c(0x209)]('');_0x2fe3c4[_0x503c2c(0x296)]=_0x503c2c(0x465)+_0x2bf4dc[_0x503c2c(0x42e)](_0x4b3fb8,0x1)+_0x503c2c(0x24e)+(_0x2bf4dc[_0x503c2c(0x43b)](_0x384153,_0x2bf4dc[_0x503c2c(0x2d2)])?_0x2bf4dc[_0x503c2c(0x361)]:_0x2bf4dc[_0x503c2c(0x43b)](_0x384153,_0x2bf4dc[_0x503c2c(0x321)])?_0x2bf4dc[_0x503c2c(0x350)]:_0x2bf4dc[_0x503c2c(0x328)])+_0x503c2c(0x2f1)+_0x34241e+'</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>'+_0x177c80[_0x503c2c(0x46f)]+_0x503c2c(0x397)+_0x21dfbb+_0x503c2c(0x3e4)+(_0x177c80[_0x503c2c(0x36b)]||_0x503c2c(0x34b))+_0x503c2c(0x417)+_0x3c3f69+_0x503c2c(0x19d)+_0x4f14cb+_0x503c2c(0x19d)+_0xc59089+_0x503c2c(0x1a1),_0x5886dd[_0x503c2c(0x444)](_0x2fe3c4);}else _0x2d93ba[_0xbf48ac][_0x503c2c(0x21f)]=!_0x21e228[_0x17788a][_0x503c2c(0x21f)],_0x2bf4dc[_0x503c2c(0x1e2)](_0x16a464),_0xf01549();}),_0x2bf4dc[_0x79d4ab(0x1e2)](initializeReviewVideos);}function initializeReviewVideos(){const _0x24d505=_0x2f2fe6,_0x2649de={'JeZcj':function(_0x32da0d){return _0x32da0d();},'oPBcS':'.m3u8','xVMuN':function(_0x5a4600,_0x58cf27){return _0x5a4600===_0x58cf27;},'JenPz':_0x24d505(0x2f4),'frBjA':_0x24d505(0x302),'eCmjA':function(_0x2dea7a,_0x1c1aa2,_0x233a75){return _0x2dea7a(_0x1c1aa2,_0x233a75);}};document[_0x24d505(0x1a9)]('video[data-src]')[_0x24d505(0x33e)](_0x3be349=>{const _0xdb6be4=_0x24d505,_0x1d80bb=_0x3be349[_0xdb6be4(0x20e)][_0xdb6be4(0x33c)];if(_0x1d80bb&&_0x1d80bb['includes'](_0x2649de[_0xdb6be4(0x462)]))_0x2649de[_0xdb6be4(0x3fc)](_0x2649de[_0xdb6be4(0x34e)],_0x2649de[_0xdb6be4(0x1bb)])?_0x2649de['JeZcj'](_0x30e780):_0x2649de[_0xdb6be4(0x2f3)](setupVideo,_0x3be349,_0x1d80bb);else _0x1d80bb&&(_0x3be349[_0xdb6be4(0x33c)]=_0x1d80bb);});}function retakeQuiz(){const _0x5b439a=_0x2f2fe6,_0x1921a3={'PUqaM':function(_0x241565,_0x484b9d){return _0x241565(_0x484b9d);},'tFEdU':function(_0x4bc354,_0x1abf2e){return _0x4bc354(_0x1abf2e);},'AYAZU':function(_0x3bfe67,_0x3e11c3){return _0x3bfe67===_0x3e11c3;},'KXIrr':_0x5b439a(0x1c5),'hgNZV':_0x5b439a(0x1f3),'QDpVZ':'customQuizData','AvwrB':function(_0x46d81a){return _0x46d81a();}};if(_0x1921a3[_0x5b439a(0x445)](confirm,_0x5b439a(0x1b0))){if(_0x1921a3[_0x5b439a(0x3ab)](_0x1921a3['KXIrr'],_0x1921a3[_0x5b439a(0x1f9)]))window[_0x5b439a(0x1a3)][_0x5b439a(0x3e9)]['endsWith'](_0x1921a3['hgNZV'])&&localStorage[_0x5b439a(0x24a)](_0x1921a3[_0x5b439a(0x3c6)]),_0x1921a3[_0x5b439a(0x215)](clearProgress),location['reload']();else{const _0xbdb6e4=_0x1921a3[_0x5b439a(0x445)](_0x317853,_0x2f5a32[_0x5b439a(0x39c)](_0x5b439a(0x278)));_0x1921a3[_0x5b439a(0x439)](_0x336e29,_0xbdb6e4);}}}function loadBookmarkedQuestions(){const _0x4ce31b=_0x2f2fe6,_0x90ab3b={'KUPgY':function(_0x281232,_0x4e3786){return _0x281232-_0x4e3786;},'ZarAz':function(_0x160b16){return _0x160b16();},'qGxGl':_0x4ce31b(0x2b4),'LKdDi':_0x4ce31b(0x2c6),'UVqqp':function(_0x11e2e3,_0x46c144){return _0x11e2e3!==_0x46c144;},'GdYfH':function(_0x47f3fc,_0xc7f1d2){return _0x47f3fc===_0xc7f1d2;},'lmlyM':function(_0x2be8d9,_0x498182){return _0x2be8d9===_0x498182;},'JxJrk':'qEgbj','optvx':_0x4ce31b(0x23a),'tLKYk':_0x4ce31b(0x189),'sYzbw':_0x4ce31b(0x3ef)},_0x2d4f78=JSON[_0x4ce31b(0x468)](localStorage[_0x4ce31b(0x204)](_0x90ab3b[_0x4ce31b(0x246)]))||[];_0x2d4f78['forEach'](_0x5606d1=>{const _0x545ab1=_0x4ce31b,_0x4fa78a={'hOcWD':function(_0x62574a,_0xd6e760){const _0x119bd0=_0x3c9d;return _0x90ab3b[_0x119bd0(0x1ad)](_0x62574a,_0xd6e760);},'BgkXL':function(_0x38afa0,_0x515c8e){const _0x6db198=_0x3c9d;return _0x90ab3b[_0x6db198(0x263)](_0x38afa0,_0x515c8e);},'GshME':'incorrect'};if(_0x90ab3b['lmlyM'](_0x90ab3b[_0x545ab1(0x38d)],'ydZZA')){const _0x20e070=_0x50f91f[_0x35ae27];_0x4fa78a[_0x545ab1(0x203)](_0x20e070[_0x545ab1(0x193)],null)&&(_0x4fa78a[_0x545ab1(0x2af)](_0x2befdb['choices'][_0x20e070[_0x545ab1(0x193)]]['id'],_0x4c70a9[_0x545ab1(0x1bf)])?(_0x531417++,_0x20e070[_0x545ab1(0x29e)]=_0x545ab1(0x28b)):(_0x43ab83++,_0x20e070[_0x545ab1(0x29e)]=_0x4fa78a[_0x545ab1(0x44a)]));}else _0x5606d1['quizFile'][_0x545ab1(0x2d1)](quizName[_0x545ab1(0x39a)]()['replace'](/ /g,'-'))&&(_0x90ab3b[_0x545ab1(0x1ad)](_0x90ab3b[_0x545ab1(0x461)],_0x90ab3b[_0x545ab1(0x18b)])?_0x5606d1[_0x545ab1(0x447)]<questionsData[_0x545ab1(0x2a8)]&&(_0x90ab3b[_0x545ab1(0x1ad)](_0x545ab1(0x383),_0x545ab1(0x442))?questionStates[_0x5606d1[_0x545ab1(0x447)]][_0x545ab1(0x188)]=!![]:(_0x5b82bf&&(_0x4978b0[_0x3d49a5][_0x545ab1(0x3d9)]+=_0x90ab3b[_0x545ab1(0x474)](_0x521799['now'](),_0xd5d909)),_0x4ea99f--,_0x90ab3b['ZarAz'](_0x594207),_0x90ab3b['ZarAz'](_0xe9d510))):_0x288553['getElementById'](_0x90ab3b[_0x545ab1(0x1db)])['classList'][_0x545ab1(0x35e)](_0x90ab3b[_0x545ab1(0x1aa)]));});}function toggleBookmark(){const _0x3d2568=_0x2f2fe6,_0x36a5f8={'yStuI':function(_0xb9c07c){return _0xb9c07c();},'Tcukm':_0x3d2568(0x3ef),'RlXIa':function(_0x5df758,_0x5e05c3){return _0x5df758!==_0x5e05c3;},'kTVdX':_0x3d2568(0x38c),'tcUNj':_0x3d2568(0x1e6)},_0xa4321e=!questionStates[currentQuestionIndex][_0x3d2568(0x188)];questionStates[currentQuestionIndex][_0x3d2568(0x188)]=_0xa4321e;let _0x436c8f=JSON[_0x3d2568(0x468)](localStorage[_0x3d2568(0x204)](_0x36a5f8['Tcukm']))||[];if(_0xa4321e){const _0x267b4a={'quizName':quizName,'quizFile':window[_0x3d2568(0x1a3)][_0x3d2568(0x3e9)][_0x3d2568(0x23e)]('/')[_0x3d2568(0x244)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x3d2568(0x1de)]()};_0x436c8f[_0x3d2568(0x1ca)](_0x267b4a);}else _0x36a5f8['RlXIa'](_0x36a5f8[_0x3d2568(0x42a)],_0x36a5f8[_0x3d2568(0x3ad)])?_0x436c8f=_0x436c8f['filter'](_0x1625b3=>!(_0x1625b3[_0x3d2568(0x309)][_0x3d2568(0x2d1)](quizName[_0x3d2568(0x39a)]()[_0x3d2568(0x223)](/ /g,'-'))&&_0x1625b3[_0x3d2568(0x447)]===currentQuestionIndex)):_0x36a5f8['yStuI'](_0x4a82db);localStorage[_0x3d2568(0x199)](_0x36a5f8[_0x3d2568(0x406)],JSON[_0x3d2568(0x196)](_0x436c8f)),updateBookmarkButton(),_0x36a5f8[_0x3d2568(0x32a)](updateQuestionNav);}function updateBookmarkButton(){const _0xc110af=_0x2f2fe6,_0x31f999={'Rotdf':_0xc110af(0x297),'upjdT':_0xc110af(0x375),'Lpwti':_0xc110af(0x34f),'KthRq':_0xc110af(0x3ac),'hmEEH':_0xc110af(0x476)},_0x4b4690=document[_0xc110af(0x1a8)](_0xc110af(0x430)),_0x37fe94=document[_0xc110af(0x1a8)](_0x31f999['Rotdf']),_0x9d346d=questionStates[currentQuestionIndex][_0xc110af(0x188)];_0x4b4690[_0xc110af(0x459)]=_0x9d346d?_0x31f999[_0xc110af(0x277)]:_0x31f999[_0xc110af(0x426)],_0x37fe94[_0xc110af(0x18d)]=_0x9d346d?_0x31f999[_0xc110af(0x1d9)]:_0x31f999[_0xc110af(0x32f)];}function toggleMarkForReview(){const _0x39efe0=_0x2f2fe6,_0x139b8d={'uGIYC':function(_0x39078e){return _0x39078e();}};questionStates[currentQuestionIndex]['markedForReview']=!questionStates[currentQuestionIndex]['markedForReview'],_0x139b8d[_0x39efe0(0x18f)](updateMarkReviewButton),_0x139b8d[_0x39efe0(0x18f)](updateQuestionNav);}function updateMarkReviewButton(){const _0x2eca21=_0x2f2fe6,_0x13ed6b={'iEsHE':_0x2eca21(0x32b),'EXqZB':_0x2eca21(0x3da),'ptiuO':'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','mzqFD':_0x2eca21(0x2e4)},_0x1f118f=document['getElementById'](_0x2eca21(0x317)),_0x938019=document[_0x2eca21(0x1a8)](_0x13ed6b[_0x2eca21(0x264)]),_0x4cf3c0=questionStates[currentQuestionIndex]['markedForReview'];_0x1f118f[_0x2eca21(0x459)]=_0x4cf3c0?_0x13ed6b[_0x2eca21(0x44c)]:_0x13ed6b[_0x2eca21(0x384)],_0x938019[_0x2eca21(0x18d)]=_0x4cf3c0?_0x2eca21(0x3c2):_0x13ed6b[_0x2eca21(0x3af)];}function previousQuestion(){const _0x557919=_0x2f2fe6,_0x117b31={'AGELj':function(_0xa047e9){return _0xa047e9();},'TSotZ':function(_0x3519e4){return _0x3519e4();},'wnWHQ':_0x557919(0x367),'QdCxF':_0x557919(0x35f),'ihbhp':function(_0x19e47f,_0x44f334){return _0x19e47f!==_0x44f334;},'NayRc':_0x557919(0x3d0),'SURSL':function(_0x1c4e56,_0x41bfea){return _0x1c4e56===_0x41bfea;},'ehCcd':_0x557919(0x420),'orhqG':function(_0x2327f6,_0x4b9f83){return _0x2327f6-_0x4b9f83;},'zXUTr':function(_0x2a17a8){return _0x2a17a8();}};if(currentQuestionIndex>0x0){if(_0x117b31[_0x557919(0x198)](_0x117b31['NayRc'],_0x117b31['NayRc']))_0x117b31[_0x557919(0x1ae)](_0x48b763)?(_0x1912e1[_0x557919(0x1a8)]('modeModal')['style']['display']=_0x557919(0x22c),_0x25089e()):(_0x117b31[_0x557919(0x2b8)](_0x2825ca),_0x2e9d39['getElementById'](_0x117b31['wnWHQ'])[_0x557919(0x1c9)][_0x557919(0x216)]=_0x117b31['QdCxF']);else{if(questionStartTime){if(_0x117b31[_0x557919(0x43f)](_0x117b31['ehCcd'],_0x117b31['ehCcd']))questionStates[currentQuestionIndex]['timeSpent']+=_0x117b31[_0x557919(0x288)](Date['now'](),questionStartTime);else{if(_0x4daffe)_0x34a926[_0x557919(0x296)]+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x44998c+_0x557919(0x368);}}currentQuestionIndex--,_0x117b31[_0x557919(0x356)](displayQuestion),_0x117b31[_0x557919(0x1ae)](saveProgress);}}}function nextQuestion(){const _0x1ea865=_0x2f2fe6,_0x152fcc={'pPXNn':'selected','qcfIJ':function(_0x2cc9af){return _0x2cc9af();},'XxbwB':'modeModal','wyLAJ':_0x1ea865(0x35f),'gSyjB':function(_0x127686,_0x4c9cd3){return _0x127686<_0x4c9cd3;},'zlRJL':_0x1ea865(0x1a5),'bKfwS':_0x1ea865(0x378),'mquof':function(_0x588bc6,_0x2b233d){return _0x588bc6<_0x2b233d;},'tcGZy':'PPeZk','KkfZA':function(_0x42eb99){return _0x42eb99();},'SoygR':function(_0x11784e){return _0x11784e();},'sjtSF':function(_0x22ea08,_0x1ecf30){return _0x22ea08===_0x1ecf30;},'Ybufw':_0x1ea865(0x1f4),'LErTL':'test','McGsF':'timed_exam','TJsqO':function(_0x3e5a71,_0x348a60){return _0x3e5a71(_0x348a60);},'cFRlr':_0x1ea865(0x441),'oIncj':function(_0x4d311a,_0x144944){return _0x4d311a!==_0x144944;},'CredI':'zgTMW','HAYHY':function(_0x34baae,_0xf5cfbd){return _0x34baae(_0xf5cfbd);},'ggMSy':'You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?'};questionStartTime&&(_0x152fcc['zlRJL']!==_0x152fcc[_0x1ea865(0x218)]?questionStates[currentQuestionIndex][_0x1ea865(0x3d9)]+=Date['now']()-questionStartTime:_0x5979d6[_0x1ea865(0x33a)][_0x1ea865(0x2b9)](_0x152fcc[_0x1ea865(0x1c6)],_0x259799===_0x433d97)),_0x152fcc[_0x1ea865(0x2bc)](currentQuestionIndex,questionsData[_0x1ea865(0x2a8)]-0x1)?_0x1ea865(0x1d1)!==_0x152fcc[_0x1ea865(0x245)]?(currentQuestionIndex++,_0x152fcc[_0x1ea865(0x1d8)](displayQuestion),_0x152fcc[_0x1ea865(0x329)](saveProgress)):(_0x152fcc[_0x1ea865(0x285)](_0x44a994),_0x3993b1[_0x1ea865(0x1a8)](_0x152fcc['XxbwB'])[_0x1ea865(0x1c9)][_0x1ea865(0x216)]=_0x152fcc[_0x1ea865(0x2d6)]):_0x152fcc[_0x1ea865(0x1f2)](_0x152fcc[_0x1ea865(0x2a3)],_0x152fcc[_0x1ea865(0x2a3)])?_0x152fcc['sjtSF'](currentMode,_0x152fcc[_0x1ea865(0x17a)])||currentMode===_0x152fcc[_0x1ea865(0x1cb)]?_0x152fcc[_0x1ea865(0x3cc)](confirm,_0x152fcc[_0x1ea865(0x2f0)])&&(_0x152fcc[_0x1ea865(0x41f)](_0x152fcc[_0x1ea865(0x1be)],'natXN')?submitQuiz():(_0x248bf4[_0x1ea865(0x1a8)]('modeModal')[_0x1ea865(0x1c9)][_0x1ea865(0x216)]=_0x1ea865(0x22c),_0x152fcc[_0x1ea865(0x285)](_0x3a50d3))):_0x152fcc[_0x1ea865(0x304)](confirm,_0x152fcc['ggMSy'])&&(currentQuestionIndex=0x0,_0x152fcc[_0x1ea865(0x329)](displayQuestion),_0x152fcc[_0x1ea865(0x285)](saveProgress)):_0x2d1cc6[_0x1ea865(0x309)][_0x1ea865(0x2d1)](_0x51cdc1[_0x1ea865(0x39a)]()['replace'](/ /g,'-'))&&(_0x152fcc[_0x1ea865(0x413)](_0x4143b1[_0x1ea865(0x447)],_0x4a046d[_0x1ea865(0x2a8)])&&(_0x1d631c[_0x1500cc['questionIndex']][_0x1ea865(0x188)]=!![]));}function startTimer(){const _0x49a83e=_0x2f2fe6,_0x5b451f={'TBpLQ':function(_0x1dd4ab,_0x5a3cba){return _0x1dd4ab+_0x5a3cba;},'weUMd':_0x49a83e(0x2e7),'LkYeS':_0x49a83e(0x2c6),'ftgrz':function(_0x7a78a2){return _0x7a78a2();},'VENYJ':function(_0x1d8999,_0x103f47){return _0x1d8999<=_0x103f47;},'IVDPP':function(_0x460d4c,_0x398503){return _0x460d4c!==_0x398503;},'NlEZI':function(_0x3c79a3,_0x51e0ce){return _0x3c79a3(_0x51e0ce);},'ZnSBH':function(_0x1b0361,_0x31e47d){return _0x1b0361===_0x31e47d;},'stolT':_0x49a83e(0x24b),'UBBrS':_0x49a83e(0x403),'AXYYs':function(_0x57c863,_0x3da565){return _0x57c863(_0x3da565);},'SjuBJ':function(_0x5dbbb8){return _0x5dbbb8();},'jcWxu':function(_0x528cfe,_0x23b645,_0x700ed7){return _0x528cfe(_0x23b645,_0x700ed7);}};if(timer)_0x5b451f[_0x49a83e(0x2f2)](clearInterval,timer);timeRemaining=0x78,_0x5b451f[_0x49a83e(0x3f2)](updateTimerDisplay),timer=_0x5b451f[_0x49a83e(0x333)](setInterval,()=>{const _0x4fea08=_0x49a83e,_0x3bbfbf={'TceFf':function(_0x750209,_0x13556e){const _0x454c0f=_0x3c9d;return _0x5b451f[_0x454c0f(0x372)](_0x750209,_0x13556e);},'GWVED':_0x4fea08(0x370),'ymWNS':_0x5b451f[_0x4fea08(0x26c)],'Ztrfw':_0x5b451f[_0x4fea08(0x45a)]};timeRemaining--,_0x5b451f[_0x4fea08(0x3f3)](updateTimerDisplay);if(_0x5b451f[_0x4fea08(0x450)](timeRemaining,0x0)){if(_0x5b451f[_0x4fea08(0x1bd)]('bgCcC',_0x4fea08(0x1ff))){_0x5b451f[_0x4fea08(0x3e7)](clearInterval,timer);if(_0x5b451f[_0x4fea08(0x29a)](currentMode,_0x5b451f[_0x4fea08(0x272)]))submitQuiz();else{if(_0x5b451f[_0x4fea08(0x29a)](_0x4fea08(0x403),_0x5b451f[_0x4fea08(0x37b)]))_0x5b451f[_0x4fea08(0x3f3)](nextQuestion);else{let _0x5cce0b;try{_0x5cce0b=_0x408f4c(wYnErm['TceFf'](wYnErm[_0x4fea08(0x283)](wYnErm['GWVED'],wYnErm[_0x4fea08(0x25b)]),');'))();}catch(_0x248635){_0x5cce0b=_0x359f5f;}return _0x5cce0b;}}}else _0x2c44e3[_0x4fea08(0x33a)][_0x4fea08(0x35e)](_0x3bbfbf[_0x4fea08(0x3c7)]);}},0x3e8);}function updateTimerDisplay(){const _0x39a949=_0x2f2fe6,_0x49dea1={'epShJ':function(_0x36f27e,_0x533257){return _0x36f27e/_0x533257;},'zGzAM':function(_0xd1e7f1,_0x44b5ed){return _0xd1e7f1%_0x44b5ed;},'VBDOf':_0x39a949(0x2c5),'cKcDx':function(_0x1a57c0,_0x4d3beb){return _0x1a57c0+_0x4d3beb;},'PPKnC':function(_0x1d2d03,_0x1b93d5){return _0x1d2d03+_0x1b93d5;}},_0x384cbc=Math[_0x39a949(0x247)](_0x49dea1['epShJ'](timeRemaining,0x3c)),_0x4399ad=_0x49dea1['zGzAM'](timeRemaining,0x3c);document[_0x39a949(0x1a8)](_0x49dea1[_0x39a949(0x232)])[_0x39a949(0x18d)]=_0x49dea1[_0x39a949(0x457)](_0x49dea1[_0x39a949(0x1b4)](_0x384cbc,':'),_0x4399ad[_0x39a949(0x314)]()[_0x39a949(0x25c)](0x2,'0'));}function _0x3d4e(){const _0x46ef59=['border-gray-600','pGbHw','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','innerHTML','bookmarkText','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Spleen\x20tyrosine\x20kinase\x20inhibitor</span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Prasugrel</span></span></span></p>','ZnSBH','application/vnd.apple.mpegurl','quizPerformanceData','BJVne','status','ArrowRight','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Tranexamic\x20acid</span></span></span></p>','TueDs','div','Ybufw','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Before\x20administering\x20parenteral\x20iron,\x20the\x20dose\x20should\x20be\x20diluted\x20and\x20checked\x20for\x20anaphylaxis.</span></span></span></p>','ADJpJ','XImVK','choices','length','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Rivaroxaban</span></span></span></p>','UFhHh','dRxof','KcQjA','hxhzL','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20C.\x20Ciraparantag-\x20fondaparinux</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Ciraparantag\x20(also\x20known\x20as\x20aripazine)</strong>\x20is\x20an\x20investigational\x20drug\x20being\x20studied\x20as\x20a\x20<strong>universal\x20reversal\x20agent</strong>\x20for\x20the\x20<strong>anticoagulant</strong>\x20effects\x20of<strong>\x20various\x20anticoagulants</strong>,\x20including\x20<strong>heparins\x20and\x20direct\x20oral\x20anticoagulants\x20(DOACs)</strong>.\x20However,\x20it\x20<strong>has\x20not</strong>\x20been\x20approved\x20for\x20clinical\x20use\x20till\x20now,\x20and\x20therefore,\x20it\x20is<strong>\x20not\x20currently</strong>\x20an\x20established<strong>\x20antidote\x20for\x20fondaparinux\x20</strong>or\x20any\x20<strong>other\x20anticoagulant.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.\x20Idarucizumab-\x20dabigatran:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Idarucizumab\x20is\x20a<strong>\x20monoclonal\x20antibody</strong>\x20that\x20is\x20the\x20approved\x20<strong>antidote\x20for\x20dabigatran</strong>.\x20It\x20<strong>reverses\x20the\x20anticoagulant</strong>\x20effect\x20of\x20<strong>dabigatran</strong>\x20by\x20<strong>binding\x20to\x20it</strong>\x20with\x20<strong>high\x20affinity.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Andexanet\x20alfa-\x20rivaroxaban:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Andexanet\x20alfa</strong>\x20is\x20a\x20<strong>recombinant\x20modified\x20</strong>human\x20factor<strong>\x20Xa\x20decoy\x20protein</strong>\x20that\x20<strong>acts</strong>\x20as\x20an\x20<strong>antidote\x20to\x20factor\x20Xa\x20inhibitors,</strong>\x20including\x20<strong>rivaroxaban.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Andexanet-\x20apixaban:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Andexanet\x20alfa</strong>\x20is\x20also\x20the\x20approved\x20<strong>antidote\x20for\x20apixaban,</strong>\x20reversing\x20<strong>its\x20anticoagulant\x20effect</strong>\x20by\x20acting\x20as\x20a\x20<strong>decoy\x20for\x20the\x20drug.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20know\x20the<strong>\x20specific\x20antidotes\x20for\x20various\x20anticoagulants\x20</strong>and\x20to\x20be\x20aware\x20of\x20the\x20<strong>correct\x20pairing</strong>\x20<strong>between</strong>\x20<strong>these\x20antidotes</strong>\x20and\x20their\x20<strong>corresponding\x20drugs.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Antidotes\x20for\x20anticoagulants\x20(DOAC)</span></span></strong></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture15.jpg\x22\x20style=\x22height:515px;\x20width:1000px\x22\x20/></span></span></strong></p>','BgkXL','HvxOv','incomplete','JlRGn','QEXys','performanceModal','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>It\x20is\x20contraindicated\x20in\x20stroke.</span></span></span></p>','wcXVS','AVgnu','TSotZ','toggle','KwZeV','ktcqr','mquof','constructor','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20D.\x20Dabigatran</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Dabigatran</strong>\x20is\x20an<strong>\x20orally\x20active\x20anticoagulant\x20</strong>that\x20<strong>directly\x20inhibits\x20thrombin.</strong>\x20It\x20is\x20a\x20<strong>direct\x20thrombin\x20inhibitor\x20(DTI)</strong>\x20used\x20to\x20<strong>prevent</strong>\x20<strong>stroke\x20</strong>in\x20patients\x20with\x20<strong>non-valvular\x20atrial\x20fibrillation</strong>,\x20<strong>treat\x20and\x20prevent\x20deep\x20vein\x20thrombosis\x20and\x20pulmonary\x20embolism</strong>,\x20and\x20for\x20other\x20indications\x20where\x20<strong>anticoagulation\x20is\x20necessary.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.\x20Hirudin:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Hirudin\x20is\x20a<strong>\x20naturally\x20occurring\x20peptide</strong>\x20from\x20the\x20<strong>medicinal\x20leech</strong>\x20that\x20<strong>directly\x20inhibits\x20thrombin.</strong>\x20However,\x20it\x20is\x20<strong>not\x20orally\x20active.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Argatroban:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Argatroban\x20is\x20a<strong>\x20synthetic\x20direct\x20thrombin\x20inhibitor</strong>,\x20but\x20it\x20is\x20<strong>administered\x20intravenously\x20</strong>and\x20not\x20orally.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Bivalirudin:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Bivalirudin\x20is\x20<strong>another\x20direct\x20thrombin\x20inhibitor\x20</strong>that\x20is\x20used<strong>\x20intravenously,</strong>\x20particularly\x20during<strong>\x20percutaneous</strong>\x20<strong>coronary\x20interventions</strong>,\x20and\x20is<strong>\x20not\x20taken\x20orally.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20recognize\x20the\x20different\x20<strong>anticoagulant\x20drugs\x20</strong>available\x20for<strong>\x20thrombin\x20inhibition</strong>\x20and\x20to\x20understand\x20their\x20<strong>routes\x20of\x20administration</strong>.\x20Distinguishing\x20between\x20<strong>orally\x20active\x20and\x20non-orally\x20active\x20anticoagulants</strong>\x20is\x20essential\x20for\x20<strong>proper\x20patient</strong>\x20<strong>management\x20and\x20treatment\x20planning.</strong></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Antithrombin\x203\x20deficiency</span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Thrombopoietin\x20agonist</span></span></span></p>','table','ClinicalVignette','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20C.\x20HIT\x20is\x20caused\x20by\x20the\x20formation\x20of\x20antibodies\x20against\x20platelet\x20factor\x204\x20(PF4)\x20complexed\x20with\x20heparin.</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Heparin-induced\x20thrombocytopenia\x20(HIT)\x20</strong>is\x20an<strong>\x20immune-mediated\x20adverse\x20effect</strong>\x20of<strong>\x20heparin\x20therapy.\x20</strong>It\x20occurs\x20when\x20the<strong>\x20immune</strong>\x20<strong>system\x20</strong>forms<strong>\x20antibodies\x20against\x20a\x20complex\x20of\x20heparin\x20and\x20platelet\x20factor\x204\x20(PF4).</strong>\x20This\x20immune\x20reaction\x20can<strong>\x20activate\x20platelets,</strong>\x20leading\x20to\x20<strong>thrombocytopenia\x20and\x20an\x20increased\x20risk\x20of\x20thrombosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Incorrect</strong>.\x20<strong>HIT</strong>\x20is<strong>\x20not</strong>\x20related\x20to<strong>\x20von\x20Willebrand\x20factor\x20(vWF)</strong>;\x20<strong>vWF\x20deficiency</strong>\x20causes<strong>\x20von\x20Willebrand\x20disease,</strong>\x20a\x20<strong>different</strong>\x20<strong>bleeding\x20disorder.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Incorrect</strong>.\x20<strong>HIT</strong>\x20can\x20occur\x20in\x20any<strong>\x20patient\x20receiving\x20heparin,\x20not\x20</strong>just\x20those\x20with\x20a\x20<strong>history\x20of\x20thrombosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Incorrect</strong>.\x20<strong>HIT</strong>\x20is\x20characterized\x20by\x20a<strong>\x20decreased\x20platelet\x20count\x20(thrombocytopenia)</strong>,<strong>\x20not</strong>\x20a<strong>\x20normal\x20count,\x20</strong>and\x20it\x20is\x20associated\x20with\x20an<strong>\x20increased\x20risk\x20of\x20thrombosis,\x20not\x20bleeding.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Heparin-induced\x20thrombocytopenia\x20(HIT)</strong>\x20is\x20a\x20<strong>serious\x20</strong>and\x20potentially<strong>\x20life-threatening\x20condition\x20</strong>characterized\x20by\x20the<strong>\x20formation\x20of</strong>\x20<strong>antibodies\x20</strong>to\x20complexes\x20formed\x20between<strong>\x20heparin\x20and\x20PF4,</strong>\x20leading\x20to\x20<strong>platelet\x20activation\x20and\x20an\x20increased\x20risk\x20of\x20thrombosis</strong>\x20despite\x20a<strong>\x20decrease\x20in\x20platelet\x20count</strong>.\x20Management\x20involves\x20<strong>discontinuation\x20of\x20heparin\x20and\x20initiation\x20of\x20alternative\x20anticoagulation\x20</strong>with\x20agents\x20like<strong>\x20direct\x20thrombin\x20inhibitors.</strong></span></span></span></p>','timeDisplay','hidden','Q5091579','totalAttempted','YHqXj','Q2122889','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Phospholipase\x20C</span></span></span></p>','EUzaY','wtsZh','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Eptifibatide</span></span></span></p>','xaCAK','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Inhalational</span></span></span></p>','includes','jjRpZ','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>A\x2065-year-old\x20patient,\x20with\x20a\x20history\x20of\x20hypertension\x20and\x20type\x202\x20diabetes,\x20recently\x20underwent\x20total\x20hip\x20replacement\x20surgery.\x20Post-operatively,\x20the\x20healthcare\x20team\x20is\x20focused\x20on\x20preventing\x20venous\x20thromboembolism\x20(VTE),\x20a\x20common\x20complication\x20after\x20such\x20surgeries.\x20Given\x20the\x20patient&#39;s\x20increased\x20risk\x20for\x20VTE\x20due\x20to\x20surgery,\x20immobility,\x20and\x20underlying\x20conditions,\x20the\x20decision\x20to\x20initiate\x20thromboprophylaxis\x20with\x20low\x20molecular\x20weight\x20(LMW)\x20heparin\x20was\x20made.\x20Route\x20of\x20administration\x20of\x20LMW\x20heparin\x20in\x20this\x20patient\x20is</span></span></span></p>','oiTUg','<p><span\x20style=\x22font-size:12pt;\x22>Treatment\x20should\x20be\x20stopped\x20as\x20soon\x20as\x20normal\x20haemoglobin\x20level\x20is\x20reached.</span></p>','wyLAJ','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>A\x2072-year-old\x20male\x20with\x20a\x20history\x20of\x20non-valvular\x20atrial\x20fibrillation\x20is\x20brought\x20to\x20the\x20emergency\x20department\x20following\x20a\x20minor\x20car\x20accident.\x20He\x20is\x20currently\x20taking\x20dabigatran\x20for\x20stroke\x20prevention.\x20On\x20examination,\x20he\x20has\x20a\x20laceration\x20on\x20his\x20forehead\x20that\x20is\x20bleeding\x20profusely,\x20and\x20his\x20blood\x20tests\x20reveal\x20a\x20prolonged\x20activated\x20partial\x20thromboplastin\x20time\x20(aPTT).\x20Given\x20the\x20acute\x20bleeding\x20and\x20his\x20anticoagulation\x20therapy,\x20the\x20emergency\x20physician\x20decides\x20to\x20administer\x20a\x20specific\x20antidote\x20to\x20reverse\x20the\x20effects\x20of\x20dabigatran.\x20Which\x20of\x20the\x20following\x20medications\x20should\x20be\x20used?</span></span></span></p>','Bacuv','exception','FaweM','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20statements\x20is\x20true\x20regarding\x20the\x20warfarin\x20group\x20of\x20oral\x20anticoagulants?</span></span></span></p>','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','EhQsQ','xYTTP','SUKRz','aPwcG','title','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Intravenous</span></span></span></p>','kPhRC','Mark\x20for\x20Review','pAkMr','correctCount','{}.constructor(\x22return\x20this\x22)(\x20)','\x20-\x20Brain\x20And\x20Scalpel','oaATI','JXlGu','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Oral\x20iron\x20should\x20be\x20given\x20until\x20haematocrit\x20normalizes\x20and\x20then\x20discontinued\x20due\x20to\x20gastric\x20adverse\x20effects.</span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Idarucizumab-\x20dabigatran</span></span></span></p>','XqFhS','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Intramuscular</span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Anti-thrombin\x20III</span></span></span></p>','cFRlr','-600\x20text-white\x22>','AXYYs','eCmjA','AEZNL','QfiNn','warn','mByiU','efMtw','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20A.\x20Stop\x20warfarin\x20and\x20start\x20heparin.</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>In\x20a\x20<strong>pregnant\x20patient\x20</strong>with\x20a\x20<strong>mechanical\x20heart\x20valve,</strong>\x20<strong>warfarin\x20</strong>poses\x20a\x20<strong>risk\x20to\x20the\x20fetus,</strong>\x20especially\x20in\x20the\x20<strong>first\x20trimester\x20</strong>due\x20to\x20<strong>teratogenicity\x20</strong>and\x20in\x20the\x20<strong>last\x20trimester\x20due\x20to\x20the\x20risk\x20of\x20fetal\x20bleeding.</strong>\x20The\x20approach<strong>\x20close\x20to\x20delivery\x20</strong>is\x20to<strong>\x20switch\x20from\x20warfarin</strong>\x20to\x20<strong>heparin</strong>\x20(either\x20<strong>unfractionated\x20heparin\x20or\x20low\x20molecular\x20weight\x20heparin</strong>),\x20which\x20<strong>does\x20not\x20cross</strong>\x20the\x20<strong>placenta\x20</strong>and\x20therefore<strong>\x20does</strong>\x20<strong>not\x20carry</strong>\x20the\x20same\x20<strong>risks\x20to\x20the\x20fetus.</strong>\x20An<strong>\x20INR\x20of\x203</strong>\x20indicates\x20that\x20the\x20patient\x20is<strong>\x20adequately\x20anticoagulated,\x20</strong>but\x20transitioning\x20to\x20<strong>heparin\x20is\x20recommended</strong>\x20as\x20the<strong>\x20patient\x20</strong>approaches\x20term\x20to\x20<strong>reduce\x20the\x20risk\x20of\x20bleeding</strong>\x20<strong>during\x20labor\x20and\x20delivery.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Stop\x20warfarin\x20and\x20start\x20heparin\x20plus\x20aspirin:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Aspirin\x20</strong>is\x20an<strong>\x20antiplatelet\x20agent\x20</strong>and\x20is\x20<strong>not\x20</strong>typically\x20required\x20in\x20the\x20context\x20of\x20<strong>prosthetic\x20heart\x20valve\x20</strong>management\x20during\x20pregnancy.\x20Its\x20addition\x20could\x20<strong>increase\x20the\x20risk\x20of\x20bleeding\x20without</strong>\x20providing\x20clear\x20<strong>additional\x20benefit\x20</strong>in\x20this\x20setting.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Continue\x20warfarin\x20and\x20add\x20heparin:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Continuing\x20warfarin\x20is<strong>\x20not\x20recommended\x20close\x20to\x20delivery</strong>\x20due\x20to\x20the\x20<strong>risks</strong>\x20mentioned\x20above.\x20The\x20<strong>goal\x20is</strong>\x20to\x20<strong>switch\x20to\x20heparin\x20</strong>solely.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Switch\x20to\x20aspirin:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Aspirin</strong>\x20alone\x20is<strong>\x20insufficient</strong>\x20for\x20the\x20management\x20of\x20<strong>thromboembolic\x20risk\x20in\x20patients\x20</strong>with<strong>\x20prosthetic</strong>\x20<strong>heart\x20valves.\x20Anticoagulation\x20with\x20heparin\x20is\x20necessary.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20recognize\x20the<strong>\x20importance\x20of\x20transitioning\x20from\x20warfarin\x20to\x20heparin\x20in\x20pregnant\x20patients</strong>\x20with\x20<strong>mechanical\x20heart\x20valves</strong>\x20as\x20they\x20approach<strong>\x20delivery.\x20Warfarin\x20is\x20contraindicated</strong>\x20close\x20to\x20delivery\x20due\x20to\x20the\x20<strong>risk\x20of\x20fetal\x20hemorrhage,</strong>\x20and<strong>\x20heparin\x20</strong>is\x20the\x20preferred\x20<strong>anticoagulant</strong>\x20because\x20it\x20<strong>does\x20not\x20cross\x20the\x20placenta</strong>.\x20This\x20transition\x20<strong>minimizes\x20the\x20risk\x20of</strong>\x20<strong>thromboembolism\x20</strong>associated\x20with\x20the<strong>\x20prosthetic\x20valve</strong>\x20and\x20<strong>reduces</strong>\x20the\x20potential\x20for\x20<strong>bleeding\x20complications\x20</strong>during\x20<strong>labor\x20and</strong>\x20<strong>delivery.</strong></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20C.\x20Ticagrelor</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20site\x20labelled\x20as<strong>\x20&quot;B&quot;\x20in\x20the\x20figure</strong>\x20represents\x20the\x20<strong>P2Y12\x20receptor,\x20</strong>a\x20key\x20component\x20in\x20the\x20<strong>activation\x20and\x20aggregation\x20of\x20platelets.</strong>\x20<strong>Ticagrelor</strong>\x20is\x20the\x20<strong>drug</strong>\x20among\x20the\x20options\x20provided\x20that\x20<strong>reversibly\x20binds\x20to\x20the\x20P2Y12\x20receptor.\x20Unlike\x20clopidogrel,\x20prasugrel,\x20</strong>and\x20<strong>ticlopidine,\x20</strong>which\x20are\x20<strong>thienopyridines\x20and\x20irreversibly\x20inhibit\x20the\x20P2Y12\x20receptor</strong>,<strong>\x20ticagrelor\x20binds\x20reversibly,</strong>\x20allowing\x20for\x20a<strong>\x20quicker</strong>\x20<strong>recovery\x20of\x20platelet\x20function</strong>\x20upon\x20<strong>discontinuation\x20of\x20the\x20drug.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.\x20Clopidogrel:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Clopidogrel<strong>\x20irreversibly\x20binds\x20to\x20the\x20P2Y12\x20receptor</strong>,\x20<strong>preventing\x20ADP\x20from\x20binding</strong>\x20and\x20thus\x20<strong>inhibiting</strong>\x20<strong>platelet\x20activation\x20and\x20aggregation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Prasugrel:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Prasugrel\x20is\x20another\x20<strong>thienopyridine</strong>\x20that\x20<strong>irreversibly\x20inhibits\x20the\x20P2Y12\x20receptor,</strong>\x20similar\x20to\x20clopidogrel.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Ticlopidine:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Ticlopidine\x20was\x20one\x20of\x20the<strong>\x20first\x20thienopyridine\x20drugs\x20to\x20inhibit\x20the\x20P2Y12\x20receptor\x20irreversibly.</strong>\x20It\x20is\x20<strong>less</strong>\x20<strong>commonly\x20used</strong>\x20now\x20due\x20to<strong>\x20its\x20side\x20effect\x20profile.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20understand\x20the\x20<strong>mechanism\x20of\x20action\x20of\x20P2Y12\x20inhibitors\x20</strong>and\x20to\x20<strong>differentiate\x20between\x20reversible</strong>\x20and\x20<strong>irreversible\x20inhibition\x20of\x20this\x20receptor</strong>.\x20<strong>Ticagrelor&#39;s\x20ability</strong>\x20to<strong>\x20reversibly\x20bind\x20the\x20P2Y12\x20receptor</strong>\x20on\x20<strong>platelets\x20distinguishes\x20</strong>it\x20from\x20other\x20<strong>thienopyridine\x20drugs,</strong>\x20which\x20<strong>bind\x20irreversibly,</strong>\x20and\x20has\x20<strong>clinical\x20implications\x20</strong>for\x20the\x20management\x20of\x20patients\x20requiring\x20<strong>antiplatelet\x20therapy.</strong></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Tirofiban</span></span></span></p>','true','UfrdW','Oyafe','Zaefc','selected','question_images','aRfRB','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20is\x20not\x20a\x20prodrug?</span></span></span></p>','HAYHY','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Abciximab</span></span></span></p>','prototype','test','4807285RjAchR','quizFile','notAttemptedResult','xrPha','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>These\x20interfere\x20with\x20the\x20synthesis\x20of\x20vitamin\x20K\x20dependent\x20clotting\x20factors.</span></span></span></p>','qvprr','ZGXIa','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>It\x20is\x20slower\x20acting\x20than\x20clopidogrel.</span></span></span></p>','ePPkf','FhUpX','hccfw','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20B.\x20Argatroban</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Argatroban\x20</strong>requires\x20<strong>regular\x20monitoring</strong>\x20because\x20it\x20is\x20a\x20<strong>direct\x20thrombin\x20inhibitor.\x20</strong>It\x20is\x20used\x20in\x20patients\x20with\x20<strong>heparin-induced</strong>\x20<strong>thrombocytopenia\x20(HIT)\x20</strong>and\x20has\x20a\x20<strong>narrow\x20therapeutic\x20window</strong>,\x20meaning\x20the\x20<strong>dosage\x20and\x20therapeutic\x20effect</strong>\x20must\x20be\x20<strong>carefully</strong>\x20<strong>balanced\x20</strong>to\x20<strong>avoid\x20under-\x20or\x20over-anticoagulation</strong>.\x20<strong>Monitoring\x20</strong>is\x20<strong>typically\x20done</strong>\x20using\x20the<strong>\x20activated\x20partial\x20thromboplastin\x20time\x20(aPTT)</strong>\x20to\x20ensure\x20the<strong>\x20drug&#39;s\x20efficacy\x20and\x20safety.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.\x20Enoxaparin:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Enoxaparin\x20is\x20a<strong>\x20low\x20molecular\x20weight\x20heparin\x20</strong>(LMWH)\x20used\x20for\x20the\x20<strong>prevention\x20and\x20treatment\x20of\x20deep\x20vein</strong>\x20<strong>thrombosis\x20(DVT)\x20and\x20pulmonary\x20embolism\x20(PE).</strong>\x20While\x20it\x20has\x20a\x20<strong>mor</strong>e\x20predictable\x20<strong>dose-response</strong>\x20relationship\x20compared\x20to\x20<strong>unfractionated\x20heparin</strong>,\x20routine<strong>\x20laboratory\x20monitoring\x20</strong>for\x20anticoagulation\x20effect\x20is\x20generally\x20<strong>not\x20required\x20in\x20most\x20patients.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Dabigatran:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Dabigatran\x20is\x20a\x20<strong>direct\x20oral\x20anticoagulant\x20(DOAC)</strong>\x20that<strong>\x20inhibits\x20thrombin.</strong>\x20It\x20is\x20<strong>used\x20</strong>for\x20<strong>stroke\x20prevention</strong>\x20in\x20<strong>non-valvular\x20atrial\x20fibrillation\x20</strong>and<strong>\x20treatment\x20of\x20DVT\x20</strong>and\x20<strong>PE,</strong>\x20among\x20other\x20indications.<strong>\x20Dabigatran</strong>\x20offers\x20the\x20advantage\x20of<strong>\x20fixed\x20dosing\x20without</strong>\x20the\x20need\x20for<strong>\x20routine\x20coagulation\x20monitoring.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Fondaparinux:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Fondaparinux\x20is\x20a\x20<strong>synthetic\x20pentasaccharide</strong>\x20that<strong>\x20inhibits\x20factor\x20Xa\x20indirectly\x20</strong>by\x20<strong>binding\x20to\x20antithrombin</strong>.\x20It\x20is\x20used\x20for<strong>\x20DVT\x20prevention\x20and\x20treatment</strong>\x20and\x20for<strong>\x20preventing\x20PE.\x20Like\x20LMWH,\x20fondaparinux</strong>\x20generally\x20<strong>does\x20not\x20</strong>require\x20<strong>routine</strong>\x20<strong>monitoring</strong>\x20due\x20to\x20its\x20predictable\x20pharmacokinetic\x20profile.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to<strong>\x20understand</strong>\x20which\x20<strong>anticoagulant\x20therapies</strong>\x20require<strong>\x20regular\x20monitoring\x20</strong>and\x20which<strong>\x20does\x20not.\x20</strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture6.jpg\x22\x20style=\x22height:409px;\x20width:1000px\x22\x20/></span></span></p>','toString','nav-btn-answered','filter','markReviewBtn','not_attempted','IDCOu','Kukjs','wqZZN','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Amiodarone</span></span></span></p>','TTmdG','CyTOx','target','Q6468086','AMySF','Q6805504','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Direct\x20Xa\x20inhibitors</span></span></span></p>','Q4852743','Correct','VxTXN','apply','SUeFq','SoygR','yStuI','markReviewText','bottom','VJPfQ','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Epsilon\x20aminocaproic\x20acid</span></span></span></p>','hmEEH','statsBar','gRerV','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Switch\x20to\x20aspirin.</span></span></span></p>','jcWxu','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>It\x20decreases\x20the\x20requirement\x20of\x20blood\x20transfusions.</span></span></span></p>','GpXxU','.option-button','cQiGJ','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Protein\x20C</span></span></span></p>','Not\x20Attempted','classList','quizHierarchy','src','MRkdx','forEach','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Continue\x20warfarin\x20and\x20add\x20heparin.</span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>It\x20is\x20a\x20reversible\x20antagonist\x20of\x20ADP\x20receptors.</span></span></span></p>','qBank','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>These\x20can\x20produce\x20anticoagulant\x20effect\x20both\x20in\x20vivo\x20and\x20in\x20vitro.</span></span></span></p>','incorrect','QRWoN','OumOs','hierarchy','QPXSD','BufIS','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20D.\x20Epsilon\x20aminocaproic\x20acid</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Antifibrinolytic\x20agents\x20</strong>are\x20drugs\x20that\x20help\x20to<strong>\x20prevent\x20the\x20breakdown\x20of\x20blood\x20clots\x20by\x20inhibiting\x20the\x20activity\x20of\x20fibrinolytic\x20enzymes.</strong>\x20<strong>Epsilon\x20aminocaproic\x20acid\x20(EACA)\x20</strong>and<strong>\x20tranexamic\x20acid\x20</strong>are\x20<strong>antifibrinolytic\x20agents\x20</strong>that\x20work\x20by\x20<strong>inhibiting\x20the\x20conversion\x20of</strong>\x20<strong>plasminogen\x20to\x20plasmin,\x20</strong>which\x20is\x20responsible\x20for\x20the\x20<strong>breakdown\x20of\x20fibrin\x20clots.</strong>\x20These\x20are\x20<strong>used\x20to\x20</strong>treat\x20<strong>excessive\x20bleeding</strong>\x20as\x20in\x20<strong>heavy\x20menstrual\x20flow,</strong>\x20in\x20surgical\x20settings,\x20and\x20<strong>to\x20prevent\x20bleeding\x20</strong>in\x20patients\x20<strong>with\x20hemophilia.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Dabigatran</strong>\x20is\x20a\x20<strong>direct\x20thrombin\x20inhibitor</strong>\x20that\x20<strong>prevents</strong>\x20the\x20formation\x20of<strong>\x20blood\x20clots</strong>\x20by<strong>\x20inhibiting</strong>\x20the<strong>\x20activity\x20of\x20thrombin,</strong>\x20a\x20key\x20enzyme\x20in\x20the\x20clotting\x20process.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Protamine\x20</strong>is\x20a\x20medication\x20used\x20to\x20<strong>reverse\x20the\x20effects\x20of\x20heparin</strong>.\x20Protamine\x20works\x20by\x20<strong>binding\x20to\x20heparin</strong>,<strong>\x20neutralizing\x20its</strong>\x20<strong>anticoagulant\x20effects.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Alteplase</strong>\x20is\x20a<strong>\x20thrombolytic\x20agent</strong>\x20that\x20works\x20by\x20<strong>converting\x20plasminogen\x20to\x20plasmin,\x20</strong>which\x20<strong>breaks\x20down\x20fibrin\x20clots</strong>.\x20It\x20is\x20used\x20in\x20<strong>cases\x20of\x20acute\x20MI\x20and\x20stroke.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span><br\x20/>\x0d\x0a&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Epsilon\x20aminocaproic\x20acid</strong>\x20and<strong>\x20tranexamic\x20acid\x20</strong>are\x20<strong>antifibrinolytic\x20agents</strong>\x20that\x20<strong>inhibit\x20the\x20conversion\x20of\x20plasminogen\x20to\x20plasmin,\x20preventing\x20the\x20breakdown\x20of\x20fibrin\x20clots.</strong></span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Argatroban</span></span></span></p>','No\x20solution\x20available.','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20A.\x20Aspirin</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Aspirin\x20(acetylsalicylic\x20acid)\x20</strong>works\x20by\x20<strong>irreversibly\x20inhibiting\x20cyclooxygenase-1\x20(COX-1),</strong>\x20which\x20is\x20an\x20enzyme\x20responsible\x20for<strong>\x20converting\x20arachidonic\x20acid\x20to\x20thromboxane\x20A2\x20(TXA2).\x20Thromboxane\x20A2\x20is\x20a\x20potent\x20vasoconstrictor\x20and\x20inducer\x20of\x20platelet\x20aggregation.\x20In\x20the\x20diagram,\x20Drug\x20X\x20is\x20shown\x20to\x20be\x20inhibiting\x20the\x20pathway\x20that\x20leads\x20to\x20the\x20production\x20of\x20TXA2,\x20which\x20aligns\x20with\x20the\x20action\x20of\x20aspirin.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></span></span></strong></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Clopidogrel:\x20Clopidogrel\x20is\x20an\x20ADP\x20receptor\x20inhibitor.\x20It\x20inhibits\x20the\x20P2Y12\x20receptor\x20on\x20the\x20platelet\x20surface,\x20which\x20is\x20involved\x20in\x20ADP-induced\x20platelet\x20activation\x20and\x20aggregation.\x20This\x20mechanism\x20is\x20not\x20consistent\x20with\x20the\x20action\x20of\x20Drug\x20X\x20in\x20the\x20diagram.</span></span></span></strong></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Abciximab:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Abciximab\x20is\x20a\x20glycoprotein\x20IIb/IIIa\x20inhibitor.\x20It\x20binds\x20to\x20the\x20glycoprotein\x20IIb/IIIa\x20receptor\x20on\x20the\x20platelet\x20surface,\x20preventing\x20fibrinogen\x20binding\x20and\x20platelet\x20aggregation.\x20</strong>This\x20<strong>action\x20does\x20not\x20</strong>involve\x20the<strong>\x20COX\x20pathway\x20</strong>and\x20therefore\x20does\x20<strong>not</strong>\x20correspond\x20to<strong>\x20Drug\x20X.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Atopaxar:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Atopaxar</strong>\x20is\x20a<strong>\x20protease-activated\x20receptor-1\x20(PAR-1)\x20antagonist.</strong>\x20It\x20<strong>inhibits</strong>\x20<strong>thrombin\x20receptor\x20signaling\x20</strong>on\x20<strong>platelets</strong>.\x20Sinc<strong>e\x20Drug\x20X</strong>\x20is<strong>\x20shown\x20acting</strong>\x20on\x20the<strong>\x20COX\x20pathway,</strong>\x20<strong>Atopaxar</strong>\x20is<strong>\x20not\x20</strong>the\x20<strong>correct\x20answer.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to<strong>\x20identify\x20antiplatelet\x20drugs\x20</strong>based\x20on\x20their\x20<strong>mechanism\x20of\x20action</strong>,\x20specifically\x20recognizing\x20the\x20unique\x20<strong>action\x20of\x20aspirin\x20</strong>on\x20the<strong>\x20COX-1\x20enzyme\x20</strong>leading\x20to\x20the<strong>\x20inhibition\x20of\x20thromboxane\x20A2\x20synthesis\x20and\x20subsequent\x20platelet\x20aggregation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Antiplatelet\x20Drugs</span></span></strong></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture12.jpg\x22\x20style=\x22height:521px;\x20width:1000px\x22\x20/></span></span></strong></p>','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','JenPz','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','Peyoa','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Protein\x20C\x20deficiency</span></span></span></p>','srMJH','bind','.m3u8','lKjTb','zXUTr','ntMLv','uMlzn','OLgvB','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20A.\x20Prasugrel</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Prasugrel</strong>\x20is\x20<strong>not\x20a\x20glycoprotein\x20(Gp)\x20IIb/IIIa\x20inhibitor.</strong>\x20It\x20is\x20a<strong>\x20thienopyridine</strong>\x20<strong>class\x20antiplatelet\x20agent,\x20</strong>similar\x20to\x20<strong>clopidogrel,</strong>\x20that\x20works\x20by\x20<strong>irreversibly\x20inhibiting\x20the\x20P2Y12\x20subtype\x20of\x20ADP\x20receptor\x20on\x20platelets,\x20</strong>thus\x20<strong>preventing\x20platelet\x20activation\x20</strong>and<strong>\x20aggregation.</strong>\x20<strong>Prasugrel</strong>\x20is\x20a\x20<strong>prodrug</strong>\x20that\x20requires<strong>\x20metabolic\x20activation\x20in\x20the\x20liver.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Abciximab:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Abciximab\x20is\x20a<strong>\x20Gp\x20IIb/IIIa\x20inhibitor.</strong>\x20It\x20is\x20a\x20<strong>monoclonal\x20antibody</strong>\x20that\x20<strong>binds</strong>\x20to\x20the\x20<strong>Gp\x20IIb/IIIa\x20receptor\x20</strong>on\x20<strong>platelets</strong>,\x20<strong>preventing\x20the\x20binding\x20of\x20fibrinogen</strong>\x20and\x20<strong>von\x20Willebrand\x20factor</strong>,\x20which\x20<strong>inhibits\x20platelet\x20aggregation.</strong>\x20It\x20is\x20<strong>used</strong>\x20in\x20<strong>acute</strong>\x20<strong>coronary\x20syndrome</strong>\x20and\x20during\x20<strong>percutaneous\x20coronary\x20interventions</strong>\x20to\x20<strong>prevent\x20thrombosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Tirofiban:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Tirofiban\x20is\x20a<strong>\x20non-peptide\x20antagonist\x20of\x20the\x20Gp\x20IIb/IIIa\x20receptor,\x20</strong>which\x20<strong>inhibits\x20platelet\x20aggregation</strong>\x20by\x20<strong>preventing\x20fibrinogen\x20binding\x20to\x20the\x20Gp\x20IIb/IIIa\x20receptor.</strong>\x20It\x20is\x20used\x20to<strong>\x20prevent\x20thrombotic\x20cardiovascular\x20events</strong>\x20in\x20patients\x20with\x20<strong>acute\x20coronary\x20syndrome.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Eptifibatide:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Eptifibatide\x20is\x20a\x20<strong>cyclic\x20heptapeptide\x20and\x20a\x20Gp\x20IIb/IIIa\x20inhibitor</strong>.\x20It\x20works\x20by<strong>\x20reversibly\x20blocking\x20the\x20Gp\x20IIb/IIIa\x20receptor</strong>,\x20thereby\x20<strong>inhibiting\x20platelet\x20aggregation.\x20</strong>It\x20is\x20<strong>used\x20</strong>in\x20the\x20management\x20of<strong>\x20acute\x20coronary\x20syndrome\x20</strong>and\x20during\x20<strong>percutaneous\x20coronary\x20interventions.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20<strong>recognize\x20the\x20classification\x20of\x20antiplatelet\x20agents</strong>,\x20particularly\x20<strong>distinguishing\x20between\x20Gp\x20IIb/IIIa\x20inhibitors\x20(abciximab,\x20tirofiban,\x20and\x20eptifibatide)\x20</strong>and\x20<strong>other\x20classes\x20of\x20antiplatelet\x20drugs\x20</strong>such\x20as\x20<strong>prasugrel,\x20</strong>which\x20<strong>acts\x20on</strong>\x20the\x20<strong>P2Y12\x20ADP\x20receptor</strong>,\x20not\x20the\x20Gp\x20IIb/IIIa\x20receptor.\x20</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>ANTIPLATELET\x20DRUGS</span></span></strong></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture5.jpg\x22\x20style=\x22height:474px;\x20width:1000px\x22\x20/></span></span></strong></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Oprelvekin</span></span></span></p>','XTJok','mqYEF','add','flex','fUxYH','CsiLB','answered','LPaSC','MaKzB','xXPxd','urHIk','modeModal','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','<p><span\x20style=\x22font-size:12pt;\x22>Mass\x20of\x20total\x20salt\x20is\x20important\x20in\x20determining\x20daily\x20dose.</span></p>','incorrectCount','solution','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Enoxaparin</span></span></span></p>','solutionContainer','LaWNx','GIxFN','return\x20(function()\x20','<p><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Clopidogrel</span></span></p>','TBpLQ','block','createElement','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','totalQuestionsResult','gmAiO','YcBUi','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Thromboxane\x20A2</span></span></span></p>','jxIwa','UBBrS','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Anti-depressants</span></span></span></p>','teQko','stats','osjsj','TreatmentBased','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Osteotensin</span></span></span></p>','YyrvS','CSTdG','ptiuO','kPOud','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Epsilon\x20Aminocaproic\x20acid</span></span></span></p>','questionStates','XJBrM','3027358AtjUhH','PSDco','log','vmhjw','JxJrk','GYxMi','prevBtn','UCbMa','EOoaR','7rrLAPu','qvAuN','ILmxJ','pjgeu','<p><span\x20style=\x22font-size:12pt;\x22>Monitoring\x20is\x20done\x20through\x20INR.</span></p>','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','4QGUwro','LWjSL','toLowerCase','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Factor\x20V\x20leiden\x20deficiency</span></span></span></p>','getAttribute','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Fondaparinux</span></span></span></p>','tOpRf','resume','intermediate','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20drugs\x20reversibly\x20binds\x20the\x20site\x20labelled\x20as\x20B\x20in\x20the\x20given\x20figure?</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture14.jpg\x22\x20style=\x22height:269px;\x20width:300px\x22\x20/></p>','UXypA','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>There\x20is\x2050%\x20absorption\x20from\x20325\x20mg\x20of\x20ferrous\x20sulfate\x20via\x20oral\x20route.</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20drugs\x20is\x20used\x20postoperatively\x20to\x20reverse\x20the\x20effect\x20of\x20heparin\x20used\x20intraoperatively\x20in\x20cardiac\x20surgery?</span></span></span></p>','questionMedia','yLuGR','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Sickle\x20cell\x20anaemia</span></span></span></p>','xbRVB','gfXEZ','gray','AYAZU','Bookmarked','tcUNj','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20proportion\x20of\x20iron\x20absorbed\x20reduces\x20as\x20haemoglobin\x20improves.</span></span></span></p>','mzqFD','TrOSA','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20treatment\x20should\x20be\x20discontinued\x20immediately\x20once\x20haemoglobin\x20normalizes\x20to\x20prevent\x20side\x20effects\x20of\x20iron.</span></span></span></p>','QqLtF','pHLwZ','JqCyv','addEventListener','nav-btn-incorrect','solutionText','YEleN','explanationVideoPlayer','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Andexanet\x20&alpha;</span></span></span></p>','ymWso','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Carbamazepine</span></span></span></p>','currentMode','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Idarucizumab</span></span></span></p>','XxKOL','strokeDashoffset','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','Marked','<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong>Ans.\x20C.\x20Monitoring\x20is\x20done\x20through\x20INR.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong>Option\x20C:</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong>Warfarin</strong>\x20is\x20an\x20<strong>oral\x20anticoagulant</strong>\x20that\x20acts\x20by<strong>\x20inhibiting\x20the\x20activation\x20of\x20vitamin\x20K-dependent\x20clotting\x20factors\x20II,\x20VII,\x20IX,\x20and\x20X\x20</strong>in\x20the\x20<strong>liver.</strong>\x20It\x20is\x20used\x20to\x20prevent\x20and\x20treat\x20thromboembolic\x20disorders,\x20such\x20as<strong>\x20deep\x20vein\x20thrombosis</strong>,\x20<strong>pulmonary\x20embolism</strong>,\x20<strong>atrial</strong>\x20<strong>fibrillation</strong>,\x20and<strong>\x20mechanical\x20heart\x20valves</strong>.\x20The<strong>\x20therapeutic\x20effect\x20of\x20warfarin\x20</strong>is\x20<strong>monitored</strong>\x20by\x20the<strong>\x20International\x20Normalized\x20Ratio</strong>\x20<strong>(INR)</strong>,\x20which\x20is\x20a<strong>\x20standardized</strong>\x20measure\x20of\x20the\x20patient\x27s<strong>\x20prothrombin\x20time\x20(PT)\x20</strong>compared\x20to\x20a\x20<strong>normal\x20control.</strong>\x20The\x20<strong>target\x20INR\x20</strong>range\x20<strong>depends\x20on\x20the\x20indication</strong>\x20and\x20the\x20patient\x27s\x20<strong>individual\x20risk\x20of\x20bleeding\x20and\x20thrombosis</strong>,\x20but\x20it\x20is\x20typically\x20<strong>2.0-3.0</strong>\x20for\x20most\x20indications.</span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong><u>Explanation:</u></strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong>Option\x20A.</strong>&nbsp;<strong>Act\x20through\x20inhibition\x20of\x20coagulation\x20factor\x20VIII:</strong>\x20<strong>Warfarin</strong>\x20primarily<strong>\x20inhibits\x20the\x20synthesis\x20of\x20vitamin\x20K-dependent\x20clotting</strong>\x20<strong>factors\x20II,\x20VII,\x20IX,\x20and\x20X\x20in\x20the\x20liver</strong>.\x20It\x20<strong>does\x20not</strong>\x20specifically\x20target<strong>\x20factor\x20VIII.</strong>\x20Therefore,\x20this\x20statement\x20is\x20<strong>incorrect.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong>Option\x20B.\x20Protamine\x20sulphate\x20reverses\x20its\x20action:</strong>\x20<strong>Protamine\x20sulfate</strong>\x20is\x20a\x20<strong>specific\x20antidote</strong>\x20for<strong>\x20heparin,\x20not\x20warfarin.</strong>\x20Warfarin\x27s\x20anticoagulant\x20effect\x20can\x20be<strong>\x20reversed\x20with\x20vitamin\x20K\x20</strong>or\x20<strong>prothrombin\x20complex\x20concentrate</strong>s.\x20Therefore,\x20this\x20statement\x20is<strong>\x20incorrect.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong>Option\x20D.\x20Target\x20INR\x20for\x20patients\x20of\x20Pulmonary\x20embolism\x20on\x20warfarin\x20therapy\x20is\x20generally\x206-8:&nbsp;</strong>The\x20<strong>target\x20INR\x20</strong>range\x20for\x20patients\x20on\x20<strong>warfarin\x20therapy\x20</strong>depends\x20on\x20the\x20<strong>indication,</strong>\x20but\x20a\x20<strong>target\x20INR\x20of\x206-8\x20is\x20excessively\x20high</strong>\x20and\x20associated\x20with\x20an\x20<strong>increased\x20risk\x20of</strong>\x20<strong>bleeding</strong>.\x20For\x20most\x20indications,\x20including<strong>\x20pulmonary\x20embolism,</strong>\x20the\x20<strong>target\x20INR\x20range</strong>\x20is\x20typically<strong>\x202.0-3.0.\x20</strong>Therefore,\x20this\x20statement\x20is\x20<strong>incorrect.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong><u>Educational\x20objective:</u></strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22color:black;font-size:12.0pt;\x22><strong>Monitoring\x20of\x20warfarin\x20therapy\x20</strong>is\x20done\x20through\x20the<strong>\x20International\x20Normalized\x20Ratio\x20(INR),\x20</strong>which\x20is\x20a<strong>\x20standardized\x20</strong>measure\x20of\x20the\x20patient\x27s<strong>\x20prothrombin\x20time\x20(PT)\x20</strong>compared\x20to\x20a\x20<strong>normal\x20control.</strong></span></p>','Q1676174','Q5007148','QDpVZ','Ztrfw','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Warfarin</span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ticlopidine</span></span></span></p>','ibuBb','No\x20questions\x20available\x20for\x20this\x20quiz.','TJsqO','<div\x20class=\x22mt-4\x22><img\x20src=\x22','tjJUk','mtonj','qNEPV','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20A.\x20Protamine\x20sulphate\x20</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Protamine\x20sulphate\x20</strong>is\x20a\x20drug\x20that\x20is\x20used\x20to\x20<strong>neutralize\x20the\x20anticoagulant\x20effects\x20of\x20heparin,\x20</strong>which\x20is\x20a<strong>\x20negatively\x20charged\x20molecule.</strong>\x20<strong>Protamine</strong>,\x20being<strong>\x20positively\x20charged,\x20</strong>binds\x20to<strong>\x20heparin,\x20</strong>forming\x20a\x20<strong>complex\x20that\x20inhibits\x20heparin&#39;s\x20activity,</strong>\x20effectively\x20<strong>reversing\x20its</strong>\x20<strong>effects</strong>.\x20This\x20is\x20particularly\x20important\x20in\x20the\x20<strong>context\x20of\x20cardiac\x20surgery,\x20</strong>where<strong>\x20heparin</strong>\x20is\x20commonly\x20used\x20to<strong>\x20prevent\x20clot\x20formation</strong>\x20<strong>during\x20the\x20procedure.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Vitamin\x20K:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Incorrect</strong>\x20because<strong>\x20Vitamin\x20K</strong>\x20is\x20used\x20to\x20<strong>reverse\x20the\x20effects\x20of\x20warfarin</strong>,\x20not\x20heparin.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Tranexamic\x20acid:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Incorrect\x20</strong>as\x20it\x20is\x20used\x20to\x20<strong>reduce\x20bleeding\x20by\x20inhibiting\x20fibrinolysis,\x20</strong>not\x20reversing\x20heparin.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Factor\x20VIII\x20concentrate:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Incorrect\x20</strong>as\x20it\x20is\x20used\x20in\x20the\x20<strong>treatment\x20of\x20hemophilia\x20A,\x20</strong>not\x20for\x20reversing\x20heparin\x20effects.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Protamine\x20sulphate</strong>\x20is\x20the\x20<strong>drug\x20of\x20choice</strong>\x20for\x20<strong>reversing\x20the\x20anticoagulant\x20effects\x20of\x20heparin</strong>\x20following<strong>\x20cardiac\x20surgeries</strong>\x20or\x20other\x20<strong>procedures\x20</strong>where\x20<strong>heparin\x20has\x20been\x20used</strong>.\x20It\x20works\x20by<strong>\x20binding\x20to\x20and\x20neutralizing\x20heparin.</strong></span></span></span></p>','Q1787905','DCUFg','IiikE','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>A\x2045-year-old\x20patient\x20was\x20started\x20on\x20anticoagulant\x20therapy\x20for\x20DVT.\x20Few\x20days\x20after\x20he\x20presented\x20to\x20emergency\x20with\x20the\x20features\x20as\x20shown\x20in\x20figure.\x20Which\x20could\x20be\x20the\x20culprit\x20drug?</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture9.jpg\x22\x20style=\x22height:142px;\x20width:300px\x22\x20/></span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>It\x20can\x20cause\x20hypertension.</span></span></span></p>','abcWR','Q1803786','timeSpent','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','erUjY','WivTe','LIDOb','toISOString','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ciraparantag-\x20fondaparinux</span></span></span></p>','correctResult','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Low\x20molecular\x20weight\x20heparin</span></span></span></p>','DOfHu','bLxPd','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','vgqGi','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','NlEZI','KprTn','pathname','xztuf','lTKVA','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20A.\x20Anti-thrombin\x20III</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Anti-thrombin\x20III:\x20Heparin\x20</strong>acts\x20by<strong>\x20binding\x20to\x20and\x20enhancing</strong>\x20the\x20<strong>activity\x20of\x20antithrombin\x20III,\x20</strong>a\x20<strong>natural\x20anticoagulant\x20</strong>that\x20<strong>inhibits\x20the</strong>\x20activity\x20of\x20<strong>clotting\x20factors</strong>\x20such\x20as<strong>\x20thrombin\x20and\x20factor\x20Xa</strong>.<strong>\x20Heparin</strong>\x20<strong>accelerates</strong>\x20the\x20ability\x20of\x20<strong>antithrombin\x20III\x20</strong>to\x20<strong>inhibit\x20</strong>these\x20<strong>clotting\x20factors</strong>,\x20resulting\x20in\x20the<strong>\x20prevention\x20and\x20treatment\x20of\x20thrombotic\x20events.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:\x20Protein\x20C:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Protein\x20C\x20is\x20a\x20<strong>natural\x20anticoagulant</strong>\x20that\x20is\x20<strong>activated\x20by\x20thrombomodulin</strong>,\x20a\x20<strong>protein\x20</strong>expressed\x20on\x20the<strong>\x20surface\x20of</strong>\x20<strong>endothelial\x20cells</strong>.\x20<strong>Protein\x20C\x20inactivates\x20factors\x20V\x20and\x20VIII,</strong>\x20which\x20are<strong>\x20involved</strong>\x20in\x20the\x20<strong>clotting\x20process</strong>.\x20<strong>Heparin\x20does\x20not</strong>\x20directly\x20<strong>activate\x20protein\x20C.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:\x20Protein\x20S:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Protein\x20S\x20is\x20a\x20<strong>cofactor\x20for\x20protein\x20C,\x20</strong>which\x20<strong>enhances\x20its\x20activity.</strong>\x20<strong>Heparin\x20does\x20not\x20</strong>directly\x20a<strong>ctivate\x20protein\x20S.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D:\x20Thrombomodulin:\x20</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Thrombomodulin\x20</strong>is\x20a\x20<strong>protein\x20</strong>expressed\x20on\x20the<strong>\x20surface\x20of\x20endothelial\x20cells</strong>\x20that\x20<strong>binds\x20to</strong>\x20and<strong>\x20activates</strong>\x20<strong>protein\x20C</strong>.\x20<strong>Heparin</strong>\x20<strong>does\x20not\x20</strong>directly<strong>\x20activate\x20thrombomodulin.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><br\x20/>\x0d\x0a<span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Heparin\x20</strong>acts\x20by<strong>\x20enhancing\x20the\x20activity\x20of\x20anti-thrombin\x20III,\x20</strong>which<strong>\x20inhibits\x20clotting\x20factors</strong>\x20such\x20as\x20<strong>thrombin\x20and\x20factor\x20Xa.</strong></span></span></span></span></span></p>','click','(((.+)+)+)+$','bookmarkedQuestions','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Heparin\x20acts\x20via\x20activation\x20of\x20which\x20of\x20the\x20following\x20molecules?</span></span></span></p>','kjgIW','SjuBJ','ftgrz','totalQuestions','nav-btn-marked-review','eoaWu','jbYMK','<p><span\x20style=\x22font-size:12pt;\x22>Act\x20through\x20inhibition\x20of\x20coagulation\x20factor\x20VIII</span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20drugs\x20is\x20commonly\x20used\x20in\x20treatment\x20for\x20cancer\x20associated\x20thromboembolism?\x20</span></span></span></p>','Q4513329','xcmXE','xVMuN','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20B.\x20Before\x20administering\x20parenteral\x20iron,\x20the\x20dose\x20should\x20be\x20diluted\x20and\x20checked\x20for\x20anaphylaxis.</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Parenteral\x20iron</strong>\x20therapy\x20requires\x20a\x20test\x20<strong>dose\x20to\x20monitor\x20</strong>for\x20potential<strong>\x20allergic\x20reactions</strong>,\x20including<strong>\x20anaphylaxis.</strong>\x20It\x20is\x20a\x20<strong>crucial\x20safety</strong>\x20measure\x20given\x20the\x20<strong>risk</strong>\x20of\x20<strong>severe\x20hypersensitivity\x20reactions.</strong>\x20This\x20therapy\x20is\x20usually\x20considered\x20when\x20<strong>oral\x20iron\x20is\x20not\x20tolerated,</strong>\x20is\x20<strong>ineffective,</strong>\x20or\x20if\x20there\x20is\x20a\x20need\x20for<strong>\x20rapid\x20repletion\x20of\x20iron\x20stores.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Oral\x20iron</strong>\x20therapy\x20typically\x20<strong>continues\x20until\x20hemoglobin\x20and\x20hematocrit\x20are\x20normalized\x20</strong>and\x20should\x20proceed\x20for\x20<strong>several</strong>\x20<strong>months\x20afterward\x20</strong>to\x20<strong>replenish\x20iron\x20stores.</strong>\x20<strong>Discontinuation\x20</strong>solely\x20due\x20to\x20<strong>gastric\x20side\x20effects</strong>\x20is\x20<strong>not\x20routine\x20practice.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Absorption\x20of\x20oral\x20ferrous\x20sulfate</strong>\x20is\x20<strong>not</strong>\x20as\x20high\x20as\x20<strong>50%;\x20</strong>it\x20is<strong>\x20usually\x20</strong>around\x20<strong>10-20%,\x20</strong>and\x20it\x20is\x20influenced\x20by\x20various\x20factors\x20like\x20<strong>dietary\x20components\x20and\x20patient&rsquo;s\x20iron\x20status.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Oral\x20iron</strong>\x20is\x20the\x20preferred\x20<strong>initial\x20treatment\x20for\x20iron\x20deficiency\x20anemia</strong>\x20due\x20to\x20<strong>convenience,\x20cost-effectiveness</strong>,\x20and\x20generally<strong>\x20good\x20tolerability.\x20Parenteral\x20iron</strong>\x20is\x20<strong>reserved</strong>\x20for\x20<strong>specific\x20circumstances.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>When\x20using\x20<strong>parenteral\x20iron</strong>\x20for\x20<strong>iron\x20deficiency\x20anemia,</strong>\x20a\x20<strong>test\x20</strong>dose\x20is\x20necessary\x20to\x20<strong>monitor\x20for\x20anaphylaxis</strong>.\x20<strong>Oral\x20iron\x20</strong>remains\x20the\x20<strong>first-line\x20treatment</strong>,\x20with\x20<strong>continuation\x20after\x20normalization\x20of\x20hematocrit\x20</strong>to<strong>\x20replenish\x20iron\x20stores</strong>,\x20while<strong>\x20parenteral\x20iron</strong>\x20is\x20used\x20<strong>under\x20specific\x20conditions.</strong></span></span></span></p>','mLVyQ','pdsbY','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20B.\x20Ticagrelor</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Ticagrelor</strong>\x20is\x20not\x20a\x20prodrug.\x20It\x20is\x20an\x20<strong>oral\x20antiplatelet\x20agent\x20</strong>that\x20belongs\x20to\x20the\x20class\x20of\x20<strong>cyclopentyltriazolopyrimidines</strong>.\x20Unlike\x20<strong>prodrugs,</strong>\x20which\x20require<strong>\x20metabolic\x20activation\x20</strong>to\x20become\x20<strong>pharmacologically\x20active</strong>,\x20<strong>ticagrelor\x20</strong>is\x20<strong>active</strong>\x20in\x20its<strong>\x20administered\x20form</strong>.\x20It\x20exerts\x20its<strong>\x20antiplatelet\x20effect\x20</strong>by<strong>\x20directly\x20and\x20reversibly\x20binding\x20to\x20the\x20P2Y12\x20class\x20of\x20ADP\x20receptors\x20on\x20platelets</strong>,<strong>\x20inhibiting\x20platelet</strong>\x20<strong>activation\x20and\x20aggregation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.\x20Ticlopidine:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Ticlopidine\x20is\x20a<strong>\x20thienopyridine\x20antiplatelet\x20agent</strong>,\x20<strong>similar</strong>\x20to<strong>\x20clopidogrel\x20and\x20prasugrel,\x20</strong>and\x20is\x20a\x20prodrug.\x20It\x20requires<strong>\x20metabolic\x20activation</strong>\x20by\x20the<strong>\x20liver\x20</strong>to\x20form\x20its\x20<strong>active\x20metabolite</strong>,\x20which\x20then\x20<strong>inhibits\x20the\x20P2Y12\x20adenosine\x20diphosphate\x20(ADP</strong>)\x20r<strong>eceptor\x20on\x20platelets,\x20preventing\x20platelet\x20activation\x20and\x20aggregation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Clopidogrel:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Clopidogrel\x20is\x20another<strong>\x20thienopyridine</strong>\x20class<strong>\x20antiplatelet\x20medication</strong>\x20and\x20a\x20<strong>prodrug.\x20</strong>It\x20requires<strong>\x20hepatic</strong>\x20<strong>biotransformation</strong>\x20to\x20an\x20<strong>active\x20metabolite\x20</strong>that<strong>\x20inhibits\x20the\x20P2Y12\x20component\x20of\x20ADP\x20receptors\x20on\x20the\x20surface\x20of\x20platelets</strong>,\x20<strong>reducing\x20platelet\x20aggregation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Prasugrel:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Prasugrel\x20is\x20also\x20a<strong>\x20thienopyridine\x20antiplatelet\x20drug\x20</strong>and\x20a\x20<strong>prodrug</strong>.\x20It\x20is<strong>\x20rapidly\x20metabolized</strong>\x20to\x20<strong>its\x20active</strong>\x20<strong>metabolite\x20</strong>in\x20the\x20body,\x20which\x20then\x20<strong>irreversibly\x20binds</strong>\x20to\x20the\x20<strong>P2Y12\x20receptor\x20on\x20platelets,</strong>\x20<strong>inhibiting\x20platelet\x20activation\x20</strong>and\x20<strong>aggregation</strong>\x20<strong>more\x20efficiently</strong>\x20and\x20consistently\x20than<strong>\x20clopidogrel.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20<strong>identify\x20the\x20antiplatelet\x20agent</strong>\x20that\x20is<strong>\x20not\x20a\x20prodrug\x20</strong>among\x20the\x20options\x20provided.\x20Understanding\x20the\x20<strong>distinction\x20</strong>between\x20<strong>prodrugs\x20and\x20drugs</strong>\x20that\x20are\x20<strong>active\x20in\x20their\x20administered\x20form\x20</strong>is\x20crucial\x20for\x20<strong>pharmacological\x20knowledge,</strong>\x20especially\x20in\x20the\x20context\x20of\x20antiplatelet\x20therapy<strong>.\x20Prodrugs\x20</strong>require<strong>\x20metabolic\x20activation\x20</strong>to\x20exert\x20their\x20<strong>pharmacological\x20effects,</strong>\x20whereas\x20drugs\x20like<strong>\x20ticagrelor\x20are\x20active\x20upon\x20administration,</strong>\x20offering\x20a\x20<strong>different\x20profile\x20of\x20onset,\x20duration,\x20and\x20potentially\x20side</strong>\x20<strong>effect\x20profiles,</strong>\x20which\x20can\x20impact<strong>\x20clinical\x20decisions</strong>\x20in\x20the\x20management\x20of<strong>\x20cardiovascular\x20diseases.</strong></span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Thrombopoietin\x20antagonist</span></span></span></p>','18sUFCax','CRult','Qjbyg','yDpAP','Tcukm','studyModeLegend','nBieW','review-question\x20','eyDvD','TeyfE','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Atopaxar</span></span></span></p>','isArray','FfPOi','QaFxP','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20B.\x20It\x20results\x20in\x20decrease\x20in\x20reticulocyte\x20count.</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Erythropoietin\x20</strong>is\x20a\x20<strong>growth\x20factor</strong>\x20that\x20<strong>stimulates\x20erythropoiesis</strong>\x20or<strong>\x20red\x20blood\x20cell\x20production.</strong>\x20It\x20is\x20indeed\x20used\x20to\x20<strong>treat\x20anaemia</strong>,\x20particularly\x20the\x20type\x20caused\x20by<strong>\x20chronic\x20renal\x20failure</strong>.\x20It\x20should\x20lead\x20to\x20an<strong>\x20<em>increase</em>\x20in\x20reticulocyte\x20count</strong>\x20as\x20it\x20stimulates\x20the\x20<strong>bone</strong>\x20<strong>marrow\x20to\x20produce\x20more\x20red\x20blood\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>&nbsp;Correct.</strong>\x20<strong>Erythropoietin</strong>\x20is\x20used\x20to<strong>\x20treat\x20anaemia</strong>\x20due\x20to\x20<strong>chronic\x20renal\x20failure\x20</strong>because\x20the<strong>\x20kidneys</strong>\x20in\x20such\x20patients\x20<strong>do\x20not</strong>\x20produce\x20enough\x20<strong>endogenous\x20erythropoietin.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Correct.</strong>\x20By\x20<strong>stimulating\x20red\x20blood\x20cell\x20production,</strong>\x20<strong>erythropoietin</strong>\x20<strong>reduces</strong>\x20the\x20need\x20for\x20<strong>blood\x20transfusions.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Correct.</strong>\x20<strong>Erythropoietin</strong>\x20can\x20sometimes\x20cause\x20<strong>hypertension\x20</strong>as\x20a\x20<strong>side\x20effect\x20</strong>because\x20of\x20the<strong>\x20increased\x20red\x20blood\x20cell\x20mass</strong>\x20and\x20<strong>possibly</strong>\x20other\x20<strong>mechanisms.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Erythropoietin\x20</strong>treatment\x20should\x20result\x20in\x20an\x20<strong>increased\x20reticulocyte\x20count,</strong>\x20reflecting\x20the\x20<strong>stimulated\x20production\x20of\x20red\x20blood\x20cells</strong>.\x20It\x20is\x20<strong>beneficial\x20in\x20chronic\x20renal\x20failure-related\x20anaemia\x20</strong>and\x20can\x20help\x20<strong>decrease\x20</strong>the\x20need\x20for\x20<strong>transfusions,</strong>\x20although\x20it\x20may\x20cause\x20<strong>hypertension\x20</strong>as\x20a<strong>\x20side\x20effect.</strong></span></span></span></p>','siieP','timed_study','gSyjB','GKbFu','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Osteophysin</span></span></span></p>','<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22>For\x20oral\x20iron\x20supplements\x20used\x20for\x20iron\x20deficiency\x20anaemia,\x20which\x20of\x20the\x20following\x20statements\x20is\x20correct?</span></p>','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','explanation_video','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>All\x20are\x20ADP\x20inhibitors\x20except:</span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Aspirin</span></span></span></p>','znROj','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Andexanet\x20alfa-\x20rivaroxaban</span></span></span></p>','question_audio','jiRTU','oIncj','BJtou','Q5188570','GXnAu','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>A\x2036-week\x20pregnant\x20female\x20was\x20taking\x20warfarin\x20for\x20prosthetic\x20heart\x20valves\x20and\x20has\x20INR\x20value\x20of\x203.\x20Next\x20step\x20in\x20the\x20management\x20is?\x20</span></span></span></p>','GwLuu','Lpwti','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Hirudin</span></span></span></p>','agXsF','currentQuestionIndex','kTVdX','nav-btn-bookmarked','emFPK','</span><span>','yVsjj','reduce','bookmarkBtn','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Osteocalcin</span></span></span></p>','CezcB','testModeReviewLegend','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>All\x20the\x20following\x20drugs\x20increase\x20bleeding\x20when\x20given\x20to\x20a\x20patient\x20on\x20warfarin\x20except?</span></span></span></p>','WpTsM','frgSt','referrer','pCePG','tFEdU','canPlayType','MVfDq','KeToe','RNrWV','euJuE','SURSL','syXPm','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','Vskmr','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','appendChild','PUqaM','explanation_audio_eng','questionIndex','BWNwT','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Andexanet-\x20apixaban</span></span></span></p>','GshME','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>HIT\x20is\x20a\x20bleeding\x20disorder\x20caused\x20by\x20a\x20deficiency\x20of\x20von\x20Willebrand\x20factor\x20(vWF)\x20</span></span></span></p>','EXqZB','rsfOL','accuracyScore','Option\x20','VENYJ','2611880lGSuZB','KZDbl','notAttempted','Q2798642','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','question_video','cKcDx','iuHUT','className','LkYeS','No\x20question\x20text\x20available','navBtn_','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Decrease\x20the\x20risk\x20of\x20bleeding.</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20is\x20a\x20antagonist\x20of\x20PAR-1\x20receptors\x20of\x20thrombin?</span></span></span></p>','Q3408072','DBjbM','optvx','oPBcS','CqtOW','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Phenytoin</span></span></span></p>','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','totalTimeResult','lNGSV','parse','jLvKP','startAt','OgJdi','ImageBased','hematology-ba21e5d9.html','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Sulfasalazine</span></span></span></p>','text','userHistory','loadSource','2858466sKMHCm','TyTPk','KUPgY','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>HIT\x20is\x20characterized\x20by\x20a\x20normal\x20platelet\x20count\x20and\x20increased\x20risk\x20of\x20bleeding.</span></span></span></p>','Bookmark','EPgjC','reviewQuestionsContainer','IYucU','NXDSV','ddhtv','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Isoniazid</span></span></span></p>','LErTL','Gkhay','DiagnosisBased','Q1909165','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Antithrombin\x20III\x20inhibitors</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20statements\x20is\x20NOT\x20a\x20characteristic\x20feature\x20of\x20treatment\x20of\x20iron\x20deficiency\x20anaemia\x20with\x20oral\x20iron\x20supplements?</span></span></span></p>','Cerebellum','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Dabigatran</span></span></span></p>','round','phwiR','DzoHJ','rkGim','search','incorrectResult','bookmarked','suQMv','hdLlr','tLKYk','endsWith','textContent','JmqGs','uGIYC','questionText','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Cimetidine</span></span></span></p>','wLhKw','selectedAnswer','rlfiF','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>What\x20is\x20the\x20recommended\x20management\x20for\x20a\x20patient\x20who\x20experiences\x20excessive\x20bleeding\x20after\x20receiving\x20fibrinolytic\x20therapy\x20for\x20an\x20acute\x20myocardial\x20infarction?\x20</span></span></span></p>','stringify','No\x20solution\x20provided','ihbhp','setItem','KcJRX','Q6614565','solutionImages','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Vorapaxar</span></span></span></p>','KZukI','10Nwiidc','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','RkyBk','location','Q3242885','ZrXUj','eLfuK','nav-btn-correct','getElementById','querySelectorAll','LKdDi','Factual','QObBz','UVqqp','AGELj','border-red-500','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','UvYxp','eCeFc','PPKnC','hDLgx','avgTimeResult','PMQys','IoGJA','console','YWZOw','frBjA','quizSidebar','IVDPP','CredI','correct_choice_id','mMSOR','Q9726448','error','remove','explanation_images','YagpX','pPXNn','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Stop\x20warfarin\x20and\x20start\x20heparin.</span></span></span></p>','mLEua','style','push','McGsF','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','xwlWl','zxhMH','Q5755001','HWekc','tOjQN','green','Progress\x20loaded.','sYEsW','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Subcutaneous</span></span></span></p>','AXKTU','4|2|3|0|1|5','KkfZA','KthRq','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>PGF\x202&alpha;</span></span></span></p>','qGxGl','study','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','now','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Clopidogrel</span></span></span></p>','<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong>Ans.\x20A.\x20Tolerable\x20dose\x20will\x20deliver\x2040\x20to\x2060\x20mg\x20of\x20iron\x20per\x20dose.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong>Option\x20A:</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong>For\x20treating\x20iron\x20deficiency\x20anaemia,</strong>\x20a\x20tolerable\x20dose\x20of\x20<strong>oral\x20iron\x20supplements\x20</strong>typically\x20delivers\x20between\x20<strong>40\x20to\x2060\x20mg\x20of\x20elemental</strong>\x20<strong>iron\x20per\x20dose,</strong>\x20which\x20is\x20<strong>adequate\x20to\x20correct\x20anaemia\x20without</strong>\x20causing\x20significant<strong>\x20gastrointestinal\x20side\x20effects.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong><u>Explanation:</u></strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong>Option\x20B:</strong>\x20It\x20is\x20the<strong>\x20mass\x20of\x20elemental\x20iron</strong>,\x20rather\x20than\x20the\x20<strong>mass\x20of\x20total\x20salt</strong>,\x20that\x20is\x20critical\x20in\x20determining\x20the\x20<strong>daily\x20dose,</strong>\x20because\x20the<strong>\x20percentage\x20of\x20elemental\x20iron\x20</strong>varies\x20between\x20<strong>different\x20iron\x20salts.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong>Option\x20C:</strong>\x20<strong>Treatment</strong>\x20with\x20<strong>oral\x20iron</strong>\x20should<strong>\x20not\x20be\x20stopped</strong>\x20as\x20soon\x20as\x20<strong>normal\x20haemoglobin\x20level\x20is\x20reached;</strong>\x20it\x20should\x20continue\x20for\x20<strong>several\x20months\x20to\x20replenish\x20iron\x20stores.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong>Option\x20D:</strong>\x20The\x20<strong>desired\x20rate\x20of\x20haemoglobin\x20improvement</strong>\x20is\x20usually<strong>\x200.5\x20to\x201\x20g/dL\x20per\x20week,</strong>\x20not\x20per\x20day.</span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12pt;\x22><strong><u>Educational\x20objective:</u></strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>When\x20treating\x20<strong>iron\x20deficiency\x20anaemia,</strong>\x20it\x27s\x20important\x20to\x20consider\x20the\x20<strong>amount\x20of\x20elemental\x20iron\x20in\x20oral\x20supplements\x20</strong>and\x20<strong>continue</strong>\x20<strong>treatment\x20beyond\x20the\x20normalization\x20of\x20haemoglobin</strong>\x20to<strong>\x20fully\x20replenish\x20iron\x20stores.</strong></span></p>','\x22\x20data-option-index=\x22','RkwgF','INZlz','qobjY','bmDIi','oeCze','zgtdq','ktVsJ','495217nzqjUf','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Warfarin\x20embryopathy\x20is\x20due\x20to\x20the\x20action\x20of?\x20</span></span></span></p>','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','difficult','Q5389743','CWkYQ','EmaOE','solutionAudio','Q7026114','sjtSF','custom_quiz.html','ZFQgF','HgwkJ','\x22\x20data-src=\x22','ydzob','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Stop\x20warfarin\x20and\x20start\x20heparin\x20plus\x20aspirin.</span></span></span></p>','KXIrr','YeCtS','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Filgrastim</span></span></span></p>','aAcaE','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>It\x20is\x20used\x20for\x20the\x20treatment\x20of\x20anaemia\x20due\x20to\x20chronic\x20renal\x20failure.</span></span></span></p>','XdBDZ','gpiBu','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20B.\x20Subcutaneous</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Low\x20molecular\x20weight\x20(LMW)\x20heparin</strong>\x20is\x20administered\x20<strong>subcutaneously\x20for\x20thromboprophylaxis\x20in\x20post-operative\x20patients.</strong>\x20This\x20route\x20is\x20preferred\x20because\x20it\x20provides\x20a<strong>\x20reliable\x20and\x20consistent\x20absorption,</strong>\x20leading\x20to\x20<strong>predictable\x20anticoagulant\x20effects.</strong>\x20<strong>Subcutaneous\x20</strong>administration\x20is\x20particularly\x20suitable\x20for\x20the<strong>\x20prophylaxis\x20of\x20venous\x20thromboembolism\x20(VTE)</strong>\x20in\x20patients\x20who\x20have\x20<strong>undergone\x20surgeries\x20</strong>such\x20as<strong>\x20total\x20hip\x20replacement,\x20</strong>as\x20it\x20can\x20be\x20given\x20<strong>outside\x20of\x20a\x20hospital\x20setting,\x20does\x20not\x20</strong>require\x20frequent\x20<strong>monitoring\x20of\x20anticoagulation\x20levels</strong>,\x20and\x20has\x20a\x20<strong>lower\x20risk\x20of\x20hematoma</strong>\x20compared\x20to<strong>\x20intramuscular\x20injections.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.\x20Intramuscular:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20LMW\x20heparin</strong>\x20is\x20<strong>not\x20</strong>administered\x20<strong>intramuscularly</strong>\x20due\x20to\x20the<strong>\x20risk\x20of\x20hematoma\x20formation\x20in\x20the\x20muscle,</strong>\x20which\x20can\x20be\x20particularly\x20problematic\x20in\x20patients\x20with\x20a<strong>\x20heightened\x20risk\x20of\x20bleeding</strong>\x20or\x20those\x20who\x20are\x20<strong>receiving\x20anticoagulation</strong>\x20<strong>therapy.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Intravenous:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20While<strong>\x20LMW\x20heparin</strong>\x20can\x20be\x20<strong>administered\x20intravenously,</strong>\x20this\x20route\x20is<strong>\x20not\x20</strong>typically\x20used\x20for\x20<strong>thromboprophylaxis</strong>\x20in\x20the<strong>\x20post-operative\x20setting.</strong>\x20Intravenous\x20administration\x20is\x20more\x20common\x20for\x20<strong>unfractionated\x20heparin,</strong>\x20which\x20requires<strong>\x20monitoring\x20of\x20the\x20anticoagulant\x20effect</strong>\x20and\x20is\x20used\x20in\x20<strong>acute\x20settings.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Inhalational:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20This\x20route\x20is<strong>\x20not</strong>\x20<strong>applicable\x20to\x20LMW\x20heparin</strong>\x20as\x20it\x20i<strong>s\x20not\x20designed\x20for\x20inhalation.\x20</strong>The\x20<strong>inhalational</strong>\x20route\x20of\x20administration\x20is\x20used\x20for\x20<strong>drugs</strong>\x20intended\x20to<strong>\x20act\x20directly\x20on\x20the\x20lungs.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20understand\x20the<strong>\x20appropriate\x20route\x20of\x20administration\x20for\x20low\x20molecular\x20weight\x20heparin\x20</strong>in\x20the\x20context\x20of<strong>\x20thromboprophylaxis\x20in\x20post-operative\x20patients</strong>.\x20<strong>Subcutaneous\x20</strong>administration\x20is\x20the<strong>\x20preferred\x20and\x20recommended\x20route\x20</strong>because\x20it\x20offers\x20<strong>consistent\x20absorption\x20and\x20effective\x20prevention\x20</strong>of\x20<strong>VTE\x20without\x20</strong>the\x20need\x20for\x20routine<strong>\x20anticoagulation\x20monitoring</strong>,\x20<strong>minimizing\x20the\x20risk\x20of\x20complications\x20</strong>associated\x20with<strong>\x20other\x20routes\x20of\x20administration.</strong></span></span></span></p>','correctAnswers','customQuizData','hOcWD','getItem','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Chloroquine</span></span></span></p>','optionsContainer','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20B.\x20Oprelvekin</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Oprelvekin</strong>\x20is\x20the\x20correct\x20answer\x20because\x20it\x20is\x20a\x20<strong>recombinant\x20form\x20of\x20interleukin-11\x20(IL-11)\x20</strong>and\x20is\x20specifically\x20used\x20to\x20treat\x20<strong>thrombocytopenia</strong>,\x20which\x20is\x20a\x20d<strong>ecrease\x20in\x20the\x20number\x20of\x20platelets\x20in\x20the\x20blood,</strong>\x20<strong>secondary\x20to\x20anticancer\x20therapy.\x20Oprelvekin</strong>\x20works\x20by\x20<strong>stimulating\x20the\x20proliferation\x20of\x20megakaryocyte\x20progenitor\x20cells</strong>,\x20which\x20are\x20the\x20<strong>precursors\x20to\x20platelets,</strong>\x20thus<strong>\x20increasing\x20platelet</strong>\x20<strong>production</strong>.\x20This\x20mechanism\x20<strong>directly\x20addresses\x20</strong>the\x20condition\x20of<strong>\x20thrombocytopenia</strong>\x20by\x20enhancing\x20the\x20body&#39;s\x20ability\x20to\x20produce\x20<strong>platelets</strong>,\x20making\x20it\x20an<strong>\x20effective\x20treatment\x20</strong>option\x20in\x20this\x20context.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation</span></u></strong><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.\x20Filgrastim:&nbsp;</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Filgrastim\x20is\x20a\x20<strong>granulocyte\x20colony-stimulating\x20factor\x20(G-CSF)\x20</strong>that\x20is\x20used\x20to<strong>\x20increase\x20neutrophil\x20counts</strong>\x20in\x20patients<strong>\x20undergoing\x20chemotherapy.</strong>\x20It\x20<strong>stimulates\x20</strong>the\x20production\x20of<strong>\x20white\x20blood\x20cells,</strong>\x20not\x20platelets,\x20and\x20is\x20therefore\x20<strong>used\x20to\x20treat\x20</strong>or\x20<strong>prevent\x20neutropenia</strong>,\x20not\x20thrombocytopenia.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Erythropoietin:&nbsp;</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Erythropoietin\x20is\x20a\x20<strong>glycoprotein\x20hormone</strong>\x20that<strong>\x20stimulates\x20erythropoiesis,\x20</strong>or\x20<strong>red\x20blood\x20cell\x20production,</strong>\x20in\x20the<strong>\x20bone\x20marrow</strong>.\x20It\x20is<strong>\x20used\x20to</strong>\x20treat<strong>\x20anemia,</strong>\x20particularly\x20in<strong>\x20chronic\x20kidney\x20disease\x20</strong>and\x20in\x20patients\x20<strong>undergoing\x20chemotherapy.</strong>\x20It\x20<strong>does\x20not</strong>\x20directly<strong>\x20increase\x20platelet\x20counts.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Iron\x20dextran:&nbsp;</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Iron\x20dextran\x20is\x20an<strong>\x20intravenous\x20iron\x20supplement</strong>\x20used\x20to\x20treat\x20<strong>iron\x20deficiency\x20anemia.\x20</strong>It\x20<strong>does\x20not\x20</strong>stimulate\x20the\x20production\x20of\x20<strong>platelets\x20or\x20megakaryocyte\x20progenitors</strong>\x20and\x20is<strong>\x20not\x20used\x20</strong>to\x20treat\x20<strong>thrombocytopenia\x20secondary\x20to\x20anticancer\x20therapy.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20understand\x20the<strong>\x20hematopoietic\x20growth\x20factors\x20</strong>and\x20their\x20role\x20in\x20<strong>treatment\x20</strong>options\x20for\x20<strong>adverse\x20effects</strong>\x20of<strong>\x20anticancer\x20drugs</strong>.&nbsp;\x20and\x20to\x20recognize\x20that\x20<strong>oprelvekin</strong>\x20is\x20<strong>used\x20for\x20its\x20ability\x20to\x20stimulate\x20progenitor\x20megakaryocytes</strong>,\x20leading\x20to\x20an\x20<strong>increase\x20in\x20platelet\x20production.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Hematopoietic\x20Growth\x20Factors:</span></span></strong></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture3.jpg\x22\x20style=\x22height:543px;\x20width:1000px\x22\x20/></span></span></strong></p>','XdqXL','join','Q4998383','znyYo','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20is\x20orally\x20active\x20direct\x20Xa\x20inhibitor?\x20</span></span></span></p>','width','dataset','ylhiA','ZWoik','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Protamine</span></span></span></p>','1486137hzBErA','CJWda','cCOjT','AvwrB','display','nnnGz','bKfwS','uprqZ','currentQuestion','alalq','Q7148093','hRtna','Q1588862','markedForReview','TDdmb','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Erythropoietin</span></span></span></p>','get','replace','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Which\x20of\x20the\x20following\x20drugs\x20is\x20least\x20likely\x20to\x20precipitate\x20megaloblastic\x20anaemia\x20in\x20a\x20patient\x20with\x20subclinical\x20folate\x20deficiency?</span></span></span></p>','FElvS','PBpWy','lxysy','closest','ArrowLeft','wvTHK','gtdEw','none','beginner','ZmCnl','SxhXh','3000459CNDOgA','wDGHJ','VBDOf','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20statements\x20about\x20prasugrel\x20is\x20true\x20as\x20compared\x20to\x20clopidogrel?</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Based\x20on\x20the\x20mechanism\x20of\x20action\x20shown\x20in\x20figure,\x20Drug\x20X\x20is\x20likely\x20to\x20be:</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture10.jpg\x22\x20style=\x22height:232px;\x20width:300px\x22\x20/></span></span></span></p>','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','WlDed','incorrectAnswers','name','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20D.\x20Vorapaxar</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Vorapaxar</strong>\x20is\x20a<strong>\x20novel\x20antiplatelet\x20agent</strong>\x20that\x20works\x20by\x20<strong>antagonizing\x20protease-activated\x20receptor-1\x20(PAR-1)\x20on\x20platelets.</strong>\x20<strong>Thrombin\x20</strong>is\x20a\x20<strong>potent\x20platelet\x20activator\x20</strong>that\x20works\x20through<strong>\x20PAR-1</strong>\x20to\x20induce<strong>\x20platelet\x20aggregation.</strong>\x20<strong>Vorapaxar&#39;s\x20inhibition\x20of\x20PAR-1\x20prevents</strong>\x20<strong>thrombin</strong>\x20from<strong>\x20activating\x20platelets,</strong>\x20thus\x20<strong>reducing\x20thrombotic\x20events.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>:\x20Prasugrel</strong>\x20is\x20a<strong>\x20P2Y12\x20adenosine\x20diphosphate\x20receptor\x20inhibitor,</strong>\x20not\x20a\x20PAR-1\x20inhibitor.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>\x20Ticlopidine</strong>\x20is\x20also\x20a\x20<strong>P2Y12\x20adenosine\x20diphosphate\x20receptor\x20inhibitor,</strong>\x20used\x20less\x20commonly\x20due\x20to\x20side\x20effects.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Tirofiban</strong>\x20is\x20a<strong>\x20glycoprotein\x20IIb/IIIa\x20</strong>inhibitor\x20that<strong>\x20blocks\x20fibrinogen</strong>\x20<strong>binding\x20and\x20platelet\x20aggregation,</strong>\x20not\x20a\x20PAR-1\x20antagonist.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Vorapaxar</strong>\x20is\x20a<strong>\x20PAR-1\x20antagonist\x20</strong>that<strong>\x20inhibits\x20platelet\x20aggregation</strong>\x20by<strong>\x20preventing\x20thrombin</strong>\x20from\x20<strong>binding\x20to\x20PAR-1\x20on\x20platelets,</strong>\x20offering\x20a\x20therapeutic\x20approach\x20in\x20the<strong>\x20prevention\x20of\x20thrombotic\x20cardiovascular\x20events.\x20</strong></span></span></span></p>','FlcXT','index.html','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','findIndex','split','gkAEv','QAQju','wcsih','qavFv','explanation_audio_hin','pop','tcGZy','sYzbw','floor','HcGmW','reload','removeItem','timed_exam','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20D.\x20Idarucizumab</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Idarucizumab\x20</strong>is\x20a\x20<strong>monoclonal\x20antibody\x20</strong>fragment\x20that\x20is\x20used\x20as\x20a<strong>\x20specific\x20antidote\x20against\x20dabigatran</strong>.\x20It\x20<strong>binds\x20to\x20dabigatran</strong>\x20and\x20<strong>its\x20active\x20metabolites</strong>\x20with\x20<strong>high\x20affinity,\x20neutralizing</strong>\x20their<strong>\x20anticoagulant\x20effect\x20</strong>almost\x20<strong>immediately</strong>.\x20This\x20is\x20particularly\x20useful\x20in\x20<strong>emergency\x20situations\x20</strong>where<strong>\x20rapid\x20reversal\x20of\x20anticoagulation</strong>\x20is<strong>\x20necessary,</strong>\x20such\x20as\x20in\x20the\x20case\x20of\x20<strong>significant\x20bleeding\x20</strong>or\x20when\x20<strong>urgent\x20surgery</strong>\x20is\x20required.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.\x20Protamine\x20sulfate:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Protamine\x20sulfate\x20is\x20used\x20to\x20<strong>reverse\x20the\x20effects\x20of\x20heparin,</strong>\x20not\x20direct\x20thrombin\x20inhibitors\x20like\x20dabigatran.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Vitamin\x20K:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Vitamin\x20K\x20is\x20used\x20to\x20<strong>reverse\x20the\x20anticoagulant\x20effects\x20of\x20warfarin,</strong>\x20a<strong>\x20vitamin\x20K\x20antagonist</strong>.\x20It\x20is\x20<strong>not\x20</strong>effective\x20against\x20the<strong>\x20anticoagulant\x20effects\x20of\x20dabigatran.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Andexanet\x20&alpha;:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20Andexanet\x20alfa\x20is\x20an\x20<strong>antidote</strong>\x20for\x20the\x20<strong>reversal\x20of\x20the\x20anticoagulant\x20effects\x20of\x20Factor\x20Xa\x20inhibitors</strong>,\x20not\x20direct\x20thrombin\x20inhibitors.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20know\x20the\x20<strong>antidotes\x20of\x20different\x20anti-coagulants\x20</strong>particularly<strong>\x20idarucizumab\x20</strong>as\x20the\x20specific<strong>\x20reversal</strong>\x20<strong>agent\x20for\x20dabigatran</strong>,\x20a\x20<strong>direct\x20thrombin\x20inhibitor.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>ANTIDOTES\x20OF\x20ANTI-COAGULANTS</span></span></strong></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture13.jpg\x22\x20style=\x22height:272px;\x20width:1000px\x22\x20/></span></span></strong></p>','totalTime','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','bKkFE','Incorrect','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20is\x20given\x20to\x20treat\x20thrombocytopenia\x20secondary\x20to\x20anti-cancer\x20therapy\x20and\x20is\x20known\x20to\x20stimulate\x20progenitor\x20megakaryocytes?</span></span></span></p>','whVuH','key','rSYkC','PIEee','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ticagrelor</span></span></span></p>','piUdJ','attachMedia','XmOnd','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Alteplase</span></span></span></p>','ymWNS','padStart','<p><span\x20style=\x22font-size:12pt;\x22>Desired\x20rate\x20of\x20haemoglobin\x20improvement\x20is\x200.5\x20mg\x20per\x20day.</span></p>','scoreCircle','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20C.\x20Osteocalcin</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Warfarin\x20embryopathy\x20</strong>refers\x20to\x20a\x20constellation\x20of<strong>\x20developmental\x20abnormalities\x20</strong>in<strong>\x20fetuses\x20</strong>exposed\x20to<strong>\x20warfarin\x20during\x20pregnancy.</strong>\x20The\x20mechanism\x20underlying\x20<strong>warfarin\x20embryopathy</strong>\x20involves<strong>\x20interference\x20with\x20the\x20vitamin\x20K-dependent\x20carboxylation\x20of\x20osteocalcin,</strong>\x20a<strong>\x20bone\x20matrix\x20protein\x20</strong>crucial\x20for<strong>\x20proper\x20bone\x20development.</strong>\x20<strong>Osteocalcin</strong>,\x20when\x20<strong>carboxylated,</strong>\x20plays\x20a\x20role\x20in<strong>\x20bone</strong>\x20<strong>mineralization\x20and\x20matrix\x20formation</strong>.<strong>\x20Warfarin\x20inhibits</strong>\x20the\x20enzyme\x20<strong>vitamin\x20K\x20epoxide\x20reductase,</strong>\x20leading\x20to\x20<strong>decreased\x20levels\x20of</strong>\x20<strong>reduced\x20vitamin\x20K</strong>,\x20which\x20is\x20necessary\x20for\x20the\x20<strong>carboxylation\x20of\x20osteocalcin.\x20</strong>Consequently,\x20<strong>impaired\x20carboxylation</strong>\x20of<strong>\x20osteocalcin</strong>\x20results\x20in<strong>\x20skeletal\x20abnormalities\x20</strong>characteristic\x20of\x20<strong>warfarin\x20embryopathy,</strong>\x20such\x20as\x20<strong>nasal\x20hypoplasia,</strong>\x20stippled\x20epiphyses,\x20and\x20<strong>long\x20bone\x20deformities.</strong>\x20Thus,\x20the<strong>\x20action\x20of\x20warfarin</strong>\x20causing<strong>\x20embryopathy</strong>\x20is\x20primarily\x20mediated\x20through\x20its\x20<strong>interference\x20with\x20osteocalcin</strong>\x20<strong>carboxylation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.\x20Osteophysin:\x20</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>There\x20is<strong>\x20no\x20</strong>known\x20substance\x20called<strong>\x20osteophysin</strong>.\x20It\x20<strong>does\x20not\x20</strong>play\x20a\x20role\x20in<strong>\x20warfarin\x20embryopathy.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Osteotensin:</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Osteotensin</strong>\x20is\x20<strong>not\x20</strong>associated\x20<strong>with\x20warfarin\x20embryopathy.</strong>\x20It\x20is<strong>\x20not</strong>\x20a\x20<strong>recognized\x20factor</strong>\x20involved\x20in<strong>\x20bone</strong>\x20<strong>development</strong>\x20or\x20the\x20<strong>effects\x20of\x20warfarin\x20</strong>on<strong>\x20fetal\x20development.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Osteogenin:\x20</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Osteogenin,</strong>\x20also\x20known\x20as\x20<strong>bone\x20morphogenetic\x20protein-3\x20(BMP-3),</strong>\x20is\x20a<strong>\x20protein</strong>\x20involved\x20in\x20<strong>bone\x20formation</strong>\x20<strong>and\x20development</strong>.\x20However,\x20it\x20is<strong>\x20not</strong>\x20implicated\x20in\x20the\x20<strong>mechanism\x20of\x20warfarin\x20embryopathy.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span><br\x20/>\x0d\x0a&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Warfarin\x20embryopathy</strong>\x20results\x20from\x20the\x20<strong>inhibition\x20of\x20vitamin\x20K-dependent\x20carboxylation\x20of\x20osteocalcin,</strong>\x20a\x20<strong>bone\x20matrix\x20protein</strong>\x20essential\x20for\x20<strong>proper\x20bone\x20development\x20during\x20fetal\x20life.</strong></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20A.\x20Rivaroxaban</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Rivaroxaban</strong>\x20is\x20an<strong>\x20orally\x20active\x20direct\x20Factor\x20Xa\x20inhibitor.</strong>\x20It\x20works\x20by<strong>\x20selectively\x20inhibiting\x20Factor\x20Xa,</strong>\x20an\x20important\x20enzyme\x20in\x20the\x20<strong>coagulation\x20cascade\x20</strong>that<strong>\x20leads\x20to\x20the\x20formation\x20of\x20thrombin</strong>\x20and\x20<strong>development\x20of\x20a\x20clot.</strong>\x20By\x20<strong>inhibiting\x20Factor\x20Xa</strong>,<strong>\x20rivaroxaban</strong>\x20<strong>reduces</strong>\x20the\x20<strong>generation\x20of\x20thrombin\x20and\x20the\x20subsequent\x20formation\x20of\x20blood\x20clots</strong>.\x20It\x20is\x20used\x20for\x20the\x20<strong>prevention\x20and\x20treatment</strong>\x20of\x20various<strong>\x20thromboembolic\x20disorders</strong>,\x20including<strong>\x20deep\x20vein\x20thrombosis\x20(DVT),\x20pulmonary\x20embolism\x20(PE),\x20and</strong>\x20<strong>stroke\x20prevention</strong>\x20in\x20patients\x20with\x20<strong>non-valvular\x20atrial\x20fibrillation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Option\x20B.\x20Argatroban</strong>:\x20Argatroban\x20is\x20a<strong>\x20direct\x20thrombin\x20inhibitor,</strong>\x20not\x20a\x20Factor\x20Xa\x20inhibitor.\x20It\x20is\x20administered<strong>\x20intravenously\x20</strong>and\x20is\x20<strong>used\x20</strong>primarily\x20in\x20patients\x20with\x20<strong>heparin-induced\x20thrombocytopenia\x20(HIT).</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Option\x20C.\x20Dabigatran:</strong>\x20<strong>Dabigatran</strong>\x20is\x20also\x20a<strong>\x20direct\x20thrombin\x20inhibitor</strong>\x20but\x20<strong>differs\x20from\x20argatroban</strong>\x20in\x20that\x20it\x20is<strong>\x20orally\x20active</strong>.\x20It\x20is\x20<strong>not</strong>\x20a\x20<strong>Factor\x20Xa\x20inhibitor.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Option\x20D.\x20Bivalirudin:</strong>\x20<strong>Bivalirudin</strong>\x20is\x20<strong>another\x20direct\x20thrombin\x20inhibitor,</strong>\x20used\x20<strong>intravenously,\x20</strong>particularly\x20in\x20patients\x20undergoing\x20<strong>percutaneous\x20coronary\x20intervention\x20(PCI).\x20</strong>It\x20is<strong>\x20not\x20</strong>a<strong>\x20Factor\x20Xa\x20inhibitor</strong>\x20and\x20<strong>not\x20orally\x20active.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>The\x20educational\x20objective\x20is\x20to\x20recognize\x20the<strong>\x20classification\x20of\x20anticoagulant\x20drugs</strong>,\x20specifically\x20identifying\x20<strong>rivaroxaban\x20</strong>as\x20an\x20<strong>orally\x20active\x20direct\x20Factor\x20Xa\x20inhibitor.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Classification\x20of\x20Anticoagulants</span></span></strong></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture8.jpg\x22\x20style=\x22height:466px;\x20width:1000px\x22\x20/></span></span></strong></p>','GdYfH','iEsHE','pyeYQ','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20anticoagulant\x20and\x20its\x20FDA\x20approved\x20antidote\x20is\x20not\x20correctly\x20matched?</span></span></p>','xcdbA','ElwNl','cWfqD','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Recombinant\x20IL-11</span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>If\x20200-300\x20mg\x20elemental\x20iron\x20is\x20consumed,\x20about\x2050\x20mg\x20is\x20absorbed.</span></span></span></p>','weUMd','FZwXD','JlYHr','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Protamine\x20sulfate</span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Bivalirudin</span></span></span></p>','contains','stolT','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20A.\x20Protein\x20C\x20deficiency</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><br\x20/>\x0d\x0a<span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Warfarin-induced\x20skin\x20necrosis\x20(WISN)\x20</strong>is\x20a\x20<strong>rare\x20</strong>complication\x20of<strong>\x20warfarin\x20therapy.\x20</strong>It\x20is\x20characterized\x20by\x20the\x20development\x20of\x20painful\x20<strong>skin\x20lesions\x20</strong>in\x20<strong>patients\x20taking\x20warfarin</strong>.\x20This\x20condition\x20is\x20thought\x20to\x20be\x20<strong>caused\x20by\x20a\x20transient\x20hypercoagulable\x20state</strong>\x20resulting\x20from\x20a\x20<strong>rapid\x20reduction\x20in\x20protein\x20C\x20levels</strong>,\x20particularly\x20in\x20patients\x20with\x20<strong>underlying\x20protein\x20C\x20deficiency\x20</strong>or\x20other\x20risk\x20factors.\x20The\x20<strong>lesions</strong>\x20<strong>typically\x20occur\x20in\x20areas</strong>\x20with\x20a<strong>\x20high\x20concentration\x20of\x20adipose\x20tissue</strong>,\x20such\x20as\x20the<strong>\x20breasts,\x20thighs,\x20and\x20buttocks</strong>.\x20The\x20initial\x20symptoms\x20of<strong>\x20WISN</strong>\x20include\x20<strong>red\x20or\x20purple\x20spots\x20on\x20the\x20skin</strong>\x20that\x20can<strong>\x20quickly\x20progress\x20to\x20painful,\x20necrotic\x20lesions\x20</strong>with\x20a<strong>\x20central\x20blister\x20or\x20eschar.</strong>\x20The<strong>\x20diagnosis</strong>\x20is\x20usually\x20made\x20<strong>clinically\x20</strong>based<strong>\x20</strong>on\x20the\x20characteristic<strong>\x20appearance\x20of\x20the\x20lesions</strong>\x20and\x20the<strong>\x20patient&#39;s\x20history\x20of\x20warfarin\x20therapy</strong>.\x20The\x20<strong>treatment\x20of\x20WISN\x20</strong>involves\x20<strong>stopping\x20warfarin\x20</strong>and\x20<strong>initiating\x20alternative\x20anticoagulant\x20therapy</strong>,\x20such\x20as<strong>\x20heparin\x20or\x20low</strong>\x20<strong>molecular\x20weight\x20heparin</strong>.<strong>\x20</strong>In<strong>\x20severe\x20</strong>cases<strong>,\x20surgical\x20intervention</strong>\x20may\x20be\x20necessary\x20to\x20<strong>remove\x20the\x20necrotic\x20tissue</strong>\x20and\x20<strong>prevent</strong>\x20<strong>further\x20damage.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.\x20Sickle\x20cell\x20anaemia:\x20</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Sickle\x20cell\x20anaemia\x20is\x20<strong>not\x20</strong>associated\x20with<strong>\x20warfarin-induced\x20skin\x20necrosis</strong>.\x20<strong>Skin\x20manifestations</strong>\x20in\x20sickle\x20cell\x20disease\x20are\x20typically\x20related\x20to<strong>\x20vaso-occlusive\x20crises</strong>\x20and\x20may\x20include\x20<strong>painful\x20swelling\x20of\x20the\x20hands\x20and\x20feet\x20(dactylitis),\x20leg\x20ulcers,</strong>\x20and<strong>\x20skin\x20infections.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.\x20Factor\x20V\x20Leiden\x20deficiency:\x20</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Factor\x20V\x20Leiden\x20deficiency\x20is\x20<strong>not</strong>\x20associated\x20with\x20<strong>warfarin-induced\x20skin\x20necrosis.</strong>\x20<strong>Factor\x20V</strong>\x20<strong>Leiden\x20mutation\x20</strong>predisposes\x20individuals\x20to\x20<strong>thrombosis\x20</strong>by\x20making\x20them\x20<strong>resistant\x20to\x20the\x20anticoagulant\x20effects\x20</strong>of\x20<strong>activated\x20protein\x20C.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.\x20Antithrombin\x203\x20deficiency:\x20</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Antithrombin\x203\x20deficiency\x20is<strong>\x20not</strong>\x20associated\x20with\x20<strong>warfarin-induced\x20skin\x20necrosis.\x20Antithrombin</strong>\x20<strong>deficiency</strong>\x20<strong>increases\x20the\x20risk\x20of\x20thrombosis\x20</strong>due\x20to<strong>\x20impaired\x20inhibition\x20of\x20coagulation\x20factors</strong>,\x20but\x20it\x20<strong>does\x20not\x20</strong>predispose\x20individuals\x20to\x20<strong>warfarin-induced\x20skin\x20necrosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><br\x20/>\x0d\x0a<span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Warfarin-induced\x20skin\x20necrosis</strong>\x20is\x20primarily\x20seen\x20in\x20patients\x20with\x20<strong>underlying\x20protein\x20C\x20deficiency\x20</strong>or\x20other\x20risk\x20factors,\x20characterized\x20by\x20the<strong>\x20development\x20of\x20painful\x20necrotic\x20lesions,</strong>\x20especially\x20in\x20areas\x20with<strong>\x20high\x20adipose\x20tissue\x20concentration.</strong></span></span></span></p>','vvnIj','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Ans.\x20C.\x20These\x20can\x20produce\x20bleeding\x20like\x20hematuria\x20and\x20cerebral\x20hemorrhage</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Warfarin</strong>\x20group\x20of\x20drugs\x20act\x20by<strong>\x20inhibiting\x20the\x20activation\x20of\x20vitamin\x20K\x20dependent\x20clotting\x20factors.</strong>\x20These\x20factors\x20include\x20<strong>clotting\x20factors\x20II,\x20VII,\x20IX\x20and\x20X.\x20</strong>These\x20<strong>do\x20not\x20inhibit\x20synthesis</strong>\x20of\x20these\x20factors.\x20Therefore\x20option\x20a\x20is<strong>\x20incorrect.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20A.</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>These\x20interfere\x20with\x20the\x20synthesis\x20of\x20vitamin\x20K\x20dependent\x20clotting\x20factors.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>This\x20statement\x20is\x20<strong>incorrect.</strong>\x20Warfarin\x20and\x20other\x20drugs\x20in\x20its\x20<strong>class\x20inhibit\x20the\x20activation\x20of\x20vitamin\x20K-dependent\x20clotting</strong>\x20<strong>factors</strong>\x20rather\x20than\x20interfering\x20with\x20<strong>their\x20synthesis</strong>.\x20These\x20factors\x20include\x20<strong>II,\x20VII,\x20IX,\x20and\x20X.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20B.</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>These\x20can\x20produce\x20anticoagulant\x20effect\x20both\x20in\x20vivo\x20and\x20in\x20vitro.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>This\x20statement\x20is<strong>\x20incorrect</strong>.\x20Warfarin\x20and\x20similar\x20drugs\x20primarily\x20exert\x20their\x20<strong>anticoagulant\x20effects\x20in\x20vivo</strong>,\x20<strong>within\x20the</strong>\x20<strong>body</strong>.\x20They\x20<strong>do\x20not</strong>\x20directly\x20affect\x20<strong>clotting\x20factors\x20outside\x20of\x20the\x20body\x20(in\x20vitro).</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20C.</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>These\x20can\x20produce\x20bleeding\x20like\x20hematuria\x20and\x20cerebral\x20hemorrhage.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>This\x20statement\x20is\x20<strong>true</strong>.\x20Bleeding,\x20including\x20<strong>hematuria\x20(blood\x20in\x20the\x20urine)\x20</strong>and\x20<strong>cerebral\x20hemorrhage\x20(bleeding\x20in\x20the</strong>\x20<strong>brain)</strong>,\x20is\x20a\x20<strong>common\x20adverse\x20effect</strong>\x20of<strong>\x20warfarin\x20and\x20other\x20oral\x20anticoagulants</strong>.\x20This<strong>\x20risk\x20</strong>is\x20particularly\x20relevant\x20when\x20<strong>using</strong>\x20these\x20<strong>medications</strong>\x20due\x20to\x20their\x20<strong>anticoagulant\x20effects.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Option\x20D.</span></strong><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>\x20<strong>Their\x20action\x20starts\x20immediately,\x20so\x20are\x20useful\x20for\x20initiation\x20of\x20therapy\x20in\x20deep\x20vein\x20thrombosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>This\x20statement\x20is<strong>\x20incorrect</strong>.\x20The\x20action\x20of<strong>\x20warfarin\x20and\x20similar\x20drugs\x20is\x20delayed</strong>,\x20typically\x20taking\x20<strong>1-3\x20days\x20</strong>to\x20produce\x20a\x20<strong>therapeutic\x20effect.\x20</strong>Therefore,\x20they\x20are<strong>\x20not\x20useful\x20for\x20the\x20immediate\x20initiation\x20of\x20therapy</strong>\x20in\x20conditions\x20like\x20<strong>deep\x20vein</strong>\x20<strong>thrombosis</strong>,\x20where<strong>\x20more\x20rapid\x20anticoagulation\x20</strong>is\x20<strong>required.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><strong><u><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Warfarin\x20and\x20similar\x20oral\x20anticoagulants</strong>\x20primarily\x20exert\x20their\x20<strong>effects\x20in\x20vivo,</strong>\x20can\x20lead\x20to\x20<strong>bleeding\x20complications</strong>\x20such\x20as<strong>\x20hematuria</strong>\x20and\x20<strong>cerebral\x20hemorrhage</strong>,\x20and\x20have\x20a<strong>\x20delayed\x20onset\x20of\x20action,</strong>\x20making\x20them<strong>\x20unsuitable\x20for\x20immediate\x20therapy</strong>\x20initiation\x20in\x20conditions\x20like<strong>\x20deep\x20vein\x20thrombosis.</strong></span></span></span></span></span></p>','WVbjN','upjdT','data-option-index','fromCharCode','zsTnc','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20among\x20the\x20following\x20is\x20an\x20orally\x20active\x20anti\x20thrombin\x20drug?</span></span></span></p>','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','Hematology','Q8061906','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20statements\x20about\x20erythropoietin\x20is\x20false?</span></span></span></p>','fqtTj','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Factor\x20VIII\x20concentrate</span></span></span></p>','Q8130860','TceFf','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20statements\x20is\x20correct\x20about\x20heparin-induced\x20thrombocytopenia\x20(HIT)?</span></span></span></p>','qcfIJ','keydown','\x20>\x20','orhqG','isSupported','map','correct','QmyRK','disabled','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20of\x20the\x20following\x20anticoagulant\x20therapy\x20needs\x20regular\x20monitoring?\x20</span></span></span></p>','<p><span\x20style=\x22font-size:12pt\x22><span\x20style=\x22font-family:Aptos,sans-serif\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Heparin</span></span></span></p>','nQYxc','questions','DOMContentLoaded'];_0x3d4e=function(){return _0x46ef59;};return _0x3d4e();}function toggleSidebar(){const _0x34e636=_0x2f2fe6,_0x39c759={'zrJiR':_0x34e636(0x1bc),'UfrdW':'open'};document[_0x34e636(0x1a8)](_0x39c759['zrJiR'])['classList'][_0x34e636(0x2b9)](_0x39c759[_0x34e636(0x2fd)]);}document[_0x2f2fe6(0x3b5)](_0x2f2fe6(0x292),()=>{const _0x3c8369=_0x2f2fe6,_0x5271c4={'erUjY':_0x3c8369(0x190),'QRWoN':_0x3c8369(0x3cb),'OesTV':_0x3c8369(0x343),'FhUpX':_0x3c8369(0x250),'zRmsU':function(_0xb0b4d2,_0x195dee){return _0xb0b4d2<=_0x195dee;},'Gkhay':function(_0x5cb71c,_0x4dd86d){return _0x5cb71c(_0x4dd86d);},'pHLwZ':function(_0x25c0b8,_0x2d8a68){return _0x25c0b8===_0x2d8a68;},'QyYQO':_0x3c8369(0x24b),'aAcaE':function(_0x617d18){return _0x617d18();},'mByiU':function(_0x56483e,_0x5dc572){return _0x56483e===_0x5dc572;},'UCbMa':_0x3c8369(0x252),'TyTPk':_0x3c8369(0x367),'PBpWy':function(_0x5b2275){return _0x5b2275();},'CWkYQ':function(_0x5cb07a,_0x483874){return _0x5cb07a===_0x483874;},'bLxPd':function(_0x245e81){return _0x245e81();},'nwcTy':_0x3c8369(0x1f3),'WSsdT':function(_0x2c8a5a,_0x31918e){return _0x2c8a5a!==_0x31918e;},'mqYEF':_0x3c8369(0x422),'EOoaR':_0x3c8369(0x35f),'pGbHw':_0x3c8369(0x1a2)};if(resume){if(_0x5271c4[_0x3c8369(0x1fc)](loadProgress)){if(_0x5271c4[_0x3c8369(0x2f7)](_0x5271c4[_0x3c8369(0x390)],_0x3c8369(0x252)))document[_0x3c8369(0x1a8)](_0x5271c4[_0x3c8369(0x473)])[_0x3c8369(0x1c9)][_0x3c8369(0x216)]=_0x3c8369(0x22c),_0x5271c4[_0x3c8369(0x226)](initializeQuiz);else{_0x2c018e[_0x3c8369(0x1a8)](_0x5271c4[_0x3c8369(0x3db)])['innerHTML']=_0x5271c4[_0x3c8369(0x344)];return;}}else _0x5271c4[_0x3c8369(0x1ee)](_0x3c8369(0x377),_0x3c8369(0x2da))?_0x285dbd():(_0x5271c4[_0x3c8369(0x3e3)](clearProgress),document[_0x3c8369(0x1a8)](_0x5271c4['TyTPk'])['style']['display']=_0x3c8369(0x35f));}else!window['location'][_0x3c8369(0x3e9)][_0x3c8369(0x18c)](_0x5271c4['nwcTy'])?_0x5271c4['WSsdT'](_0x5271c4[_0x3c8369(0x35d)],'McvxY')?(_0x5271c4[_0x3c8369(0x3e3)](clearProgress),document[_0x3c8369(0x1a8)](_0x3c8369(0x367))['style'][_0x3c8369(0x216)]=_0x5271c4[_0x3c8369(0x391)]):(_0x3fc34a=_0x5271c4['OesTV'],_0x145d8d=_0x5271c4[_0x3c8369(0x311)]):_0x5271c4['WSsdT'](_0x5271c4[_0x3c8369(0x294)],_0x3c8369(0x21b))?_0x5271c4[_0x3c8369(0x226)](initializeQuiz):(_0x3121e1--,_0x3f6daf(),_0x5271c4['zRmsU'](_0x4a5aa8,0x0)&&(_0x5271c4[_0x3c8369(0x17b)](_0x258d0c,_0x25f1a2),_0x5271c4[_0x3c8369(0x3b3)](_0x3a290d,_0x5271c4['QyYQO'])?_0x5271c4[_0x3c8369(0x1fc)](_0x1721f8):_0x77e132()));}),document[_0x2f2fe6(0x3b5)](_0x2f2fe6(0x286),function(_0x189f3d){const _0x29b785=_0x2f2fe6,_0x318f67={'OSahn':'correctCount','iuHUT':_0x29b785(0x36a),'INZlz':_0x29b785(0x2c8),'gtdEw':function(_0x326799,_0x7371d7){return _0x326799>_0x7371d7;},'eLfuK':function(_0x4f3466,_0xcc1001){return _0x4f3466*_0xcc1001;},'IgbcL':function(_0x3061e0,_0x538b52){return _0x3061e0/_0x538b52;},'XyVkb':function(_0x388877,_0x4b8ed6){return _0x388877+_0x4b8ed6;},'ERRTy':function(_0x2c1a65,_0x12822e){return _0x2c1a65/_0x12822e;},'VGucC':function(_0x580719,_0x41c385){return _0x580719/_0x41c385;},'xYTTP':function(_0x2341b3,_0x50ba16){return _0x2341b3%_0x50ba16;},'xaCAK':'timeSpent','abcWR':function(_0x3872fa,_0x211600){return _0x3872fa+_0x211600;},'DCUFg':function(_0x406410,_0x536f35){return _0x406410+_0x536f35;},'aPwcG':function(_0x1043d7,_0x50271c){return _0x1043d7+_0x50271c;},'jjkjN':_0x29b785(0x2e8),'JlRGn':_0x29b785(0x3f4),'lTKVA':function(_0x52b3bc,_0x4a8b9b){return _0x52b3bc===_0x4a8b9b;},'ddhtv':_0x29b785(0x28b),'Qjbyg':_0x29b785(0x343),'KcQjA':function(_0x208ba9,_0x4d9e1b){return _0x208ba9!==_0x4d9e1b;},'JqCyv':function(_0x4b6286,_0x219872){return _0x4b6286===_0x219872;},'QfiNn':_0x29b785(0x2b4),'EPgjC':_0x29b785(0x2c6),'bKkFE':function(_0x224207,_0x48a85c){return _0x224207>=_0x48a85c;},'wvoSN':function(_0x57ccf4,_0xcd81ec){return _0x57ccf4!==_0xcd81ec;},'jbYMK':_0x29b785(0x2a5),'KwZeV':function(_0x11c22e,_0x5a84d3){return _0x11c22e-_0x5a84d3;},'PAYzP':function(_0xc63f31,_0x562437){return _0xc63f31(_0x562437);},'eyDvD':function(_0x115007){return _0x115007();},'WpTsM':'study','pAkMr':_0x29b785(0x412),'XmOnd':_0x29b785(0x307),'TTmdG':'timed_exam','TyEsq':function(_0x9c030,_0x49165d){return _0x9c030===_0x49165d;},'ZWoik':function(_0x68be5b,_0x5efdec){return _0x68be5b===_0x5efdec;},'cWfqD':function(_0x26106a,_0x525647){return _0x26106a===_0x525647;},'Bacuv':_0x29b785(0x35c)};if(_0x318f67[_0x29b785(0x2ac)](document[_0x29b785(0x1a8)]('modeModal')[_0x29b785(0x1c9)]['display'],_0x29b785(0x22c)))return;if(_0x318f67[_0x29b785(0x3b4)](document[_0x29b785(0x1a8)](_0x318f67[_0x29b785(0x2f5)])[_0x29b785(0x33a)][_0x29b785(0x271)](_0x318f67[_0x29b785(0x477)]),![]))return;if(_0x318f67[_0x29b785(0x24f)](_0x189f3d[_0x29b785(0x253)],'1')&&_0x189f3d['key']<='4'){if(_0x318f67['wvoSN'](_0x318f67[_0x29b785(0x3f7)],_0x318f67[_0x29b785(0x3f7)])){_0x1e9df3[_0x29b785(0x1a8)](_0x318f67['OSahn'])[_0x29b785(0x18d)]=_0x44d9c1[_0x29b785(0x201)],_0x3c05c8[_0x29b785(0x1a8)](_0x318f67[_0x29b785(0x458)])[_0x29b785(0x18d)]=_0x5383f2[_0x29b785(0x237)],_0x217fba[_0x29b785(0x1a8)](_0x318f67[_0x29b785(0x1e3)])[_0x29b785(0x18d)]=_0x3e7b6b[_0x29b785(0x2c8)];const _0x139abd=_0x318f67[_0x29b785(0x22b)](_0x5c1ffc[_0x29b785(0x2c8)],0x0)?_0x4da601[_0x29b785(0x182)](_0x318f67[_0x29b785(0x1a6)](_0x318f67['IgbcL'](_0x929736['correctAnswers'],_0x4a93ae['totalAttempted']),0x64)):0x0;_0x573e15[_0x29b785(0x1a8)]('accuracy')[_0x29b785(0x18d)]=_0x318f67['XyVkb'](_0x139abd,'%'),_0x3a6d29[_0x29b785(0x24d)]=_0xa3627f[_0x29b785(0x42f)]((_0x227033,_0x57233e)=>_0x227033+_0x57233e['timeSpent'],0x0);const _0x58e6fe=_0x21a49b['floor'](_0x318f67['ERRTy'](_0x3fbfc3['totalTime'],0x3e8)),_0x49aad0=_0x418933[_0x29b785(0x247)](_0x318f67['VGucC'](_0x58e6fe,0x3c)),_0x5204b2=_0x318f67[_0x29b785(0x2de)](_0x58e6fe,0x3c);_0x548595[_0x29b785(0x1a8)](_0x318f67[_0x29b785(0x2cf)])[_0x29b785(0x18d)]=_0x318f67[_0x29b785(0x3d7)](_0x318f67[_0x29b785(0x3d3)](_0x49aad0,':'),_0x5204b2[_0x29b785(0x314)]()[_0x29b785(0x25c)](0x2,'0'));}else{const _0x137eb2=_0x318f67[_0x29b785(0x2ba)](_0x318f67['PAYzP'](parseInt,_0x189f3d[_0x29b785(0x253)]),0x1),_0x4bac37=document[_0x29b785(0x1a9)](_0x29b785(0x336));if(_0x137eb2<_0x4bac37[_0x29b785(0x2a8)])selectOption(_0x137eb2);}}else{if(_0x189f3d[_0x29b785(0x253)]===_0x29b785(0x229))_0x318f67[_0x29b785(0x40a)](previousQuestion);else{if(_0x189f3d[_0x29b785(0x253)]===_0x29b785(0x29f)||_0x318f67[_0x29b785(0x3b4)](_0x189f3d[_0x29b785(0x253)],'\x20'))_0x189f3d['preventDefault'](),nextQuestion();else{if(_0x318f67[_0x29b785(0x3eb)](_0x189f3d[_0x29b785(0x253)][_0x29b785(0x39a)](),'b')&&(_0x318f67[_0x29b785(0x3eb)](currentMode,_0x318f67[_0x29b785(0x435)])||currentMode===_0x318f67[_0x29b785(0x2e5)]))_0x318f67['eyDvD'](toggleBookmark);else{if(_0x189f3d[_0x29b785(0x253)][_0x29b785(0x39a)]()==='m'&&(_0x318f67[_0x29b785(0x3eb)](currentMode,_0x318f67[_0x29b785(0x259)])||_0x318f67[_0x29b785(0x3eb)](currentMode,_0x318f67[_0x29b785(0x31d)])))'GypjX'===_0x29b785(0x225)?(_0x3eefa0=_0x591ed7[_0x29b785(0x291)],_0x4f0f36=_0x2a90eb[_0x29b785(0x238)],_0x333e07=_0x169c12[_0x29b785(0x346)],_0x929cce[_0x29b785(0x2e1)]=_0x318f67[_0x29b785(0x2e0)](_0x2d8a9c,_0x318f67['jjkjN']),_0x5c3647[_0x29b785(0x1a8)](_0x318f67[_0x29b785(0x2b2)])['textContent']=_0x1362a8[_0x29b785(0x2a8)],_0x46a23e[_0x29b785(0x1a8)](_0x29b785(0x33b))['textContent']=_0x585937[_0x29b785(0x209)](_0x29b785(0x287))):_0x318f67['eyDvD'](toggleMarkForReview);else _0x318f67['TyEsq'](_0x189f3d[_0x29b785(0x253)][_0x29b785(0x39a)](),'s')&&(currentMode===_0x318f67[_0x29b785(0x259)]||_0x318f67[_0x29b785(0x210)](currentMode,'timed_exam'))&&(_0x318f67[_0x29b785(0x269)](_0x318f67[_0x29b785(0x2d8)],_0x318f67[_0x29b785(0x2d8)])?submitQuiz():_0x318f67[_0x29b785(0x3eb)](_0x3efab0['choices'][_0x5a94e8[_0x29b785(0x193)]]['id'],_0x478738['correct_choice_id'])?(_0xed16d6++,_0x47d176['status']=_0x318f67[_0x29b785(0x178)]):(_0x51fbde++,_0x367151[_0x29b785(0x29e)]=_0x318f67[_0x29b785(0x404)]));}}}}});</script>

</body></html>